References - Infectious disease
^ Levy SB (ed) (1994) Drug Resistance: The New Apocalypse (special issue) Trends Microbiol 2: 341–425
^ International Health Regulations Review - background
^ WHO | International Health Regulations
^ WHO | Frequently asked questions about the International Health Regulations
^ Introduction to the National Notifiable Diseases Surveillance System
^ HPA | NOIDS | General Information
^ HPA | NOIDS | Day Care and Child Minding (National Standards)
^ Defra, UK - Disease surveillance and control - Notifiable diseases
^ NNDSS History
^ a b c Australia: Australian national notifiable diseases list and case definitions
^ a b c Malaysia: Primary Care Doctors Organization Malaysia
^ a b c UK: List of Notifiable Diseases
^ a b c USA: Nationally Notifiable Infectious Diseases from CDC (public domain resource)
· ^ a b c d e f g h i j k Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; & Mitchell, Richard N. (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier. pp. 810-811 ISBN 978-1-4160-2973-1
· ^ King MD, Randall W.; David Johnson, MD, FACEP (2006-07-13). "Osteomyelitis". eMedicine. WebMD. http://www.emedicine.com/emerg/topic349.htm. Retrieved on 2007-11-11.
· ^ Baer M.D., William S. (01 Jul 1931). "The Treatment of Chronic Osteomyelitis with the Maggot (Larva of the Blow Fly)". Journal of Bone and Joint Surgery 13 (3): 438–475. http://www.ejbjs.org/cgi/content/abstract/13/3/438. Retrieved on 2007-11-12.
· ^ McKeever, Duncan Clark (June 2008). "The classic: maggots in treatment of osteomyelitis: a simple inexpensive method. 1933". Clin. Orthop. Relat. Res. 466 (6): 1329–35. doi:10.1007/s11999-008-0240-5. PMID 18404291.
· ^ Mader JT, Adams KR, Sutton TE (1987). "Infectious diseases: pathophysiology and mechanisms of hyperbaric oxygen". J. Hyperbaric Med 2 (3): 133–140. http://archive.rubicon-foundation.org/4339. Retrieved on 2008-05-16.
· ^ Kawashima M, Tamura H, Nagayoshi I, Takao K, Yoshida K, Yamaguchi T (2004). "Hyperbaric oxygen therapy in orthopedic conditions". Undersea Hyperb Med 31 (1): 155–62. PMID 15233171. http://archive.rubicon-foundation.org/4000. Retrieved on 2008-05-16.
· ^ Putland M.D, Michael S., Hyperbaric Medicine, Capital Regional Medical Center, Tallahassee, Florida, personal inquiry June 2008.
· ^ Haggerty, Maureen (2002). "Streptococcal Infections". Gale Encyclopedia of Medicine. The Gale Group. http://www.healthline.com/galecontent/streptococcal-infections-1. Retrieved on 2008-03-14.
· ^ a b Carek, P.J.; L.M. Dickerson; J.L. Sack (2001-06-15). "Diagnosis and management of osteomyelitis.". Am Fam Physician 63 (12): 2413–20.
· ^ Weinstein, Lenny; Knowlton, Christin A.; Smith, Miriam A. (2007-12-16). "Cervical osteomyelitis caused by Burkholderia cepacia after rhinoplasty". J Infect Developing Countries 2 (1): 76–77. ISSN 1972-2680. http://www.jidc.org/issn1972-2680/current-issue/59-vol-2-no-1-february-2008/152-cervical-osteomyelitis-caused-by-burkholderia-cepacia-after-rhinoplasty.
http://en.wikipedia.org/wiki/Immunization
^ Rosen FS, Cooper MD, Wedgwood RJ (1995). "The primary immunodeficiencies". N. Engl. J. Med. 333 (7): 431–40. doi:10.1056/NEJM199508173330707. PMID 7616993.
http://en.wikipedia.org/wiki/Incubation_period
http://en.wikipedia.org/wiki/Discitis
· ^ septic arthritis at Dorland's Medical Dictionary
· ^ Cuéllar ML, Silveira LH, Espinoza LR (May 1992). "Fungal arthritis". Ann. Rheum. Dis. 51 (5): 690–7. doi:10.1136/ard.51.5.690. PMID 1616344. PMC: 1005712. http://ard.bmj.com/cgi/pmidlookup?view=long&pmid=1616344.
· ^ infectious arthritis at Dorland's Medical Dictionary
· ^ Ytterberg SR (July 1999). "Viral arthritis". Curr Opin Rheumatol 11 (4): 275–80. doi:10.1097/00002281-199907000-00009. PMID 10411381. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1040-8711&volume=11&issue=4&spage=275.
· ^ a b Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease. St. Louis, Mo: Elsevier Saunders. pp. 1310. ISBN 0-7216-0187-1.
· ^ a b O'Callaghan C, Axford JS (2004). Medicine (2nd ed.). Oxford: Blackwell Science. ISBN 0-632-05162-0.
· ^ a b Kaandorp CJ, Dinant HJ, van de Laar MA, Moens HJ, Prins AP, Dijkmans BA (August 1997). "Incidence and sources of native and prosthetic joint infection: a community based prospective survey". Ann Rheum Dis. 56 (8): 470–5. doi:10.1136/ard.56.8.470. PMID 9306869.
Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M (April 1999). "Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991". Ann Rheum Dis. 58 (4): 214–9. doi:10.1136/ard.58.4.214. PMID 10364899.
· ^ Bowerman SG, GreenNE, MencioGA (August 1997). "Decline of bone and joint infections attributable to haemophilus influenzae type b". Clin Orthop Relat Res. (341): 128–33. PMID 9269165. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0009-921X&volume=341&spage=128.
Peltola H, Kallio MJ, Unkila-Kallio L (May 1998). "Reduced incidence of septic arthritis in children by Haemophilus influenzae type-b vaccination. Implications for treatment". J Bone Joint Surg Br. 80 (3): 471–3. doi:10.1302/0301-620X.80B3.8296. PMID 9619939. http://www.jbjs.org.uk/cgi/pmidlookup?view=long&pmid=9619939.
· ^ Topics in Infectious Diseases Newsletter, August 2001, Pseudomonas aeruginosa.
· ^ "BestBets: Distinguishing between septic arthritis of the hip and transient synovitis in children". http://www.bestbets.org/bets/bet.php?id=1072.
· ^ Geirsson AJ, Statkevicius S, Víkingsson A (May 2008). "Septic arthritis in Iceland 1990-2002: increasing incidence due to iatrogenic infections". Ann Rheum Dis. 67 (5): 638–43. doi:10.1136/ard.2007.077131. PMID 17901088.
· ^ "BestBets: Is a negative gram stain in suspected septic arthritis sufficient to rule out septic arthritis". http://www.bestbets.org/bets/bet.php?id=1636.
· ^ a b c d e f g h i Mitchell RS, Kumar V, Robbins SL, Abbas AK, Fausto N (2007). Robbins Basic Pathology (8th ed. ed.). Saunders/Elsevier. pp. 406–8. ISBN 1-4160-2973-7.
· ^ Morris AM (January 2006). "How best to deal with endocarditis". Curr Infect Dis Rep 8 (1): 14–22. doi:10.1007/s11908-006-0030-8. PMID 16448596.
· ^ a b Kasper DL, Brunwald E, Fauci AS, Hauser S, Longo DL, Jameson JL (May 2005). Harrison's Principles of Internal Medicine. McGraw-Hill. pp. 731–40. ISBN 0-07-139140-1. OCLC 54501403 56437106 56801936 56967424.
· ^ Wilson W, Taubert KA, Gewitz M, et al (October 2007). "Prevention of infective endocarditis: guidelines from the American Heart Association". Circulation 116 (15): 1736–54. doi:10.1161/CIRCULATIONAHA.106.183095. PMID 17446442. http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=17446442.
· ^ Durack D, Lukes A, Bright D (1994). "New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service". Am J Med 96 (3): 200–9. doi:10.1016/0002-9343(94)90143-0. PMID 8154507.
· ^ a b Weisse A, Heller D, Schimenti R, Montgomery R, Kapila R (1993). "The febrile parenteral drug user: a prospective study in 121 patients". Am J Med 94 (3): 274–80. doi:10.1016/0002-9343(93)90059-X. PMID 8452151.
· ^ a b Samet J, Shevitz A, Fowle J, Singer D (1990). "Hospitalization decision in febrile intravenous drug users". Am J Med 89 (1): 53–7. doi:10.1016/0002-9343(90)90098-X. PMID 2368794.
· ^ a b c Marantz P, Linzer M, Feiner C, Feinstein S, Kozin A, Friedland G (1987). "Inability to predict diagnosis in febrile intravenous drug abusers". Ann Intern Med 106 (6): 823–8. PMID 3579068.
· ^ a b Leibovici L, Cohen O, Wysenbeek A (1990). "Occult bacterial infection in adults with unexplained fever. Validation of a diagnostic index". Arch Intern Med 150 (6): 1270–2. doi:10.1001/archinte.150.6.1270. PMID 2353860.
· ^ a b Mellors J, Horwitz R, Harvey M, Horwitz S (1987). "A simple index to identify occult bacterial infection in adults with acute unexplained fever". Arch Intern Med 147 (4): 666–71. doi:10.1001/archinte.147.4.666. PMID 3827454.
· ^ Kaech C, Elzi L, Sendi P, et al (2006). "Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre". Clin Microbiol Infect 12 (4): 345–52. doi:10.1111/j.1469-0691.2005.01359.x. PMID 16524411.
· ^ Shively B, Gurule F, Roldan C, Leggett J, Schiller N (1991). "Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis". J Am Coll Cardiol 18 (2): 391–7. PMID 1856406.
· ^ Erbel R, Rohmann S, Drexler M, et al (1988). "Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study". Eur Heart J 9 (1): 43–53. PMID 3345769.
· ^ Topics in Infectious Diseases Newsletter, August 2001, Pseudomonas aeruginosa.
· ^ Chew SSB, Lubowski DZ (2001). "Clostridium septicum and malignancy". http://www.blackwell-synergy.com/doi/abs/10.1046/j.1445-1433.2001.02231.x?cookieSet=1&journalCode=ans.
· ^ Mirabelle Kelly, MD (June 7, 2005). "HACEK Group Infections". http://www.emedicine.com/med/topic935.htm.
· ^ Silver, Malcolm D.; Bloom, Sherman; Lie, J. T. (1997). Diagnostic criteria for cardiovascular pathology: acquired diseases. Philadelphia: Lippincott-Raven. pp. 114. ISBN 0-397-51630-4.
· ^ Cosgrove SE, ViglianiGA, Campion M, et al. (2009). "Initial low‐dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic". Clin Infect Dis 48 (6): 713–721. doi:10.1086/597031.
· ^ a b c Hunter JG, Boon NA, Davidson S, Colledge NR, Walker B (2006). Davidson's Principles & Practice of Medicine. Elsevier/Churchill Livingstone. pp. 629–33. ISBN 0-443-10057-8. OCLC 65765046.
· ^ a b c d e f Feldman AM, McNamara D (November 2000). "Myocarditis". N. Engl. J. Med. 343 (19): 1388–98. doi:10.1056/NEJM200011093431908. PMID 11070105.
· ^ Eckart RE, Scoville SL, Campbell CL, et al (December 2004). "Sudden death in young adults: a 25-year review of autopsies in military recruits". Ann. Intern. Med. 141 (11): 829–34. PMID 15583223. http://www.annals.org/cgi/content/full/141/11/829.
· ^ Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; & Mitchell, Richard N. (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier. pp. 414-416 ISBN 978-1-4160-2973-1
· ^ Skouri HN, Dec GW, Friedrich MG, Cooper LT (2006). "Noninvasive imaging in myocarditis". J. Am. Coll. Cardiol. 48 (10): 2085–93. doi:10.1016/j.jacc.2006.08.017. PMID 17112998.
· ^ Cooper LT (April 2009). "Myocarditis". N. Engl. J. Med. 360 (15): 1526-35. http://content.nejm.org/cgi/content/full/360/15/1526.
^ Merck Manual, Online edition, Kawasaki Disease]
^ Kawasaki T (1967). "[Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]" (in Japanese). Arerugi 16 (3): 178–222. PMID 6062087.
^ a b "Kawasaki Disease - Signs and Symptoms". http://www.ucsfhealth.org/childrens/medical_services/heart_center/acquired/conditions/kawasaki/signs.html.
^ a b c d e "Who Kawasaki Disease Affects". Children's Hospital Boston. http://www.childrenshospital.org/clinicalservices/Site468/mainpageS468P5.html. Retrieved on 2009-01-04.
^ Rowley AH, Baker SC, Orenstein JM, Shulman ST (May 2008). "Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight". Nat. Rev. Microbiol. 6 (5): 394–401. doi:10.1038/nrmicro1853. PMID 18364728.
^ "Kawasaki Disease". American Heart Association. http://www.americanheart.org/presenter.jhtml?identifier=4634. Retrieved on 3 January 2009.
^ "Kawasaki Disease: Causes". Mayo Clinic. http://www.mayoclinic.com/health/kawasaki-disease/DS00576/DSECTION=causes. Retrieved on 3 January 2009.
^ Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H (2008). "Monthly observation of the number of patients with Kawasaki disease and its incidence rates in Japan: chronological and geographical observation from nationwide surveys" ([dead link] – Scholar search). J Epidemiol 18 (6): 273–9. doi:10.2188/jea.JE2008030. PMID 19075496. http://joi.jlc.jst.go.jp/JST.JSTAGE/jea/JE2008030?from=PubMed.
^ Freeman AF, Shulman ST (June 2001). "Recent developments in Kawasaki disease". Curr Opin Infect Dis 14 (3): 357–61. PMID 11964855.
^ Onouchi Y, Gunji T, Burns JC, et al (January 2008). "ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms". Nat. Genet. 40 (1): 35–42. doi:10.1038/ng.2007.59. PMID 18084290.
^ Keren G, Danon YL, Orgad S, Kalt R, Gazit E (August 1982). "HLA Bw51 is increased in mucocutaneous lymph node syndrome in Israeli patients". Tissue Antigens 20 (2): 144–6. PMID 6958087.
^ Park AH, Batchra N, Rowley A, Hotaling A (May 1997). "Patterns of Kawasaki syndrome presentation". Int. J. Pediatr. Otorhinolaryngol. 40 (1): 41–50. doi:10.1016/S0165-5876(97)01494-8. PMID 9184977. http://linkinghub.elsevier.com/retrieve/pii/S0165587697014948.
^ "Kawasaki Disease - June 1999 - American Academy of Family Physicians". http://www.aafp.org/afp/990600ap/3093.html.
^ Oates-Whitehead RM, Baumer JH, Haines L, et al (2003). "Intravenous immunoglobulin for the treatment of Kawasaki disease in children". Cochrane Database Syst Rev (4): CD004000. doi:10.1002/14651858.CD004000. PMID 14584002.
^ Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM (December 2004). "Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited". Pediatrics 114 (6): e689–93. doi:10.1542/peds.2004-1037. PMID 15545617. http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=15545617.
^ Sundel RP, Baker AL, Fulton DR, Newburger JW (June 2003). "Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial". J. Pediatr. 142 (6): 611–6. doi:10.1067/mpd.2003.191. PMID 12838187. http://linkinghub.elsevier.com/retrieve/pii/S0022347603001173.
^ Newburger JW et al, Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease, N Engl J Med. 2007 Feb 25;356(7):663-75
· ^ a b c d e "DPDx – Trypanosomiasis, American. Fact Sheet". Centers for Disease Control (CDC). http://www.dpd.cdc.gov/dpdx/HTML/TrypanosomiasisAmerican.htm. Retrieved on 2008-09-11.
· ^ a b Chagas C (1909). "Neue Trypanosomen". Vorläufige Mitteilung Arch Schiff Tropenhyg 13: 120–2.
· ^ a b Redhead SA, CushionMT, Frenkel JK, Stringer JR (2006). "Pneumocystis and Trypanosoma cruzi: nomenclature and typifications". J Eukaryot Microbiol 53 (1): 2–11. doi:10.1111/j.1550-7408.2005.00072.x. PMID 16441572.
· ^ Coutinho M (June 1999). "Review of Historical Aspects of American Trypanosomiasis (Chagas' Disease) by Matthias Perleth" (fee required). Isis 90 (2): 397. doi:10.1086/384393. http://links.jstor.org/sici?sici=0021-1753%28199906%2990%3A2%3C397%3AHAOAT%28%3E2.0.CO%3B2-H.
· ^ Hulsebos LH, Choromanski L, Kuhn RE (1989). "The effect of interleukin-2 on parasitemia and myocarditis in experimental Chagas' disease". J Protozool 36 (3): 293–8. PMID 2499678.
· ^ Chagas C (1909). "Nova tripanozomiase humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem [New human trypanosomiasis. Studies about the morphology and life-cycle of Schizotripanum cruzi, etiological agent of a new morbid entity of man]". Mem Inst Oswaldo Cruz 1 (2): 159–218.
· ^ http://www.drwebsa.com.ar/alcha/hist4.htm Mal de Chagas-Mazza
· ^ Adler D (1989). "Darwin's Illness". Isr J Med Sci 25 (4): 218–21. PMID 2496051.
· ^ Santos Ferreira C, Amato Neto V, Gakiya E, Bezerra RC, Alarcón RS (2003). "Microwave treatment of human milk to prevent transmission of Chagas disease". Rev Inst Med Trop São Paulo 45 (1): 41–2. PMID 12751321.
· ^ Hudson L, Turner MJ (November 1984). "Immunological consequences of infection and vaccination in South American trypanosomiasis [and discussion]". Philos Trans R Soc Lond, B, Biol Sci 307 (1131): 51–61. doi:10.1098/rstb.1984.0108. PMID 6151688. http://www.jstor.org/pss/2990154. Retrieved February 22, 2007 through JSTOR.
· ^ "Chagas’ disease (American trypanosomiasis) in southern Brazil" (PDF). CDR Weekly (United Kingdom Health Protection Agency) 15 (13). April 2005. http://www.hpa.org.uk/CDR/archives/2005/cdr1305.pdf. Retrieved on 2007-11-26.
· ^ Shikanai-Yasuda MA, Marcondes CB, Guedes LA, et al (1991). "Possible oral transmission of acute Chagas' disease in Brazil". Rev Inst Med Trop São Paulo 33 (5): 351–7. PMID 1844961.
· ^ da Silva Valente SA, de Costa Valente V, Neto HF (1999). "Considerations on the epidemiology and transmission of Chagas disease in the Brazilian Amazon". Mem Inst Oswaldo Cruz 94 Suppl 1: 395–8. PMID 10677763. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-0276(99)09400077&lng=en&nrm=iso&tlng=en.
· ^ Reis, T (August 18, 2007). "Açaí faz 1 vítima de Chagas a cada 4 dias na Amazônia" (in Portuguese). Folha de São Paulo. http://www1.folha.uol.com.br/folha/cotidiano/ult95u321060.shtml. Retrieved on 2008-08-29.
· ^ a b c d e f Carlier Y (27 February 2003). Chagas Disease (American Trypanosomiasis). eMedicine. Retrieved on 11 September 2008.
· ^ Guimarães FN, da Silva NN, Clausell DT, de Mello AL, Rapone T, Snell T, Rodrigues N (1968). "Um surto epidêmico de doença de Chagas de provável transmissão digestiva, ocorrido em Teutonia (Estrêla - Rio Grande Do Sul)". Hospital (Rio J) 73 (6): 1767–804. http://en.calameo.com/read/00000948401a1fdb85f76.
· ^ Brumpt E (1914). "Le xénodiagnostic. Application au diagnostic de quelques infections parasitaires et en particulier à la trypanosomose de Chagas" (PDF). Bull Soc Pathol Exot 7 (10): 706–10. http://www.pathexo.fr/documents/articles-bull/1914/1914n10/T7-10-706.pdf.
· ^ Garcia S, Ramos CO, Senra JF, et al (April 2005). "Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations". Antimicrob Agents Chemother 49 (4): 1521–8. doi:10.1128/AAC.49.4.1521-1528.2005. PMID 15793134. PMC: 1068607. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=15793134.
· ^ Buckner FS, Wilson AJ, White TC, Van Voorhis WC (December 1998). "Induction of resistance to azole drugs in Trypanosoma cruzi". Antimicrob Agents Chemother 42 (12): 3245–50. PMID 9835521. PMC: 106029. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=9835521.
· ^ Lauria-Pires L, BragaMS, Vexenat AC, et al (2000). "Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives". Am J Trop Med Hyg 63 (3–4): 111–8. PMID 11388500. http://www.ajtmh.org/cgi/pmidlookup?view=long&pmid=11388500.
· ^ Bocchi EA, Bellotti G, Mocelin AO, et al (June 1996). "Heart transplantation for chronic Chagas' heart disease". Ann Thorac Surg 61 (6): 1727–33. doi:10.1016/0003-4975(96)00141-5. PMID 8651775. http://linkinghub.elsevier.com/retrieve/pii/0003-4975(96)00141-5.
· ^ Vilas-Boas F, Feitosa GS, SoaresMB, et al (August 2006). "[Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease]" (in Portuguese). Arq Bras Cardiol 87 (2): 159–66. PMID 16951834. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2006001500014&lng=en&nrm=iso&tlng=en.
· ^ a b c Scientific Working Group on Chagas Disease [April 2005] (July 2007). Guhl F, Lazdins-Helds JK (eds.): Reporte del grupo de trabajo científico sobre la enfermedad de Chagas (in Spanish). Geneva: WHO. Retrieved on August 29, 2008. Executive summary in English
· ^ Urbina JA, Concepcion JL, Rangel S, Visbal G, Lira R (2002). "Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana". Mol Biochem Parasitol 125 (1–2): 35–45. doi:10.1016/S0166-6851(02)00206-2. PMID 12467972. http://linkinghub.elsevier.com/retrieve/pii/S0166685102002062.
· ^ Engel JC, Doyle PS, Hsieh I, McKerrow JH (August 1998). "Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection". J Exp Med 188 (4): 725–34. doi:10.1084/jem.188.4.725. PMID 9705954. PMC: 2213346. http://www.jem.org/cgi/pmidlookup?view=long&pmid=9705954.
· ^ Brand GD, Leite JR, Silva LP, et al (December 2002). "Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells". J Biol Chem 277 (51): 49332–40. doi:10.1074/jbc.M209289200. PMID 12379643. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=12379643.
· ^ Brengio SD, Belmonte SA, Guerreiro E, Giordano OS, Pietrobon EO, Sosa MA (April 2000). "The sesquiterpene lactone dehydroleucodine (DhL) affects the growth of cultured epimastigotes of Trypanosoma cruzi". J Parasitol 86 (2): 407–12. PMID 10780563.
· ^ Fairlamb AH, Cerami A (1992). "Metabolism and functions of trypanothione in the Kinetoplastida". Annu Rev Microbiol 46: 695–729. doi:10.1146/annurev.mi.46.100192.003403. PMID 1444271. http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.mi.46.100192.003403?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov.
· ^ El-SayedNM, Myler PJ, BartholomeuDC, et al (July 2005). "The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease". Science 309 (5733): 409–15. doi:10.1126/science.1112631. PMID 16020725. http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=16020725.
· ^ "A killer that preys on the poor: Chagas disease" (pdf). Médecins Sans Frontières: Activity Report 2003/2004. http://www.msf.org/source/actrep/2004/pdf/62-63.pdf. Retrieved on 2008-08-29.
· ^ Eduardo N. Zerba (1999). "Susceptibility and resistance to insecticides of Chagas disease vectors" (PDF). Medicina (Buenos Aires) 59 (Suppl 2): 41–6. http://www.medicinabuenosaires.com/revistas/vol59-99/supl2/v59_s2_41_46.pdf.
· ^ Basso B, Moretti E, Fretes R (June 2008). "Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection". Mem Inst Oswaldo Cruz 103 (4): 370–4. doi:10.1590/S0074-02762008000400010. PMID 18660992. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762008000400010&lng=en&nrm=iso&tlng=en.
· ^ Dumonteil E, Escobedo-Ortegon J, Reyes-Rodriguez N, Arjona-Torres A, Ramirez-Sierra M (2004). "Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice". Infect Immun 72 (1): 46–53. doi:10.1128/IAI.72.1.46-53.2004. PMID 14688079.
· ^ Sánchez-Guillén MC, Barnabé C, Guégan JF, et al (October 2002). "High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico". Mem Inst Oswaldo Cruz 97 (7): 947–52. doi:10.1590/S0074-02762002000700004. PMID 12471419. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762002000700004&lng=en&nrm=iso&tlng=en.
· ^ SchmunisGA (1999). "Prevention of transfusional Trypanosoma cruzi infection in Latin America". Mem Inst Oswaldo Cruz 94 Suppl 1: 93–101. PMID 10677696. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761999000700010&lng=en&nrm=iso. Retrieved on 2008-09-01.
· ^ Vinhaes, MC (November 2001). "VIII. Os programas nacionais de controle na fase avancada de controle e os novos desafios estratégicos, políticos e epidemiológicos" (PDF). Grupo de Trabajo OPS para Consulta en Planificación, Operativa, Estrategia y Evaluación de Etapas Avanzadas del Control Antivectorial en Enfermedad de Chagas, Pan American Health Organization.
· ^ a b Morel CM, Lazdins J (October 2003). "Chagas disease". Nat Rev Microbiol 1 (1): 14–5. doi:10.1038/nrmicro735. PMID 15040175.
· ^ "Blood donor screening for Chagas disease—United States, 2006–2007". MMWR Morb Mortal Wkly Rep 56 (7): 141–3. February 2007. PMID 17318113. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5607a2.htm.
· ^ Gregory KR (September 12, 2002). "Chagas' Disease". American Association of Blood Banks. http://www.aabb.org/Content/Members_Area/Members_Area_Regulatory/Donor_Testing/chagbpac091202.htm. Retrieved on 2008-08-27.
· ^ Docampo R, Moreno SN, Muniz RP, Cruz FS, Mason RP (June 1983). "Light-enhanced free radical formation and trypanocidal action of gentian violet (crystal violet)". Science 220 (4603): 1292–5. doi:10.1126/science.6304876. PMID 6304876. http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=6304876.
· ^ Cruz FS, Marr JJ, Berens RL (September 1980). "Prevention of transfusion-induced Chagas' disease by amphotericin B". Am J Trop Med Hyg 29 (5): 761–5. PMID 6776830. http://www.ajtmh.org/cgi/pmidlookup?view=long&pmid=6776830.
· ^ "Chagas' Disease". Seattle Biomedical Research Institute. 2008. http://www.sbri.org/diseases/chagas.asp. Retrieved on 2008-09-01.
· ^ Pinto-Dias JC (1992). "Epidemiology of Chagas disease" in ISBT Brazil '92. XXII Congress of the International Society of Blood Transfusion. XX Brazilian Congress of Hematology. Extraordinary Congress of the BrazilianCollege of Hematology. Wendel S, Brener Z, Camargo ME, Rassi A (eds.) Chagas Disease—American Trypanosomiasis: its impact on transfusion and clinical medicine, São Paulo: Editorial ISBT Brazil. Retrieved on 2008-09-11.
· ^ TeixeiraAR, Monteiro PS, Rebelo JM, et al (2001). "Emerging Chagas disease: trophic network and cycle of transmission of Trypanosoma cruzi from palm trees in the Amazon". Emerging Infect Dis 7 (1): 100–12. PMID 11266300. http://www.cdc.gov/ncidod/eid/vol7no1/teixeira.htm.
· ^ a b c d Karsten V, Davis C, Kuhn R (June 1992). "Trypanosoma cruzi in wild raccoons and opossums in North Carolina". J Parasitol 78 (3): 547–9. doi:10.2307/3283667. PMID 1597808.
· ^ a b BarrSC, Brown CC, Dennis VA, Klei TR (August 1991). "The lesions and prevalence of Trypanosoma cruzi in opossums and armadillos from southern Louisiana". J Parasitol 77 (4): 624–7. doi:10.2307/3283170. PMID 1907654.
· ^ Yabsley MJ, Noblet GP (01 January 2002). "Seroprevalence of Trypanosoma cruzi in raccoons from South Carolina and Georgia". J Wildl Dis 38 (1): 75–83. PMID 11838232. http://www.jwildlifedis.org/cgi/pmidlookup?view=long&pmid=11838232.
· ^ Yaeger RG (March 1988). "The prevalence of Trypanosoma cruzi infection in armadillos collected at a site near New Orleans, Louisiana". Am J Trop Med Hyg 38 (2): 323–6. PMID 3128127. http://www.ajtmh.org/cgi/pmidlookup?view=long&pmid=3128127.
· ^ Burkholder JE, Allison TC, Kelly VP (April 1980). "Trypanosoma cruzi (Chagas) (Protozoa: Kinetoplastida) in invertebrate, reservoir, and human hosts of the lower Rio Grandevalley of Texas". J Parasitol 66 (2): 305–11. doi:10.2307/3280824. PMID 6771371.
· ^ Kirchhoff LV (August 1993). "American trypanosomiasis (Chagas' disease)—a tropical disease now in the United States". N Engl J Med 329 (9): 639–44. doi:10.1056/NEJM199308263290909. PMID 8341339. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=8341339&promo=ONFLNS19.
· ^ "Medical Encyclopedia: Chagas disease". National Institutes of Health. http://www.nlm.nih.gov/medlineplus/ency/article/001372.htm. Retrieved on 2008-09-11.
· ^ Steele LS, MacPherson DW, Kim J, Keystone JS, Gushulak BD (January 2007). "The sero-prevalence of antibodies to Trypanosoma cruzi in Latin American refugees and immigrants to Canada". J Immigr Minor Health 9 (1): 43–7. doi:10.1007/s10903-006-9014-x. PMID 17006766.
· ^ a b WHO (2004). The Southern Cone Initiative: an update. Press release. http://www.who.int/tdr/publications/tdrnews/news65/chagas.htm. Retrieved on 2008-08-29.
· ^ Massad E (September 2008). "The elimination of Chagas' disease from Brazil". Epidemiol Infect 136 (9): 1153–64. doi:10.1017/S0950268807009879. PMID 18053273. http://journals.cambridge.org/abstract_S0950268807009879.
· ^ Ramos Jr AN, Carvalho DM (2001). "Os diferentes significados da certificação conferida ao Brasil como estando livre da doença de Chagas" (in Portuguese). Cadernos de Saúde Pública 17 (6): 1403–12. doi:10.1590/S0102-311X2001000600024. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2001000600024&lng=en&nrm=iso.
· ^ Pires HH, Lazzari CR, Diotaiuti L, Lorenzo MG (June 2000). "Performance of yeast-baited traps with Triatoma sordida, Triatoma brasiliensis, Triatoma pseudomaculata, and Panstrongylus megistus in laboratory assays". Rev Panam Salud Publica 7 (6): 384–8. doi:10.1590/S1020-49892000000600005. PMID 10949899. http://openurl.ingenta.com/content/nlm?genre=article&issn=1020-4989&volume=7&issue=6&spage=384&aulast=Pires.
· ^ Luz C, Rocha LF, Nery GV, Magalhães BP, Tigano MS (March 2004). "Activity of oil-formulated Beauveria bassiana against Triatoma sordida in peridomestic areas in Central Brazil". Mem Inst Oswaldo Cruz 99 (2): 211–8. doi:10.1590/S0074-02762004000200017. PMID 15250478. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000200017&lng=en&nrm=iso&tlng=en.
· ^ Beard CB, Cordon-Rosales C, Durvasula RV (2002). "Bacterial symbionts of the Triatominae and their potential use in control of Chagas disease transmission". Annu Rev Entomol 47: 123–41. doi:10.1146/annurev.ento.47.091201.145144. PMID 11729071. http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.ento.47.091201.145144?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov.
· ^ Levy MM, Fink MP, Marshall JC, et al (April 2003). "2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference". Crit. Care Med. 31 (4): 1250–6. doi:10.1097/01.CCM.0000050454.01978.3B. PMID 12682500. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0090-3493&volume=31&issue=4&spage=1250.
· ^ a b c d Bone RC, Balk RA, Cerra FB, et al (Jun 1992). "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine". Chest 101 (6): 1644–55. doi:10.1378/chest.101.6.1644. PMID 1303622. http://www.chestjournal.org/content/101/6/1644.
· ^ Dictionary
· ^ septicemia at eMedicine Dictionary
· ^ a b c Dellinger RP, Levy MM, Carlet JM, et.al, for the International Surviving Sepsis Campaign Guidelines Committee. (2008). "Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008" (Subscription required). Crit Care Med 36 (1): 296–327. doi:10.1097/01.CCM.0000298158.12101.41. PMID 18158437. http://www.ccmjournal.com/pt/re/ccm/searchresults.htm.
· ^ Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK (Jun 2008). "Bacteremia associated with toothbrushing and dental extraction". Circulation 117 (24): 3118–25. doi:10.1161/CIRCULATIONAHA.107.758524. PMID 18541739. http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=18541739.
· ^ Wilson W, Taubert KA, Gewitz M, et al (Oct 2007). "Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group". Circulation 116 (15): 1736–54. doi:10.1161/CIRCULATIONAHA.106.183095. PMID 17446442. http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=17446442.
· ^ Martin GS, Mannino DM, Eaton S, Moss M (2003-04-17). "The epidemiology of sepsis in the United States from 1979 through 2000". N Engl J Med 348 (16): 1546–54. doi:10.1056/NEJMoa022139. PMID 12700374. http://content.nejm.org/cgi/content/full/348/16/1546.
· ^ "Sepsis can strike, kill shockingly fast" by Elizabeth Cohen, January 29, 2009, CNN
· ^ a b Goldstein B, Giroir B, Randolph A (2005). "International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics". Pediatr Crit Care Med 6 (1): 2–8. doi:10.1097/01.PCC.0000149131.72248.E6. PMID 15636651. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1529-7535&volume=6&issue=1&spage=2.
· ^ a b Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (Apr 2003). "2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference". Crit Care Med 31 (4): 1250–1256. doi:10.1097/01.CCM.0000050454.01978.3B. http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200304000-00038.htm.
· ^ Abraham E, Singer M (2007). "Mechanisms of sepsis-induced organ dysfunction" (Subscription required). Crit. Care Med. 35 (10): 2408–16. doi:10.1097/01.CCM.0000282072.56245.91. PMID 17948334. http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200710000-00026.htm.
· ^ Dagan R, Powell KR, Hall CB, Menegus MA (Dec 1985). "Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis". J. Pediatr. 107 (6): 855–60. doi:10.1016/S0022-3476(85)80175-X. PMID 4067741. http://www.jpeds.com/article/S0022-3476(85)80175-X/abstract.
· ^ Becker KL, Snider R, Nylen ES (March 2008). "Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations". Crit. Care Med. 36 (3): 941–52. doi:10.1097/CCM.0B013E318165BABB. PMID 18431284.
· ^ a b Rivers E, Nguyen B, Havstad S, et al (2001). "Early goal-directed therapy in the treatment of severe sepsis and septic shock". N. Engl. J. Med. 345 (19): 1368–77. doi:10.1056/NEJMoa010307. PMID 11794169. http://content.nejm.org/cgi/content/full/345/19/1368.
· ^ Jones AE, Brown MD, Trzeciak S, et al (October 2008). "The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis". Critical care medicine 36 (10): 2734–9. doi:10.1097/CCM.0b013e318186f839. PMID 18766093. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/CCM.0b013e318186f839.
· ^ McKenna M (December 2008). "Controversy swirls around early goal-directed therapy in sepsis: pioneer defends ground- breaking approach to deadly disease". Ann Emerg Med 52 (6): 651–4. doi:10.1016/j.annemergmed.2008.10.013. PMID 19048659.
· ^ Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr (2001-03-08). "Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis". N Engl J Med 344 (10): 699–709. doi:10.1056/NEJM200103083441001. PMID 11236773. http://content.nejm.org/cgi/content/abstract/344/10/699.
· ^ a b c d MarikPE, Pastores SM, Annane D, et al (Jun 2008). "Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine". Crit. Care Med. 36 (6): 1937–49. doi:10.1097/CCM.0b013e31817603ba. PMID 18496365. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/CCM.0b013e31817603ba.
· ^ Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E (2002-08-21). "Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock". JAMA 288 (7): 862–71. doi:10.1001/jama.288.7.862. PMID 12186604. http://jama.ama-assn.org/cgi/content/full/288/7/862.
· ^ Meduri GU, HeadleyAS, Golden E, et al (Jul 1998). "Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial". JAMA 280 (2): 159–65. doi:10.1001/jama.280.2.159. PMID 9669790. http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=9669790.
· ^ Meduri GU, Golden E, Freire AX, et al (Apr 2007). "Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial". Chest 131 (4): 954–63. doi:10.1378/chest.06-2100. PMID 17426195. http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=17426195.
· ^ Sprung CL, Annane D, Keh D, et al (Jan 2008). "Hydrocortisone therapy for patients with septic shock". N. Engl. J. Med. 358 (2): 111–24. doi:10.1056/NEJMoa071366. PMID 18184957. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=18184957&promo=ONFLNS19.
· ^ Steinberg KP, Hudson LD, Goodman RB, et al (Apr 2006). "Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome". N. Engl. J. Med. 354 (16): 1671–84. doi:10.1056/NEJMoa051693. PMID 16625008. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=16625008&promo=ONFLNS19.
· ^ Annane D, Sébille V, Bellissant E (Jan 2006). "Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome". Crit. Care Med. 34 (1): 22–30. doi:10.1097/01.CCM.0000194723.78632.62. PMID 16374152. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00003246-200601000-00004.
· ^ Carr R, Brocklehurst P, Doré CJ, Modi N (January 2009). "Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial". Lancet 373 (9659): 226–33. doi:10.1016/S0140-6736(09)60071-4. PMID 19150703.
· ^ Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW (2003). "Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule". Crit. Care Med. 31 (3): 670–5. doi:10.1097/01.CCM.0000054867.01688.D1. PMID 12626967. http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200303000-00002.htm.
· ^ "Creating an Ulcerative Colitis Diet Plan". WebMD, LLC. http://www.webmd.com/ibd-crohns-disease/ulcerative-colitis/creating-an-ulcerative-colitis-plan. Retrieved on 2008-12-13.
· ^ Perlot, Andrew. "A Raw Food Colitis Cure". www.Raw-food-Health.net. http://www.raw-food-health.net/ColitisCure.html. Retrieved on 2008-12-19.
· ^ "Clostridium Difficile Colitis - Overview". WebMD, LLC. http://www.webmd.com/digestive-disorders/tc/clostridium-difficile-colitis-overview. Retrieved on 2006-09-15.
· ^ Beutin L (2006). "Emerging enterohaemorrhagic Escherichia coli, causes and effects of the rise of a human pathogen". J Vet Med B Infect Dis Vet Public Health 53 (7): 299–305. PMID 16930272.
· ^ Geerling BJ, Dagnelie PC, Badart-Smook A, Russel MG, Stockbrügger RW, Brummer RJ (2000). "Diet as a risk factor for the development of ulcerative colitis". Am. J. Gastroenterol. 95 (4): 1008–13. doi:10.1111/j.1572-0241.2000.01942.x. PMID 10763951.
· ^ US CDC food poisoning guide
· ^ "Food-Related Diseases". http://www.cdc.gov/ncidod/diseases/food/index.htm.
· ^ Food Standards Agency
· ^ Humphrey, Tom et al. (2007). "Campylobacters as zoonotic pathogens: A food production perspective <internet>". International Journal of Food Microbiology 117 (3): 237. doi:10.1016/j.ijfoodmicro.2007.01.006. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T7K-4N0PPRG-1&_user=10&_coverDate=07%2F15%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=74b7c07635a1873ca815b3139b56d2e0.
· ^ USDA. [http://www.fsis.usda.gov/Fact_Sheets/Foodborne_Illness_What_Consumers_Need_to_Know/index.asp "Foodborne Illness: What Consumers Need to Know"]. http://www.fsis.usda.gov/Fact_Sheets/Foodborne_Illness_What_Consumers_Need_to_Know/index.asp. Retrieved on 2008.
· ^ Tribe, Ingrid G. et al.. "An outbreak of Salmonella typhimurium phage type 135 infection linked to the consumption of raw shell eggs in an aged care facility <internet>". http://www.health.gov.au/internet/main/Publishing.nsf/Content/cda-pubs-cdi-2002-cdi2601-cdi2601h.htm. Retrieved on 29 August 2008.
· ^ Centers for Disease Control and Prevention. "Salmonella Infection (salmonellosis) and Animals <internet>". http://www.cdc.gov/healthypets/diseases/salmonellosis.htm. Retrieved on 12 August 2007.
· ^ Doyle, M. P.; M. C. Erickson. "Reducing the carriage of foodborne pathogens in livestock and poultry <internet>" (PDF). http://www.poultryscience.org/ps/paperpdfs/06/p0660960.pdf. Retrieved on 12 August 2007.
· ^ E. Mount, Michael. "Fungi and Mycotoxins <internet>" (PDF). http://www.vetmed.ucdavis.edu/PHR/PHR250/2007/25007Myc.pdf. Retrieved on 11 August 2007.
· ^ Center for Food Safety & Applied Nutrition. "Aflatoxins <internet>". http://www.cfsan.fda.gov/~mow/chap41.html. Retrieved on 12 August 2007.
· ^ Food and Agriculture Organization of the United Nations. "GASGA Technical Leaflet - 3 Mycotoxins in Grain <internet>". http://www.fao.org/Wairdocs/X5008E/X5008e01.htm. Retrieved on 12 August 2007.
· ^ World Health Organization. "Chapter 2 Foodborne Hazards in Basic Food Safety for Health Workers <internet>" (PDF). http://www.who.int/entity/foodsafety/publications/capacity/en/2.pdf. Retrieved on 12 August 2007.
· ^ Food and Drug Administration. "Sec. 683.100 Action Levels for Aflatoxins in Animal Feeds (CPG 7126.33) <internet>". http://www.fda.gov/ora/compliance_ref/cpg/cpgvet/cpg683-100.html. Retrieved on 13 August 2007.
· ^ Henry, Michael H.. "Mycotoxins in Feeds: CVM’s Perspective <internet>". http://www.fda.gov/cvm/fdaaustintx823.htm. Retrieved on 13 August 2007.
· ^ Webley, D. J. et al.. "Alternaria toxins in weather-damaged wheat and sorghum in the 1995-1996 Australian harvest <internet>". http://www.publish.csiro.au/paper/A97005.htm. Retrieved on 13 August 2007.
· ^ Li, Feng-qin; Takumi Yoshizawa. "Alternaria Mycotoxins in Weathered Wheat from China <internet>". http://pubs.acs.org/cgi-bin/abstract.cgi/jafcau/2000/48/i07/abs/jf0000171.html. Retrieved on 13 August 2007.
· ^ da Motta, Silvana; Lucia M. Valente Soares. "Survey of Brazilian tomato products for alternariol, alternariol monomethyl ether, tenuazonic acid and cyclopiazonic acid <internet>". http://www.informaworld.com/smpp/content~content=a713810863~db=all. Retrieved on 13 August 2007.
· ^ Li, F. Q. et al.. "Production of Alternaria Mycotoxins by Alternaria alternata Isolated from Weather-Damaged Wheat <internet>". http://www.ingentaconnect.com/content/iafp/jfp/2001/00000064/00000004/art00025. Retrieved on 13 August 2007.
· ^ Marasas, Walter F. O.. "Fumonisins: Their implications for human and animal health <internet>". http://www3.interscience.wiley.com/cgi-bin/abstract/112640083/ABSTRACT?CRETRY=1&SRETRY=0. Retrieved on 12 August 2007.
· ^ Soriano, J.M.; S. Dragacci. "Occurrence of fumonisins in foods <internet>". http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T6V-4D636PW-1&_user=10&_coverDate=01%2F01%2F2004&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=4a033a232e75e4ebf3ee269c06744491. Retrieved on 12 August 2007.
· ^ Food and Drug Administration. "CVM and Fumonisins <internet>". http://www.fda.gov/cvm/fumonisin.htm. Retrieved on 13 August 2007.
· ^ Food Standards Agency. "More contaminated maize meal products withdrawn from sale <internet>". http://www.food.gov.uk/news/newsarchive/2003/sep/moremaize. Retrieved on 12 August 2007.
· ^ Food Standards AustraliaNew Zealand. "20th Australian Total Diet Survey - Part B <internet>". http://www.foodstandards.gov.au/newsroom/publications/20thaustraliantotaldietsurveyjanuary2003/20thaustraliantotaldietsurveyfullreport/partb20thatds/partbmetals.cfm. Retrieved on 13 August 2007.
· ^ a b FAO FOOD AND NUTRITION PAPER 81. "Worldwide regulations for mycotoxins in food and feed in 2003 <internet>". http://www.fao.org/docrep/007/y5499e/y5499e0f.htm. Retrieved on 13 August 2007.
· ^ Food and Drug Administration. "Patulin in Apple Juice, Apple Juice Concentrates and Apple Juice Products <internet>". http://vm.cfsan.fda.gov/~dms/patubckg.html. Retrieved on 16 August 2007.
· ^ Sabater-Vilar, M.. "Genotoxicity Assessment of Five Tremorgenic Mycotoxins (Fumitremorgen B, Paxilline, Penitrem A, Verruculogen, and Verrucosidin) Produced by Molds Isolated from Fermented Meats <internet>". http://www.ingentaconnect.com/content/iafp/jfp/2003/00000066/00000011/art00023. Retrieved on 16 August 2007.
· ^ Adejumo, Timothy O.. "Occurrence of Fusarium species and trichothecenes in Nigerian maize <internet>". Elsevier. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T7K-4N5CX4H-3&_user=10&_coverDate=05%2F30%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=d02d1b28456dfbef669d57692ac28244. Retrieved on 12 August 2007.
· ^ Mazur, Lynnette J.; Janice Kim. "Spectrum of Noninfectious Health Effects From Molds <internet>". AmericanAcademy of Pediatrics. http://pediatrics.aappublications.org/cgi/content/full/118/6/e1909. Retrieved on 12 August 2007.
· ^ Froquet, R. et al.. "Trichothecene toxicity on human megakaryocyte progenitors (CFU-MK) <internet>". SAGE Publications. http://het.sagepub.com/cgi/content/abstract/20/2/84. Retrieved on 12 August 2007.
· ^ Joffe, A. Z.; B. Yagen. "Comparative study of the yield of T-2 toxic produced by Fusarium poae, F. sporotrichioides and F. sporotrichioides var. tricinctum strains from different sources <internet>". SAGE Publications. http://het.sagepub.com/cgi/content/abstract/20/2/84. Retrieved on 12 August 2007.
· ^ Hay, Rod J.; B. Yagen. "Fusarium infections of the skin <internet>". http://www.co-infectiousdiseases.com/pt/re/coinfdis/abstract.00001432-200704000-00002.htm;jsessionid=G2JGL27MSRdb4TS82LyckCgxLH2zJLX3ynBfjz5kjMyfh4WpVkLg!1152499061!181195629!8091!-1. Retrieved on 12 August 2007.
· ^ Food and Drug Administration. "Guidance for Industry and FDA - Letter to State Agricultural Directors, State Feed Control Officials, and Food, Feed, and Grain Trade Organizations <internet>". http://www.cfsan.fda.gov/~dms/graingui.html. Retrieved on 13 August 2007.
· ^ Hohn, Thomas M.. "Trichothecene-resistant transgenic plants <internet>". http://www.patentstorm.us/patents/6646184.html. Retrieved on 13 August 2007.
· ^ Dubois, Eric et al.. "Intra-laboratory validation of a concentration method adapted for the enumeration of infectious F-specific RNA coliphage, enterovirus, and hepatitis A virus from inoculated leaves of salad vegetables spt on from mexican migrant workers. <internet>". http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T7K-4HYMVXK-4&_user=10&_coverDate=04%2F25%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=29d010eafc89179a9a66fd24a4b44e21. Retrieved on 11 August 2007.
· ^ Schmidt, Heather Martin. "Improving the microbilological quality and safety of fresh-cut tomatoes by low dose dlectron beam irradiation - Master thesis <internet>" (PDF). http://txspace.tamu.edu/bitstream/1969.1/2767/1/etd-tamu-2004B-FSTC-Schmidt.pdf. Retrieved on 11 August 2007.
· ^ "Food safety and foodborne illness". http://www.who.int/mediacentre/factsheets/fs237/en/.
· ^ "Report of the French sanitary agencies" (in French) (PDF). INVS/Afssa. http://www.invs.sante.fr/publications/2004/inf_origine_alimentaire/inf_origine_alimentaire.pdf.
· ^ "Summary of Report of the French sanitary agencies" (in French) (PDF). INVS/Afssa. http://www.invs.sante.fr/publications/2004/inf_origine_alimentaire/grilleLecture.pdf.
· ^ "Food borne illness in Australia" (PDF). OzFoodNet. http://www.ozfoodnet.org.au/internet/ozfoodnet/publishing.nsf/Content/reports-1/$FILE/foodborne_report.pdf.
· ^ David F. Smith, H. Lesley Diack, and T. Hugh Pennington: Food Poisoning, Policy and Politics : Corned Beef and Typhoid in Britain in the 1960s, Boydell Press, July 15, 2005, ISBN 1843831384
· ^ Healthy People 2010 Home Page
· ^ "Preliminary FoodNet Data on the Incidence of Infection with Pathogens Transmitted Commonly Through Food". CDC Morbidity and Mortality Weekly Report. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5714a2.htm. Retrieved on 2008-04-15.
^ medterms dictionary. "Definition of Diarrhea". medterms.com. http://www.medterms.com/script/main/art.asp?articlekey=2985.
^ Wilson ME (2005). "Diarrhea in nontravelers: risk and etiology". Clin. Infect. Dis. 41 Suppl 8: S541–6. doi:10.1086/432949. PMID 16267716. http://www.journals.uchicago.edu/cgi-bin/resolve?CID36827.
^ Alam NH, Ashraf H (2003). "Treatment of infectious diarrhea in children". Paediatr Drugs 5 (3): 151–65. PMID 12608880.
^ Ruuska T, Vesikari T (1990). "Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes". Scand. J. Infect. Dis. 22 (3): 259–67. doi:10.3109/00365549009027046. PMID 2371542.
^ Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006). "Functional bowel disorders". Gastroenterology 130 (5): 1480–91. doi:10.1053/j.gastro.2005.11.061. PMID 16678561.
^ Wangen, S. "The Irritable Bowel Syndrome Solution". page 113. 2006; Innate Health Publishing. ISBN 978-0-9768537-8-7. Excerpted with the author's permission at http://www.IBSTreatmentCenter.com
^ a b Intestinal Protozoa
^ Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 2005. ISBN 0-07-139140-1.
^ "BestBets: Does Withholding milk feeds reduce the duration of diarrhoea in children with acute gastroenteritis?". http://www.bestbets.org/bets/bet.php?id=1728.
^ Schiller LR (2007). "Management of diarrhea in clinical practice: strategies for primary care physicians". Rev Gastroenterol Disord 7 Suppl 3: S27–38. PMID 18192963. http://www.medreviews.com/pubmed.cfm?j=3&v=7Suppl3&i=&p=S27.
^ Nesse, R. M. Williams, G. C. (1994) 'Why We Get Sick: The New Science of Darwinian Medicine' (section,Evolution and healing, pp. 37-38) Vintage Books New York pp. ISBN 0-679-74674-9
^ DuPont, H. L. Hornick, R. B. (1973) "Adverse effect of lomotil therapy in shigellosis". JAMA. 226: 1525-1528 PubMed
^ a b c d e Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 2005. ISBN 0-07-139140-1.
^ King CK, Glass R, Bresee JS, Duggan C (2003). "Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy". MMWR Recomm Rep 52 (RR-16): 1–16. PMID 14627948. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5216a1.htm.
^ "Norovirus: Technical Fact Sheet". NationalCenter for Infectious Diseases, CDC. http://www.cdc.gov/ncidod/dvrd/revb/gastro/norovirus-factsheet.htm.
^ a b Murray PR, Pfaller MA, Rosenthal KS. Medical Microbiology. Mosby, 2005. ISBN 0323033032.
^ Seven Surfing Sicknesses, .
^ a b c d e f g Sleisenger & Fordtran's Gastrointestinal and Liver Disease 7th edition, by Mark Feldman; Lawrence S. Friedman; and Marvin H. Sleisenger, ISBN 0-7216-8973-6, Hardback, Saunders, Published July 2002
^ a b c d Mandell's Principles and Practices of Infection Diseases 6th Edition (2004) by Gerald L. Mandell MD, MACP, John E. Bennett MD, Raphael Dolin MD, ISBN 0-443-06643-4 · Hardback · 4016 Pages Churchill Livingstone
^ a b c d e f The Oxford Textbook of Medicine. Edited by David A. Warrell, Timothy M. Cox and John D. Firth with Edward J. Benz, Fourth Edition (2003), Oxford University Press, ISBN 0-19-262922-0
^ Haffejee IE (1991). "The pathophysiology, clinical features and management of rotavirus diarrhoea". Q. J. Med. 79 (288): 289–99. PMID 1649479.
^ Patel MM, Tate JE, Selvarangan R, et al (2007). "Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination" (Subscription required). Pediatr. Infect. Dis. J. 26 (10): 914–9. doi:10.1097/INF.0b013e31812e52fd. PMID 17901797.
^ "The paediatric burden of rotavirus disease in Europe". Epidemiol. Infect. 134 (5): 908–16. 2006. doi:10.1017/S0950268806006091. PMID 16650331.
^ Beards GM (1988). "Laboratory diagnosis of viral gastroenteritis". Eur. J. Clin. Microbiol. Infect. Dis. 7 (1): 11–3. doi:10.1007/BF01962164. PMID 3132369.
^ Steel HM, Garnham S, Beards GM, Brown DW (1992). "Investigation of an outbreak of rotavirus infection in geriatric patients by serotyping and polyacrylamide gel electrophoresis (PAGE)". J. Med. Virol. 37 (2): 132–6. doi:10.1002/jmv.1890370211. PMID 1321223.
^ "Practice parameter: the management of acute gastroenteritis in young children. AmericanAcademy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis". Pediatrics 97 (3): 424–35. 1996. PMID 8604285.
^ "BestBets: Fluid Treatment of Gastroenteritis in Adults". http://www.bestbets.org/bets/bet.php?id=1039.
^ "Diarrhoea and vomiting in children under 5". http://www.nice.org.uk/Guidance/CG84#summary.
^ Managing Acute Gastroenteritis Among Children: Oral Rehydration, Maintenance, and Nutritional Therapy
^ "BestBets: Gradual introduction of feeding is no better than immediate normal feeding in children with gastro-enteritis". http://www.bestbets.org/bets/bet.php?id=390. Retrieved on December 6,2008.
^ a b King CK, Glass R, Bresee JS, Duggan C (November 2003). "Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy". MMWR Recomm Rep 52 (RR-16): 1–16. PMID 14627948. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5216a1.htm.
^ "Does yogurt decrease acute diarrhoeal symptoms in children with acute gastroenteritis". http://www.bestbets.org/bets/bet.php?id=1000.
^ Rehydrate.org: Zinc Supplementation
^ "Merck - Error Page". http://www.merck.com/mmhe/sec09/ch122/ch122a.html+Merck+Manual.
^ Wingate D, Phillips SF, Lewis SJ, et al (2001). "Guidelines for adults on self-medication for the treatment of acute diarrhoea". Aliment. Pharmacol. Ther. 15 (6): 773–82. doi:10.1046/j.1365-2036.2001.00993.x. PMID 11380315. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0269-2813&date=2001&volume=15&issue=6&spage=773.
^ DeCamp LR, Byerley JS, Doshi N, Steiner MJ (September 2008). "Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis". Arch Pediatr Adolesc Med 162 (9): 858–65. doi:10.1001/archpedi.162.9.858. PMID 18762604.
^ Mehta S, Goldman RD (2006). "Ondansetron for acute gastroenteritis in children". Can Fam Physician 52 (11): 1397–8. PMID 17279195. http://www.cfp.ca/cgi/pmidlookup?view=long&pmid=17279195.
^ "BestBets: Are antiemetics helpful in young children suffering from acute viral gastroenteritis?". http://www.bestbets.org/bets/bet.php?id=902.
^ Arya SC (1984). "Rotaviral infection and intestinal lactase level". J. Infect. Dis. 150 (5): 791. PMID 6436397.
^ Victora CG, Bryce J, Fontaine O, Monasch R (2000). "Reducing deaths from diarrhoea through oral rehydration therapy". Bull. World Health Organ. 78 (10): 1246–55. PMID 11100619.
^ Rudy's List of Archaic Medical Terms
· ^ a b c d e f g h i j k l Mandell's Principles and Practices of Infection Diseases 6th Edition (2004) by Gerald L. Mandell MD, MACP, John E. Bennett MD, Raphael Dolin MD, ISBN 0-443-06643-4 · Hardback · 4016 Pages Churchill Livingstone
· ^ a b c d e f g h i j Harrison's Principles of Internal Medicine 16th Edition, The McGraw-Hill Companies, ISBN 0-07-140235-7
· ^ a b c d e f g h i j The Oxford Textbook of Medicine Edited by David A. Warrell, Timothy M. Cox and John D. Firth with Edward J. Benz, Fourth Edition (2003), Oxford University Press, ISBN 0-19-262922-0
· ^ Cecil Textbook of Medicine by Lee Goldman, Dennis Ausiello, 22nd Edition (2003), W.B. Saunders Company, ISBN 0-7216-9652-X
· ^ Irwin and Rippe's Intensive Care Medicine by Irwin and Rippe, Fifth Edition (2003), Lippincott Williams & Wilkins, ISBN 0-7817-3548-3
· ^ Fever of Unknown Origin at Mount Sinai Hospital
· ^ Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, Luig H, Becker W (2000). "Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET.". Eur J Nucl Med. 27 (11): 1617–25. doi:10.1007/s002590000341. PMID 11105817.
· ^ (PDF) The World Health Report 2004 - Changing History. World Health Organization. 2004. pp. 120–4. ISBN 92-4-156265-X. http://www.who.int/entity/whr/2004/en/report04_en.pdf.
· ^ a b c d Antibiotic Expert Group. Therapeutic guidelines: Antibiotic. 13th ed. North Melbourne: Therapeutic Guidelines; 2006.
· ^ a b c Guthrie R (2001). "Community-acquired lower respiratory tract infections: etiology and treatment". Chest 120 (6): 2021–34. doi:10.1378/chest.120.6.2021. PMID 11742937. http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=11742937.
· ^ a b BJM Clinical evidence: London, United Kingdom: BMJ, 1999-2007 : Accessed 29/3/7 at : http://0-www.clinicalevidence.com.library.newcastle.edu.au/ceweb/index.jsp.
· ^ Therapeutic guidelines : respiratory. 2nd ed ed: North Melbourne : Therapeutic Guidelines Limited, 2000.
· ^ a b c Smucny J BL, Glazier R. . Beta2-agonists for acute bronchitis. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD001726. DOI: 10.1002/14651858.CD001726.pub3.
· ^ a b Integrated pharmacology / Clive Page ... [et al.]. 2nd ed ed: Edinburgh : Mosby, 2002.
· ^ Fahey T SJ, Becker L, Glazier R. . Antibiotics for acute bronchitis. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD000245. DOI: 10.1002/14651858.CD000245.pub2.
· ^ a b c Bjerre LM VT, Kochen MM. . Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD002109. DOI: 10.1002/14651858.CD002109.pub2.
· ^ a b c Dear KB G AR, Holden J, Tatham DP. . Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD000422. DOI: 10.1002/14651858.CD000422.
· ^ a b Kabra SK LR, Pandey RM. . Antibiotics for community acquired pneumonia in children. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD004874. DOI: 10.1002/14651858.CD004874.pub2.
· ^ The Merck manual of diagnosis and therapy. 17th ed / Mark H. Beers and Robert Berkow ed: Whitehouse Station, N.J. : Merck Research Laboratories, 1999.
· ^ eTG complete [electronic resource] http://0-www.etg.hcn.net.au.library.newcastle.edu.au/. [cited; Available from: http://0-www.etg.hcn.net.au.library.newcastle.edu.au/
· ^ Chodosh S (1991). "Use of quinolones for the treatment of acute exacerbations of chronic bronchitis". Am. J. Med. 91 (6A): 93S–100S. doi:10.1016/0002-9343(91)90318-R. PMID 1662900.
· ^ Roblin PM, Hammerschlag MR (1998). "In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae". Antimicrob. Agents Chemother. 42 (4): 951–2. PMID 9559818. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=9559818.
· ^ Chodosh S, DeAbate CA, Haverstock D, Aneiro L, Church D (2000). "Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group". Respir Med 94 (1): 18–27. doi:10.1053/rmed.1999.0708. PMID 10714475.
· ^ Wilson R, Kubin R, Ballin I, et al (1999). "Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis". J. Antimicrob. Chemother. 44 (4): 501–13. doi:10.1093/jac/44.4.501. PMID 10588312. http://jac.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=10588312.
· ^ Rojas MX GC. Oral antibiotics versus parenteral antibiotics for severe pneumonia in children. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD004979. DOI: 10.1002/14651858.CD004979.pub2.
· ^ Panpanich R LP, Laopaiboon M. Azithromycin for acute lower respiratory tract infections. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD001954. DOI: 10.1002/14651858.CD001954.pub2.
· ^ AMH 2006 : Australian medicines handbook. [7th ed.] ed: Adelaide, South Australia : Australian Medicines Handbook, 2006.
· ^ Guppy MPB MS, Del Mar CB. . Advising patients to increase fluid intake for treating acute respiratory infections. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD004419. DOI: 10.1002/14651858.CD004419.pub2.
· ^ a b c Braun L. Herbs & natural supplements : an evidence-based guide / authors Lesley Braun, Marc Cohen. 2nd ed ed: Marrickville, N.S.W. : Elsevier Australia, 2006.
· ^ Wei J JN, Wu T, Chen X, Duan X, Liu G, Qiao J, Wang Q, Zhen J, Zhou L. . Chinese medicinal herbs for acute bronchitis. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD004560. DOI: 10.1002/14651858.CD004560.pub2.
· ^ Hemilä H LP. Vitamin C for preventing and treating pneumonia. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD005532. DOI: 10.1002/14651858.CD005532.pub2.
· ^ Ni J WJ, Wu T. . Vitamin A for non-measles pneumonia in children. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003700. DOI: 10.1002/14651858.CD003700.pub2.
· ^ Foxwell AR CA, Dear KBG. . Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD001958. DOI: 10.1002/14651858.CD001958.pub2.
· ^ Wu H, Pfarr DS, Johnson S, et al (2007). "Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract". J. Mol. Biol. 368 (3): 652–65. doi:10.1016/j.jmb.2007.02.024. PMID 17362988. http://linkinghub.elsevier.com/retrieve/pii/S0022-2836(07)00205-7.
^ Reveiz L, Cardona AF, Ospina EG (2007). "Antibiotics for acute laryngitis in adults". Cochrane Database Syst Rev (2): CD004783. doi:10.1002/14651858.CD004783.pub3. PMID 17443555.
^ Spurling GK, Del Mar CB, Dooley L, Foxlee R (2007). "Delayed antibiotics for respiratory infections". Cochrane Database Syst Rev (3): CD004417. doi:10.1002/14651858.CD004417.pub3. PMID 17636757.
^ Ram FS, Rodriguez-Roisin R, Granados-Navarrete A, Garcia-Aymerich J, BarnesNC (2006). "Antibiotics for exacerbations of chronic obstructive pulmonary disease". Cochrane Database Syst Rev (2): CD004403. doi:10.1002/14651858.CD004403.pub2. PMID 16625602.
^ Douglas RM, Hemilä H, Chalker E, Treacy B (2007). "Vitamin C for preventing and treating the common cold". Cochrane Database Syst Rev (3): CD000980. doi:10.1002/14651858.CD000980.pub3. PMID 17636648.
Park, David J. "Evidence Based Approach to Upper Respiratory Infections." December 10, 2006. Touro University Nevada College of Osteopathic Medicine
Testicle pain. MedlinePlus Medical Encyclopedia
· ^ Collins MM, Stafford RS, O'Leary MP, Barry MJ (1998). "How common is prostatitis? A national survey of physician visits". J. Urol. 159 (4): 1224–8. doi:10.1016/S0022-5347(01)63564-X. PMID 9507840.
· ^ Habermacher GM, Chason JT, Schaeffer AJ (2006). "Prostatitis/chronic pelvic pain syndrome". Annu. Rev. Med. 57: 195–206. doi:10.1146/annurev.med.57.011205.135654. PMID 16409145.
· ^ Taylor BC, Noorbaloochi S, McNaughton-Collins M, et al (May 2008). "Excessive antibiotic use in men with prostatitis". Am. J. Med. 121 (5): 444–9. doi:10.1016/j.amjmed.2008.01.043. PMID 18456041.
· ^ LuzziGA (2002). "Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management". Journal of the EuropeanAcademy of Dermatology and Venereology : JEADV 16 (3): 253–6. doi:10.1046/j.1468-3083.2002.00481.x. PMID 12195565.
· ^ Potts JM (2005). "Therapeutic options for chronic prostatitis/chronic pelvic pain syndrome". Current urology reports 6 (4): 313–7. doi:10.1007/s11934-005-0030-5. PMID 15978236.
· ^ Yang G, Wei Q, Li H, Yang Y, Zhang S, Dong Q (2006). "The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials". J. Androl. 27 (6): 847–52. doi:10.2164/jandrol.106.000661. PMID 16870951. "...treatment duration should be long enough (more than 3 months)".
· ^ Shoskes DA, Zeitlin SI, Shahed A, Rajfer J (1999). "Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial". Urology 54 (6): 960–3. doi:10.1016/S0090-4295(99)00358-1. PMID 10604689.
· ^ Elist J (2006). "Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study". Urology 67 (1): 60–3. doi:10.1016/j.urology.2005.07.035. PMID 16413333.
· ^ Anderson RU, Wise D, Sawyer T, Chan C (2005). "Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men". J. Urol. 174 (1): 155–60. doi:10.1097/01.ju.0000161609.31185.d5. PMID 15947608.
· ^ Anderson RU, Wise D, Sawyer T, ChanCA (2006). "Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training". J. Urol. 176 (4 Pt 1): 1534–8; discussion 1538–9. doi:10.1016/j.juro.2006.06.010. PMID 16952676.
· ^ Alexander RB, Propert KJ, Schaeffer AJ, et al (2004). "Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial". Ann. Intern. Med. 141 (8): 581–9. PMID 15492337.
· ^ Nickel JC, Downey J, Clark J, et al (2003). "Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial". Urology 62 (4): 614–7. doi:10.1016/S0090-4295(03)00583-1. PMID 14550427.
· ^ Korrovits P, Ausmees K, Mändar R, Punab M (June 2008). "Prevalence of asymptomatic inflammatory (National Institutes of Health Category IV) prostatitis in young men according to semen analysis". Urology 71 (6): 1010–5. doi:10.1016/j.urology.2007.12.082. PMID 18455767.
^ Bradshaw CS, Tabrizi SN, Read TR, et al (February 2006). "Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure". J Infect Dis. 193 (3): 336–45. doi:10.1086/499434. PMID 16388480.
^ the American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders: DSM-IV (4th ed.). Washington, DC: American Psychiatric Association. ISBN 0-89042-062-9.
^ Binik YM (Feb 2005). "Should dyspareunia be retained as a sexual dysfunction in DSM-V? A painful classification decision". Arch Sex Behav 34 (1): 11–21. doi:10.1007/s10508-005-0998-4. PMID 15772767.
^ Moser C (Feb 2005). "Dyspareunia: another argument for removal". Arch Sex Behav 34 (1): 44–6, 57–61; author reply 63–7. doi:10.1007/s10508-005-7473-z. PMID 16092029.
^ Denny E, Mann CH (2007). "Endometriosis-associated dyspareunia: the impact on women's lives". J Fam Plann Reprod Health Care 33 (3): 189–93. doi:10.1783/147118907781004831. PMID 17609078.
^ a b Bancroft J (1989). Human sexuality and its problems (2nd ed.). Edinburgh: Churchill Livingstone. ISBN 0-443-03455-9.
^ Bachmann GA, Leiblum SR, Kemmann E, Colburn DW, Swartzman L, Shelden R (Jul 1984). "Sexual expression and its determinants in the post-menopausal woman". Maturitas 6 (1): 19–29. doi:10.1016/0378-5122(84)90062-8. PMID 6433154.
^ a b Bergeron S, Binik YM, Khalifé S, Meana M, Berkley KJ, Pagidas K (1997). "The treatment of vulvar vestibulitis syndrome: Toward a multimodal approach". Sexual and Relationship Therapy 12 (4): 305–11. doi:10.1080/02674659708408174. http://www.informaworld.com/smpp/content~content=a788571576~db=all~order=page.
Bergeron S, Binik YM, Khalifé S, Pagidas K (1997). "Vulvar vestibulitis syndrome: a critical review". Clin J Pain 13 (1): 27–42. doi:10.1097/00002508-199703000-00006. PMID 9084950. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0749-8047&volume=13&issue=1&spage=27.
^ a b c MarinoffSC, Turner ML (1991). "Vulvar vestibulitis syndrome: an overview". Am J Obstet Gynecol. 165 (4 Pt 2): 1228–33. PMID 1659198.
^ a b Peckham BM, Maki DG, Patterson JJ, Hafez GR (April 1986). "Focal vulvitis: a characteristic syndrome and cause of dyspareunia. Features, natural history, and management". Am J Obstet Gynecol. 154 (4): 855–64. PMID 3963075.
^ Friedrich EG (1987). "Vulvar vestibulitis syndrome". J Reprod Med 32 (2): 110–4. PMID 3560069.
^ Kompanje EJ (2006). "Painful sexual intercourse caused by a disproportionately long penis: an historical note on a remarkable treatment devised by Guilhelmius Fabricius Hildanus (1560-1634)". Arch Sex Behav 35 (5): 603–5. doi:10.1007/s10508-006-9057-z. PMID 17031589. http://www.springerlink.com/content/m8q5725x4j066834/?p=8b89af7ac1c4419d80eefb7deeca0316&pi=8.
^ Wurn LJ, Wurn BF, King CR, Roscow AS, Scharf ES, Shuster JJ (2004). "Increasing orgasm and decreasing dyspareunia by a manual physical therapy technique". MedGenMed 6 (4): 47. PMID 15775874. PMC: 1480593. http://www.medscape.com/viewarticle/493989.
^ Wurn LJ, Wurn BF, King CR, Roscow AS, Scharf ES, Shuster JJ (Sep 2006). "Improving sexual function in patients with endometriosis via a pelvic physical therapy". Fertil Steril. 86 (3 Suppl): S29–30. doi:10.1016/j.fertnstert.2006.07.081. http://www.fertstert.org/article/S0015-0282(06)01660-8/fulltext.
The original text for this article is taken from a public domain CDC document PDF).
http://en.wikipedia.org/wiki/Dysuria
· ^ med/1037 at eMedicine
· ^ "American Cancer Society: "Can Anal Cancer Be Prevented?"". http://www.cancer.org/docroot/CRI/content/CRI_2_2_2x_Can_Anal_Cancer_Be_Prevented.asp?sitearea=. Retrieved on 2008-09-10.
· ^ Cortez, Michelle Fay and Pettypiece, Shannon. "Merck Cancer Shot Cuts Genital Warts, Lesions in Men". Bloomberg News. (Bloomberg.com) 13 Nov 2008.
· ^ HPV Vaccine Gardasil May Help Boys, Men by WebMD Health News, Nov 13, 2008
· ^ "Veragen package insert" (PDF). http://www.veregenrx.com/IL331%20Veregen%20PI%20170mm_x_420mm.pdf. Retrieved on 2008-08-18.
1. http://www.utdol.com/online/content/topic.do?topicKey=stds/7330
2. http://www.utdol.com/online/content/topic.do?topicKey=stds/3050&selectedTitle=1~28&source=search_result
· ^ a b Ryan KJ, Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. pp. 463–70. ISBN 0838585299.
· ^ KenyonCollege - Dept. of Biology (2006-08-15). "Chlamydia". MicrobeWiki. http://microbewiki.kenyon.edu/index.php/Chlamydia. Retrieved on 2008-10-27.
· ^ Budai I (March 2007). "Chlamydia trachomatis: milestones in clinical and microbiological diagnostics in the last hundred years: a review". Acta microbiologica et immunologica Hungarica 54 (1): 5–22. doi:10.1556/AMicr.54.2007.1.2. PMID 17523388.
· ^ Fredlund H, Falk L, Jurstrand M, Unemo M (2004). "Molecular genetic methods for diagnosis and characterisation of Chlamydia trachomatis and Neisseria gonorrhoeae: impact on epidemiological surveillance and interventions". APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 112 (11-12): 771–84. doi:10.1111/j.1600-0463.2004.apm11211-1205.x. PMID 15638837. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0903-4641&date=2004&volume=112&issue=11-12&spage=771.
· ^ Carlson JH, Whitmire WM, Crane DD, et al (June 2008). "The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor". Infection and immunity 76 (6): 2273–83. doi:10.1128/IAI.00102-08. PMID 18347045. PMC: 2423098. http://iai.asm.org/cgi/pmidlookup?view=long&pmid=18347045.
· ^ Ortiz L, Angevine M, Kim SK, Watkins D, DeMars R (2000). "T-cell epitopes in variable segments of Chlamydia trachomatis major outer membrane protein elicit serovar-specific immune responses in infected humans". Infect. Immun. 68 (3): 1719–23. doi:10.1128/IAI.68.3.1719-1723.2000. PMID 10678996.
· ^ "CDC - STD Surveillance - Gonorrhea". http://www.cdc.gov/std/stats/gonorrhea.htm. Retrieved on 2008-08-21.
· ^ "CDC Fact Sheet - Chlamydia". http://www.cdc.gov/std/Chlamydia/STDFact-Chlamydia.htm. Retrieved on 2008-08-21.
· ^ "Erythromycin ointment for ocular prophylaxis of neonatal chlamydial infection". http://www.ncbi.nlm.nih.gov/pubmed/7431552. Retrieved on 2008-07-14.
· ^ YT van Duynhoven (1999). "The epidemiology of Neisseria gonorrheae in Europe". Microbes and Infection 1 (6): 455–464. doi:10.1016/S1286-4579(99)80049-5. PMID 10602678.
· ^ a b c Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; & Mitchell, Richard N. (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier. pp. 705-706 ISBN 978-1-4160-2973-1
· ^ "CDC Update to Sexually Transmitted Treatment Guidelines". http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5614a3.htm?s_cid=mm5614a3_e. Retrieved on 2008-08-21.
· ^ "CDC STD Treatment Regimens". http://www.cdc.gov/std/treatment/2006/updated-regimens.htm. Retrieved on 2008-08-21.
· ^ Health Protection Agency. "The gonococcal resistance to antimicrobials surveillance programme: Annual report 2005" (PDF). http://www.hpa.org.uk/infections/topics_az/hiv_and_sti/sti-gonorrhea/publications/GRASP_2005_Annual_Report.pdf. Retrieved on 2006-10-28.
· ^ d'Urfey, Thomas. "Pills to Purge Melancholy", 1719. To Chuse a Friend
· ^ Max Bender (1898). "Ueber neuere Antigonorrhoica (insbes. Argonin und Protargol)". Archives of Dermatological Research 43 (1): 31–36. doi:10.1007/BF01986890.
· ^ "MedlinePlus - Neonatal Conjunctivitis". http://www.nlm.nih.gov/medlineplus/ency/article/001606.htm. Retrieved on 2008-08-28.
· ^ W Sanger. History of Prostitution. NY,Harper, 1910 .
· ^ P. LaCroix. The History of Prostitution—Vol. 2. NY,MacMillan, 1931.
· ^ WE Leiky. History of European Morals. NY, MacMillan, 1926.
· ^ "Gonorrhea - CDC Fact Sheet". http://www.cdc.gov/std/Gonorrhea/STDFact-gonorrhea.htm. Retrieved on 2008-07-31.
· ^ Murray P. et al. (2005), Medical Microbiology, fifth ed., Elsevier Mosby, p. 336.
· ^ Rashid RM, Janjua SA, Khachemoune A (2006). "Granuloma inguinale: a case report". Dermatol. Online J. 12 (7): 14. PMID 17459300. http://dermatology-s10.cdlib.org/127/case_reports/inguinale/khachemoune.html.
· ^ McLeod K. Precis of operations performed in the wards of the first surgeon, Medical College Hospital, during the year 1881. Indian Med Gazette 1882;11:113.
· ^ Murray P. et al. (2005), Medical Microbiology, fifth ed., Elsevier Mosby, p. 336.
· ^ Donovan, C.: Ulcerating Granuloma of the Pudenda, Indian Medical Gazette 40:414, 1905
· ^ granuloma inguinale at Dorland's Medical Dictionary
· ^ O'Farrell N (December 2002). "Donovanosis". Sex Transm Infect 78 (6): 452–7. PMID 12473810.
· ^ Murray P. et al. (2005), Medical Microbiology, fifth ed., Elsevier Mosby, p. 336.
· ^ * Boye K, Hansen DS (February 2003). "Sequencing of 16S rDNA of Klebsiella: taxonomic relations within the genus and to other Enterobacteriaceae". Int. J. Med. Microbiol. 292 (7-8): 495–503. PMID 12635932.
· ^ Carter JS, Bowden FJ, Bastian I, Myers GM, SriprakashKS, Kemp DJ (October 1999). "Phylogenetic evidence for reclassification of Calymmatobacterium granulomatis as Klebsiella granulomatis comb. nov". Int. J. Syst. Bacteriol. 49 Pt 4: 1695–700. PMID 10555350.
^ Ward H, Martin I, Macdonald N, et al (January 2007). "Lymphogranuloma venereum in the United kingdom". Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 44 (1): 26–32. doi:10.1086/509922. PMID 17143811. http://www.journals.uchicago.edu/doi/abs/10.1086/509922?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov.
^ "eMedicine - Lymphogranuloma Venereum: Article by Andrew C Bushnell". http://www.emedicine.com/EMERG/topic304.htm. Retrieved on 2007-10-26.
^ synd/1431 at Who Named It?
^ N. J. Durand, J. Nicolas, M. Favre. Lymphogranulomatose inguinale subaiguë d’origine génitale probable, peut-être vénérienne. Bulletin de la Société des Médecins des Hôpitaux de Paris, 1913, 3 sér., 35: 274-288.
^ Richardson D, Goldmeier D (January 2007). "Lymphogranuloma venereum: an emerging cause of proctitis in men who have sex with men". International journal of STD & AIDS 18 (1): 11–4; quiz 15. doi:10.1258/095646207779949916. PMID 17326855. http://ijsa.rsmjournals.com/cgi/pmidlookup?view=long&pmid=17326855.
^ Thomas H. Maugh II. Virulent Chlamydia Detected Largely Among Gay Men in U.S. Los Angeles Times: 11 May 2006
^ Michael Brown. LGV in the UK: almost 350 cases reported and still predominantly affecting HIV-positive gay men Aidsmap: 17 May 2006
^ Kivi M, Koedijk FD, van der Sande M, van de Laar MJ (April 2008). "Evaluation prompting transition from enhanced to routine surveillance of lymphogranuloma venereum (LGV) in the Netherlands". Euro surveillance: bulletin européen sur les maladies transmissibles = European communicable disease bulletin 13 (14). PMID 18445453. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8087.
^ Jebbari H, Alexander S, Ward H, et al (July 2007). "Update on lymphogranuloma venereum in the United Kingdom". Sexually transmitted infections 83 (4): 324–6. doi:10.1136/sti.2007.026740. PMID 17591663. http://sti.bmj.com/cgi/pmidlookup?view=long&pmid=17591663.
^ Stark D, van Hal S, Hillman R, Harkness J, Marriott D (March 2007). "Lymphogranuloma venereum in Australia: anorectal Chlamydia trachomatis serovar L2b in men who have sex with men". Journal of clinical microbiology 45 (3): 1029–31. doi:10.1128/JCM.02389-06. PMID 17251405. PMC: 1829134. http://jcm.asm.org/cgi/pmidlookup?view=long&pmid=17251405.
^ Schaeffer A, Henrich B (2008). "Rapid detection of Chlamydia trachomatis and typing of the Lymphogranuloma venereum associated L-Serovars by TaqMan PCR". BMC infectious diseases 8: 56. doi:10.1186/1471-2334-8-56. PMID 18447917. PMC: 2387162. http://www.biomedcentral.com/1471-2334/8/56.
^ Kapoor S (April 2008). "Re-emergence of lymphogranuloma venereum". Journal of the EuropeanAcademy of Dermatology and Venereology: JEADV 22 (4): 409–16. doi:10.1111/j.1468-3083.2008.02573.x. PMID 18363909. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0926-9959&date=2008&volume=22&issue=4&spage=409.
^ McLeanCA, Stoner BP, Workowski KA (April 2007). "Treatment of lymphogranuloma venereum". Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 44 Suppl 3: S147–52. doi:10.1086/511427. PMID 17342667. http://www.journals.uchicago.edu/doi/abs/10.1086/511427?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov.
Original article from the public domain resource "1998 Guidelines for Treatment of Sexually Transmitted Diseases" MMWR 47(RR-1);1-118 Publication date: 23 January 1998 at http://wonder.cdc.gov/wonder/prevguid/p0000480/p0000480.asp#head007005000000000 note that this has not been modified since 1998, and may be out of date.
^ C. M. Fraser et al (July 1998). "Complete Genome Sequence of Treponema pallidum, the Syphilis Spirochete". Science 281 (5375): 375–388. doi:10.1126/science.281.5375.375. http://www.sciencemag.org/cgi/content/abstract/281/5375/375.
^ "Syphilis Genome Sequence Offers Clues to Better Diagnosis, Prevention and Treatment". National Institute of Allergy and Infectious Diseases (NIAID). 1998. http://www3.niaid.nih.gov/news/newsreleases/1998/syphilis.htm.
^ "Syphilis". Online Etymology Dictionary. 2001. http://www.etymonline.com/.
^ Rudy's List of Archaic Medical Terms (2007-04-27). ""B"". Antiquus Morbus. http://www.antiquusmorbus.com/English/EnglishB.htm. Retrieved on 2008-04-28.
Referencing:
Robley Dunglison (1874). Dunglison's Medical Dictionary – A Dictionary of Medical Science. Philadelphia, USA: Collins.
^ Keys D (2007). "English syphilis epidemic pre-dated European outbreaks by 150 years". Independent News and Media Limited. http://news.independent.co.uk/health/article266422.ece. Retrieved on 2007-09-22.
^ Henneberg M, Henneberg RJ (1994). "Treponematosis in an Ancient Greek colony of Metaponto, Southern Italy 580-250 BCE". in O Dutour, G Palfi, J Berato, J-P Brun (eds). The Origin of Syphilis in Europe, Before or After 1493?. Toulon-Paris: Centre Archeologique du Var, Editions Errance. pp. 92–98.
^ Henneberg M, Henneberg RJ (2002). "Reconstructing Medical Knowledge in Ancient Pompeii from the Hard Evidence of Bones and Teeth". in J Renn, G Castagnetti (eds). Homo Faber: Studies on Nature. Technology and Science at the Time of Pompeii,. Rome: "L’ERMA" di Bretschneider. pp. pp.169–187.
^ Rose M (January/February 1997). "Origins of Syphilis". Archaeology 50 (1). http://www.archaeology.org/9701/newsbriefs/syphilis.html.
^ Baker, et al.[citation needed]
^ Debora MacKenzie (15 January 2008). "Columbus blamed for spread of syphilis". NewScientist. http://www.newscientist.com/article/dn13186-columbus-blamed-for-spread-of-syphilis-.html.
^ Harper KN, Ocampo PS, Steiner BM, et al (2008). "On the origin of the treponematoses: a phylogenetic approach". PLoS Negl Trop Dis 2 (1): e148. doi:10.1371/journal.pntd.0000148. PMID 18235852. http://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0000148.
^ a b ref:225 Crosby[citation needed]
^ a b c Lobdell J, Owsley D (August 1974). "The origin of syphilis". Journal of Sex Research 10 (1): 76–79. (via JSTOR)
^ The Metropolitan Museum of Art Bulletin, Summer 2007, pp. 55-56.
^ "Noguchi, Hideyo". The Columbia Encyclopedia (Sixth Edition ed.). http://www.bartleby.net/65/no/NoguchiH.html.
^ Wilson, A. G. (2001). Tolstoy: A Biography. New York: Norton. ISBN 0-393-32122-3.
^ Lerner V, Finkelstein Y, Witztum E (June 2004). "The enigma of Lenin's (1870-1924) malady". Eur. J. Neurol. 11 (6): 371–6. doi:10.1111/j.1468-1331.2004.00839.x. PMID 15171732. http://www.blackwell-synergy.com/action/showFullText?submitFullText=Full+Text+HTML&doi=10.1111%2Fj.1468-1331.2004.00839.x.
^ Oriel, J.D. (1994). The Scars of Venus: A History of Venereology. London: Springer-Verlag.
^ Diamond, Jared (1997). Guns, Germs and Steel. New York: W.W. Norton. pp. 210.
^ "Genetic Study Bolsters Columbus Link to Syphilis", New York Times, January 15, 2008
^ "Columbus May Have Brought Syphilis to Europe", LiveScience
^ Tithonus, Pednuad, J.. "Eugen Sandow - Father of Bodybuilding". The Human Marvels. http://thehumanmarvels.com/blog/?p=138. Retrieved on 2008-09-17. "At the time of his death in 1925, a cover story was released stating Sandow died prematurely at age 58 of a stroke shortly after pushing his car out of the mud. The actual cause of death was more likely due to complications from syphilis." [unreliable source?]
^ a b c d Pickering LK, ed. (2006), "Syphilis", Red Book, Elk Grove Village, IL: American Academy of Pediatrics, pp. 631–644
^ Centers for Disease Control (CDC) (05-2004). "STD Facts - Syphilis". Centers for Disease Control. http://www.cdc.gov/std/syphilis/STDFact-Syphilis.htm. Retrieved on 2007-05-30.
^ Dylewski J, Duong M (2 January 2007). "The rash of secondary syphilis". CMAJ. 176 (1): 33–5. doi:10.1503/cmaj.060665. PMID 17200385.
^ Clark EG, Danbolt N (1964). "The Oslo study of the natural course of untreated syphilis: An epidemiologic investigation based on a re-study of the Boeck-Bruusgaard material". Med Clin North Am. 48: 613.
^ Sapira JD (April 1981). "Quincke, de Musset, Duroziez, and Hill: some aortic regurgitations". South. Med. J. 74 (4): 459–67. PMID 7013091. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0038-4348&volume=74&issue=4&spage=459.
^ Richard B. Jamess, MD, PhD (2002). "Syphilis- Sexually Transmitted Infections, 2006.". Sexually transmitted diseases treatment guidelines.
^ Walter T, Lebouche B, Miailhes P, et al. (2006). "Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients". Clin Infect Dis 43 (6): 787–90. doi:10.1086/507099. PMID 16912958.
^ How can Syphilis be Prevented?, Centers for Disease Control and Prevention
^ Hanlon M (7 June 2007). "The magical properties of Mercury, the metal the EU wants to ban". The Daily Mail. http://www.dailymail.co.uk/pages/live/articles/news/news.html?in_article_id=460406&in_page_id=1770. Retrieved on 2007-08-07.
^ Thomas James Walker (December 4 1869). "The Treatment of Syphilis by the Hypodermic Injection of the Salts of Mercury". Br Med J. 2 (466): 605–608.
^ Ozuah, Philip O. (March 2000), "Mercury poisoning", Current Problems in Pediatrics 30 (3): 91-99 [91]
^ Brown, Kevin (2006). The Pox: The Life and Near Death of a Very Social Disease. Stroud: WSutton. pp. 85–111, 185–91.
^ Centers for Disease Control (08-04-2006). "Sexually Transmitted Diseases Treatment Guidelines, 2006". MMWR 55 (RR-11): 24–32.
^ Lukehart SA, Godornes C, Molini BJ, et al (July 2004). "Macrolide resistance in Treponema pallidum in the United States and Ireland". N. Engl. J. Med. 351 (2): 154–8. doi:10.1056/NEJMoa040216. PMID 15247355.
^ Mitchell SJ, Engelman J, Kent CK, Lukehart SA, Godornes C, Klausner JD (February 2006). "Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004". Clin. Infect. Dis. 42 (3): 337–45. doi:10.1086/498899. PMID 16392078.
^ Rolfs RT, Joesoef MR, Hendershot EF, et al (July 1997). "A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group". N. Engl. J. Med. 337 (5): 307–14. doi:10.1056/NEJM199707313370504. PMID 9235493. http://content.nejm.org/cgi/content/full/337/5/307.
^ "A A World. Reference Room. Articles. Tuskegee Syphilis Study". http://www.pbs.org/wnet/aaworld/reference/articles/tuskegee_syphilis_study.html. Retrieved on 2007-08-07.
^ Johannes Stradanus undated brief review of works hosted at the University of York in the United Kingdom. Accessed August 6, 2007.
^ Jan van der Straet's "Preparation..." at commercial art site. Accessed August 6, 2007.
^ wikisource:es:Historia de la vida del Buscón: Libro Primero: Capítulo III: continues with [...] porque se le había comido de unas búas de resfriado, que aun no fueron de vicio porque cuestan dinero;: "[...] because it had been eaten by the bubons of a cold, which were not of vice because they cost money;".
^ "O Mist�rio da Estrada de Sintra". http://www.filmesfundo.com/omisteriodaestradadesintra. Retrieved on 2007-08-07.
^ http://www.ucolick.org/~randi/aecom/syphilis.txt
· ^ a b c d Loscalzo, Joseph; Andreoli, Thomas E.; Cecil, Russell L.; Carpenter, Charles A.; Griggs, Robert C. (2001). Cecil essentials of medicine. Philadelphia: W.B. Saunders. ISBN 0-7216-8179-4. OCLC 43051599.
· ^ "STD Facts - Pelvic inflammatory disease (PID)". http://www.cdc.gov/std/PID/STDFact-PID.htm. Retrieved on 2007-11-23.
· ^ a b c Lauren Nathan; DeCherney, Alan H.; Pernoll, Martin L. (2003). Current obstetric & gynecologic diagnosis & treatment. New York: Lange Medical Books/McGraw-Hill. ISBN 0-8385-1401-4. OCLC 150148652.
· ^ Blenning CE, Muench J, Judkins DZ, Roberts KT (2007). "Clinical inquiries. Which tests are most useful for diagnosing PID?". J Fam Pract 56 (3): 216–20. PMID 17343812.
· ^ Walker CK, Wiesenfeld HC (2007). "Antibiotic therapy for acute pelvic inflammatory disease: the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines". Clin. Infect. Dis. 44 Suppl 3: S111–22. doi:10.1086/511424. PMID 17342664.
· ^ Smith KJ, Cook RL, Roberts MS (2007). "Time from sexually transmitted infection acquisition to pelvic inflammatory disease development: influence on the cost-effectiveness of different screening intervals". Value Health 10 (5): 358–66. doi:10.1111/j.1524-4733.2007.00189.x. PMID 17888100.
^ Bradshaw CS, Tabrizi SN, Read TR, et al (February 2006). "Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure". J Infect Dis. 193 (3): 336–45. doi:10.1086/499434. PMID 16388480.
· ^ a b Hunt, Richard (2007-11-21). "Hepatitis viruses". University of Southern California, Department of Pathology and Microbiology. http://pathmicro.med.sc.edu/virol/hepatitis-virus.htm. Retrieved on 2008-03-13.
· ^ a b Hassan MM, Li D, El-DeebAS, et al (October 2008). "Association between hepatitis B virus and pancreatic cancer". J. Clin. Oncol. 26 (28): 4557–62. doi:10.1200/JCO.2008.17.3526. PMID 18824707. PMC: 2562875. http://www.jco.org/cgi/pmidlookup?view=long&pmid=18824707.
· ^ Schwalbe M, Ohlenschläger O, Marchanka A, et al (March 2008). "Solution structure of stem-loop alpha of the hepatitis B virus post-transcriptional regulatory element". Nucleic Acids Res. 36 (5): 1681–9. doi:10.1093/nar/gkn006. PMID 18263618. PMC: 2275152. http://nar.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=18263618.
· ^ Mason, W.S. et al. (2008-07-08). "00.030. Hepadnaviridae - ICTVdB Index of Viruses". International Committee on Taxonomy of Viruses. http://www.ncbi.nlm.nih.gov/ICTVdb/Ictv/fs_hepad.htm. Retrieved on 2009-03-13.
· ^ a b Kramvis A, Kew M, François G (2005). "Hepatitis B virus genotypes". Vaccine 23 (19): 2409–23. doi:10.1016/j.vaccine.2004.10.045. PMID 15752827.
· ^ Magnius LO, Norder H (1995). "Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene". Intervirology 38 (1-2): 24–34. PMID 8666521.
· ^ Zuckerman AJ (1996). Hepatitis Viruses. In: Baron's Medical Microbiology (Baron S et al, eds.) (4th ed.). Univ of Texas Medical Branch. ISBN 0-9631172-1-1. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=mmed.section.3738.
· ^ Locarnini S (2004). "Molecular virology of hepatitis B virus". Semin. Liver Dis. 24 Suppl 1: 3–10. doi:10.1055/s-2004-828672. PMID 15192795.
· ^ Howard CR (1986). "The biology of hepadnaviruses". J. Gen. Virol. 67 ( Pt 7): 1215–35. doi:10.1099/0022-1317-67-7-1215. PMID 3014045.
· ^ Guo GH, Tan DM, Zhu PA, Liu F (February 2009). "Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2". HBPD INT 8 (1): 59–64. PMID 19208517. http://www.hbpdint.com/text.asp?id=1196.
· ^ Chai N, Chang HE, Nicolas E, Han Z, Jarnik M, Taylor J (August 2008). "Properties of subviral particles of hepatitis B virus". J. Virol. 82 (16): 7812–7. doi:10.1128/JVI.00561-08. PMID 18524834. PMC: 2519590. http://jvi.asm.org/cgi/pmidlookup?view=long&pmid=18524834.
· ^ Kay A, Zoulim F (2007). "Hepatitis B virus genetic variability and evolution". Virus Res. 127 (2): 164–76. doi:10.1016/j.virusres.2007.02.021. PMID 17383765.
· ^ a b Beck J, Nassal M (2007). "Hepatitis B virus replication". World J. Gastroenterol. 13 (1): 48–64. PMID 17206754.
· ^ Bouchard MJ, Schneider RJ (2004). "The enigmatic X gene of hepatitis B virus". J. Virol. 78 (23): 12725–34. doi:10.1128/JVI.78.23.12725-12734.2004. PMID 15542625.
· ^ Olinger CM, Jutavijittum P, Hübschen JM, et al (November 2008). "Possible new hepatitis B virus genotype, southeast Asia". Emerging Infect. Dis. 14 (11): 1777–80. PMID 18976569. PMC: 2630741. http://www.cdc.gov/eid/content/14/11/1777.htm.
· ^ Kurbanov F, Tanaka Y, Kramvis A, Simmonds P, Mizokami M (August 2008). "When should "I" consider a new hepatitis B virus genotype?". J. Virol. 82 (16): 8241–2. doi:10.1128/JVI.00793-08. PMID 18663008. PMC: 2519592. http://jvi.asm.org/cgi/pmidlookup?view=long&pmid=18663008.
· ^ Palumbo E (2007). "Hepatitis B genotypes and response to antiviral therapy: a review". Am J Ther 14 (3): 306–9. doi:10.1097/01.pap.0000249927.67907.eb. PMID 17515708. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00045391-200705000-00016.
· ^ Mahtab MA, Rahman S, Khan M, Karim F (October 2008). "Hepatitis B virus genotypes: an overview". HBPD INT 7 (5): 457–64. PMID 18842489. http://www.hbpdint.com/text.asp?id=1142.
· ^ Cavinta L., Sun J., May A., Yin J., von Meltzer M., Radtke M., Barzaga N.G., Cao G., Schaefer S.(2009) A new isolate of hepatitis B virus from the Philippines possibly representing a new subgenotype C6. J. Med. Virol. 81(6):983-987
· ^ Lusida M.I., Nugrahaputra V.E., Soetjipto, Handajani R., Nagano-Fujii M., Sasayama M., Utsumi T., Hotta H.(2008) Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J. Clin. Microbiol. 46(7):2160-2166
· ^ Bruss V (2007). "Hepatitis B virus morphogenesis". World J. Gastroenterol. 13 (1): 65–73. PMID 17206755.
· ^ Rick Sowadsky (1999-02-24). "What is HTLV-III?". http://www.thebody.com/Forums/AIDS/safesex/Archive/origins/Q8777.html. Retrieved on 2008-04-03.
· ^ Coffin, J., Haase, A., Levy, J. A., Montagnier, L., Oroszlan, S., Teich, N., Temin, H., Toyoshima, K., Varmus, H., Vogt, P. and Weiss, R. A. (1986). "What to call the AIDS virus?". Nature 321 (6065): 10. doi:10.1038/321010a0. PMID 3010128.
· ^ a b c Joint United Nations Programme on HIV/AIDS (2006). "Overview of the global AIDS epidemic" (PDF). 2006 Report on the global AIDS epidemic.
· ^ Greener, R. (2002). "AIDS and macroeconomic impact". in S, Forsyth (ed.). State of The Art: AIDS and Economics. IAEN. pp. 49–55.
· ^ Joint United Nations Programme on HIV/AIDS. "AIDS epidemic update, 2005" (PDF). http://www.unaids.org/epi/2005/doc/EPIupdate2005_pdf_en/epi-update2005_en.pdf. Retrieved on 2006-02-28.
· ^ Palella, F. J. Jr, Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman and D. J., Holmberg, S. D. (1998). "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators". N. Engl. J. Med 338 (13): 853–860. doi:10.1056/NEJM199803263381301. PMID 9516219.
· ^ LawnSD (2004). "AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection". J. Infect. Dis. 48 (1): 1–12. PMID 14667787.
· ^ Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. (1994). "Long-term HIV-1 infection without immunologic progression". AIDS 8 (8): 1123–8. doi:10.1097/00002030-199408000-00014. PMID 7986410.
· ^ Schneider MF, Gange SJ, Williams CM, Anastos K, Greenblatt RM, Kingsley L, Detels R, Munoz A (2005). "Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984–2004". AIDS 19 (17): 2009–18. PMID 16260908.
· ^ a b Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JA (2002). "HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?". AIDS 16 (4): 597–632. PMID 11873003.
· ^ International Committee on Taxonomy of Viruses. "61.0.6. Lentivirus". National Institutes of Health. http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/61060000.htm. Retrieved on 2006-02-28.
· ^ International Committee on Taxonomy of Viruses. "61. Retroviridae". National Institutes of Health. http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/61000000.htm. Retrieved on 2006-02-28.
· ^ Lévy, J. A. (1993). "HIV pathogenesis and long-term survival". AIDS 7 (11): 1401–10. doi:10.1097/00002030-199311000-00001. PMID 8280406.
· ^ Smith, Johanna A.; Daniel, René (Division of Infectious Diseases, Center for Human Virology, ThomasJeffersonUniversity, Philadelphia) (2006). "Following the path of the virus: the exploitation of host DNA repair mechanisms by retroviruses". ACS Chem Biol 1 (4): 217–26. doi:10.1021/cb600131q. PMID 17163676.
· ^ a b Reeves, J. D. and Doms, R. W (2002). "Human Immunodeficiency Virus Type 2". J. Gen. Virol. 83 (Pt 6): 1253–65. PMID 12029140.
· ^ "Worobey et al : : Nature". http://www.nature.com/nature/journal/v455/n7213/full/nature07390.html.
· ^ "Pneumocystis Pneumonia -- Los Angeles". http://www.cdc.gov/MMWR/preview/mmwrhtml/00043494.htm. Retrieved on 2008-05-05.
· ^ Gao, F., Bailes, E., Robertson, D. L., Chen, Y., Rodenburg, C. M., Michael, S. F., Cummins, L. B., Arthur, L. O., Peeters, M., Shaw, G. M., Sharp, P. M., and Hahn, B. H. (1999). "Origin of HIV-1 in the Chimpanzee Pan troglodytes troglodytes". Nature 397 (6718): 436–441. doi:10.1038/17130. PMID 9989410.
· ^ Keele, B. F., van Heuverswyn, F., Li, Y. Y., Bailes, E., Takehisa, J., Santiago, M. L., Bibollet-Ruche, F., Chen, Y., Wain, L. V., Liegois, F., Loul, S., Mpoudi Ngole, E., Bienvenue, Y., Delaporte, E., Brookfield, J. F. Y., Sharp, P. M., Shaw, G. M., Peeters, M., and Hahn, B. H. (2006). "Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1". Science Online 2006-05-25: 523. doi:10.1126/science.1126531. PMID 16728595. http://www.sciencemag.org/cgi/content/abstract/1126531. Retrieved on 2009-03-31.
· ^ http://www.nature.com/nature/journal/v397/n6718/abs/397436a0_fs.html
· ^ Goodier, J., and Kazazian, H. (2008). "Retrotransposons Revisited: The Restraint and Rehabilitation of Parasites". Cell 135 (1): 23–35. doi:10.1016/j.cell.2008.09.022. http://www.sciencedirect.com/science/article/B6WSN-4TK9636-8/2/2af3e1e709ed15939505cf676ce4957c. Retrieved on 2008-10-10.
· ^ a b c Brown, Phyllida (25 May 1991). "The strains of the HIV war". New Scientist. http://www.newscientist.com/channel/health/mg13017703.800-the-strains-of-the-hiv-war.html.
· ^ "Nobel Prize awarded for AIDS, cervical cancer research -". Los Angeles Times. http://articles.latimes.com/2008/oct/06/science/sci-nobel7. Retrieved on 2008-10-06.
· ^ a b Karolinska Institute (2008-10-06). The Nobel Prize in Physiology or Medicine 2008. Press release. http://nobelprize.org/nobel_prizes/medicine/laureates/2008/press.html. Retrieved on 2008-10-07.
· ^ Mark Henderson (October 6, 2008). "Nobel Medicine Prize row as HIV scientist is excluded". The Times. http://www.timesonline.co.uk/tol/news/uk/science/article4892374.ece. Retrieved on 2009-02-22.
· ^ Smith DK, Grohskopf LA, Black RJ, et al (2005). "Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States". MMWR 54 (RR02): 1–20. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm#tab1. Retrieved on 2009-03-31.
· ^ Donegan E, Stuart M, Niland JC, et al (1990). "Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations". Ann. Intern. Med. 113 (10): 733–739. PMID 2240875.
· ^ a b c Coovadia H (2004). "Antiretroviral agents—how best to protect infants from HIV and save their mothers from AIDS". N. Engl. J. Med. 351 (3): 289–292. PMID 15247337.
· ^ Kaplan EH, Heimer R (1995). "HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data". J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10 (2): 175–176. PMID 7552482.
· ^ Bell DM (1997). "Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview.". Am. J. Med. 102 (5B): 9–15. PMID 9845490.
· ^ a b c d European Study Group on Heterosexual Transmission of HIV (1992). "Comparison of female to male and male to female transmission of HIV in 563 stable couples". BMJ. 304 (6830): 809–813. PMID 1392708.
· ^ a b c d e f Varghese B, Maher JE, Peterman TA, Branson BM,Steketee RW (2002). "Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use". Sex. Transm. Dis. 29 (1): 38–43. PMID 11773877.
· ^ Leynaert B, Downs AM, de Vincenzi I (1998). "Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV". Am. J. Epidemiol. 148 (1): 88–96. PMID 9663408.
· ^ Boily M-C, Baggaley RF, Wang L, et al. (2009). "Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies". Lancet Infect Dis 9 (2): 118-129. doi:10.1016/S1473-3099(09)70021-0.
· ^ National Institute of Allergy and Infectious Diseases; National Institutes of Health, Department of Health and Human Services (2001-07-20). "Workshop Summary: Scientific Evidence on Condom Effectiveness for Sexually Transmitted Disease (STD) Prevention" (PDF).: pp.13-15. Retrieved on 2009-01-08.
· ^ "Should spermicides be used with condoms?". Condom Brochure, FDA OSHI HIV STDs. http://www.fda.gov/oashi/aids/condom.html#should. Retrieved on 2006-10-23.
· ^ Weiss, H.A.; M.A. Quigley, R.J. Hayes (2000). "Male circumcision and risk of HIV infection in sub-Saharan Africa: A systematic review and meta-analysis". AIDS 14 (15): 2361–70. doi:10.1097/00002030-200010200-00018. PMID 11089625.
· ^ Siegfried, N., Muller, M., Deeks, J., Volmink, J., Egger, M., Low, N., Walker, S. and Williamson, P. (2005). "HIV and male circumcision--a systematic review with assessment of the quality of studies". Lancet Infect. Dis. 5 (3): 165–73. PMID 15766651.
· ^ Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, de Zoysa I, Dye C, Auvert B. (2006). "The Potential Impact of Male Circumcision on
HIV in Sub-Saharan Africa.". PLoS Med 3 (7): e262. doi:10.1371/journal.pmed.0030262. PMID 16822094.
· ^ Bailey RC, Moses S, Parker CB, et al (2007). "Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial". Lancet 369 (9562): 643–56. doi:10.1016/S0140-6736(07)60312-2. PMID 17321310.
· ^ Gray RH et al (24 February 2007). "Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial". Lancet 369 (9562): 657–66. doi:10.1016/S0140-6736(07)60313-4. PMID 17321311.
· ^ WHO (2007). "WHO and UNAIDS announce recommendations from expert consultation on male circumcision for HIV prevention". WHO.int. http://www.who.int/hiv/mediacentre/news68/en/index.html. Retrieved on 2007-07-13.
· ^ Various (2005). "Repeated Use of Unsterilized Blades in Ritual Circumcision Might Contribute to HIV Spread in S. Africa, Doctors Say". Kaisernetwork.org. http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=31199. Retrieved on 2006-03-28.
· ^ LifsonAR (1988). "Do alternate modes for transmission of human immunodeficiency virus exist? A review". JAMA 259 (9): 1353–6. doi:10.1001/jama.259.9.1353. PMID 2963151.
· ^ Smith D, Richman D, Little S (2005). "HIV Superinfection". Journal of Infectious Diseases 192: 438–44. doi:10.1086/431682. PMID 15995957.
· ^ Gottlieb, et al (2004). "Dual HIV-1 infection associated with rapid disease progression". Lancet 363 (9049): 619–22. doi:10.1016/S0140-6736(04)15596-7. PMID 14987889.
· ^ Smith et al (2004). "Incidence of HIV superinfection following primary infection". JAMA 292 (10): 1177–8. doi:10.1001/jama.292.10.1177. PMID 15353529. http://jama.ama-assn.org/cgi/content/full/292/10/1177. Retrieved on 2009-03-31.
· ^ Chohan B, Lavreys L, Rainwater SM, Overbaugh J (August 2005). "Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype". J. Virol. 79 (16): 10701–8. doi:10.1128/JVI.79.16.10701-10708.2005. PMID 16051862.
· ^ Piantadosi A, Chohan B, Chohan V, McClelland RS, Overbaugh J (November 2007). "Chronic HIV-1 infection frequently fails to protect against superinfection". PLoS Pathog. 3 (11): e177. doi:10.1371/journal.ppat.0030177. PMID 18020705.
· ^ Hu DJ, Subbarao S, Vanichseni S, et al (February 2005). "Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand". AIDS 19 (3): 303–8. PMID 15718841. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00002030-200502180-00009. Retrieved on 2009-03-31.
· ^ McGovern SL, Caselli E, Grigorieff N, Shoichet BK (2002). "A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening". J Med Chem 45 (8): 1712–22. PMID 11931626.
· ^ Compared with overview in: Fisher, Bruce; Harvey, Richard P.; Champe, Pamela C. (2007). Lippincott's Illustrated Reviews: Microbiology (Lippincott's Illustrated Reviews Series). Hagerstown, MD: Lippincott Williams & Wilkins. ISBN 0-7817-8215-5. Page 3
· ^ a b c d e f g Various (2008) (PDF). HIV Sequence Compendium 2008 Introduction. http://www.hiv.lanl.gov/content/sequence/HIV/COMPENDIUM/2008/frontmatter.pdf. Retrieved on 2009-03-31.
· ^ a b c Chan, DC., Fass, D., Berger, JM., Kim, PS. (1997). "Core Structure of gp41 from the HIV Envelope Glycoprotein" (PDF). Cell 89: 263–73. PMID 9108481. http://www.its.caltech.edu/~chanlab/PDFs/Chan_Cell_1997.pdf. Retrieved on 2009-03-31.
· ^ National Institute of Health (June 17, 1998). "Crystal Structure of Key HIV Protein Reveals New Prevention, Treatment Targets". http://www3.niaid.nih.gov/news/newsreleases/1998/hivprotein.htm. Retrieved on 2006-09-14.
· ^ Ouellet DL, Plante I, Landry P, et al (April 2008). "Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element". Nucleic Acids Res. 36 (7): 2353–65. doi:10.1093/nar/gkn076. PMID 18299284. PMC: 2367715. http://nar.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=18299284.
· ^ Klase Z, Winograd R, Davis J, et al (2009). "HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression". Retrovirology 6: 18. doi:10.1186/1742-4690-6-18. PMID 19220914. PMC: 2654423. http://www.retrovirology.com/content/6//18.
· ^ Garcia JV, Miller AD (April 1991). "Serine phosphorylation-independent downregulation of cell-surface CD4 by nef". Nature 350 (6318): 508–11. doi:10.1038/350508a0. PMID 2014052.
· ^ Schwartz O, Maréchal V, Le Gall S, Lemonnier F, Heard JM (March 1996). "Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein". Nat. Med. 2 (3): 338–42. doi:10.1038/nm0396-338. PMID 8612235.
· ^ Stumptner-Cuvelette P, Morchoisne S, Dugast M, et al (October 2001). "HIV-1 Nef impairs MHC class II antigen presentation and surface expression". Proc. Natl. Acad. Sci. U.S.A. 98 (21): 12144–9. doi:10.1073/pnas.221256498. PMID 11593029.
· ^ a b c Coakley, E., Petropoulos, C. J. and Whitcomb, J. M. (2005). "Assessing ch vbgemokine co-receptor usage in HIV". Curr. Opin. Infect. Dis. 18 (1): 9–15. PMID 15647694.
· ^ Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR. (1996). "Identification of a major co-receptor for primary isolates of HIV-1". Nature 381 (6584): 661–6. doi:10.1038/381661a0. PMID 8649511.
· ^ Feng Y, Broder CC, Kennedy PE, Berger EA. (1996). "HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor". Science 272 (5263): 872–7. doi:10.1126/science.272.5263.872. PMID 8629022.
· ^ Knight, S. C., Macatonia, S. E. and Patterson, S. (1990). "HIV I infection of dendritic cells". Int. Rev. Immunol. 6 (2-3): 163–75. doi:10.3109/08830189009056627. PMID 2152500.
· ^ Tang, J. and Kaslow, R. A. (2003). "The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy". AIDS 17 (Suppl 4): S51–S60. PMID 15080180.
· ^ Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD. (1993). "Genotypic and phenotypic characterization of HIV-1 patients with primary infection". Science 261 (5125): 1179–81. doi:10.1126/science.8356453. PMID 8356453.
· ^ van’t Wout AB, Kootstra NA, Mulder-Kampinga GA, Albrecht-van Lent N, Scherpbier HJ, Veenstra J, Boer K, Coutinho RA, Miedema F, Schuitemaker H. (1994). "Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission". J Clin Invest 94 (5): 2060–7. doi:10.1172/JCI117560. PMID 7962552.
· ^ Zhu T, Wang N, Carr A, Nam DS, Moor-Jankowski R, Cooper DA, Ho DD. (1996). "Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission". J Virol 70 (5): 3098–107. PMID 8627789.
· ^ Muciaccia B, Padula F, Vicini E, Gandini L, Lenzi A, Stefanini M. (2005). "Beta-chemokine receptors 5 and 3 are expressed on the head region of human spermatozoon". Faseb J 19 (14): 2048–50. PMID 16174786.
· ^ Berlier W, Bourlet T, Lawrence P, Hamzeh H, Lambert C, Genin C, Verrier B, Dieu-Nosjean MC, Pozzetto B, Delezay O. (2005). "Selective sequestration of X4 isolates by human genital epithelial cells: Implication for virus tropism selection process during sexual transmission of HIV". J Med Virol. 77 (4): 465–74. doi:10.1002/jmv.20478. PMID 16254974.
· ^ Clevestig P, Maljkovic I, Casper C, Carlenor E, Lindgren S, Naver L, Bohlin AB, Fenyo EM, Leitner T, Ehrnst A. (2005). "The X4 phenotype of HIV type 1 evolves from R5 in two children of mothers, carrying X4, and is not linked to transmission". AIDS Res Hum Retroviruses 5 (21): 371–8. doi:10.1089/aid.2005.21.371. PMID 15929699.
· ^ Moore JP. (1997). "Coreceptors: implications for HIV pathogenesis and therapy". Science 276 (5309): 51–2. doi:10.1126/science.276.5309.51. PMID 9122710.
· ^ Karlsson A, Parsmyr K, Aperia K, Sandstrom E, Fenyo EM, Albert J. (1994). "MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance". J Infect Dis. 170 (6): 1367–75. PMID 7995974.
· ^ Koot M, van 't Wout AB, Kootstra NA, de Goede RE, Tersmette M, Schuitemaker H. (1996). "Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection". J Infect Dis. 173 (2): 349–54. PMID 8568295.
· ^ a b c d e f g Chan D, Kim P (1998). "HIV entry and its inhibition". Cell 93 (5): 681–4. doi:10.1016/S0092-8674(00)81430-0. PMID 9630213.
· ^ a b c d e f Wyatt R, Sodroski J (1998). "The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens". Science 280 (5371): 1884–8. doi:10.1126/science.280.5371.1884. PMID 9632381.
· ^ Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, Wei D, Xiao Z, Veenstra TD, Conrad TP, Lempicki RA, McLaughlin S, Pascuccio M, Gopaul R, McNally J, Cruz CC, Censoplano N, Chung E, Reitano KN, Kottilil S, Goode DJ, Fauci AS. (2008). "HIV-1 envelope protein binds to and signals through integrin alpha(4)beta(7), the gut mucosal homing receptor for peripheral T cells". Nature Immunol. In Press: 301. doi:10.1038/ni1566. PMID 18264102.
· ^ a b Pope M, Haase A (2003). "Transmission, acute HIV-1 infection and the quest for strategies to prevent infection". Nat Med 9 (7): 847–52. doi:10.1038/nm0703-847. PMID 12835704.
· ^ a b c Zheng, Y. H., Lovsin, N. and Peterlin, B. M. (2005). "Newly identified host factors modulate HIV replication". Immunol. Lett. 97 (2): 225–34. doi:10.1016/j.imlet.2004.11.026. PMID 15752562.
· ^ Hiscott J, Kwon H, Genin P. (2001). "Hostile takeovers: viral appropriation of the NF-kappaB pathway". J Clin Invest. 107 (2): 143–151. doi:10.1172/JCI11918. PMID 11160127.
· ^ Pollard, V. W. and Malim, M. H. (1998). "The HIV-1 Rev protein". Annu. Rev. Microbiol. 52: 491–532. doi:10.1146/annurev.micro.52.1.491. PMID 9891806.
· ^ Gelderblom, H. R (1997). "Fine structure of HIV and SIV". in Los Alamos National Laboratory (ed.) (PDF). HIV Sequence Compendium. Los Alamos, New Mexico: Los Alamos National Laboratory. pp. 31–44.
· ^ a b c d Robertson DL, Hahn BH, Sharp PM. (1995). "Recombination in AIDS viruses". J Mol Evol. 40 (3): 249–59. doi:10.1007/BF00163230. PMID 7723052.
· ^ Holzammer S, Holznagel E, Kaul A, Kurth R, Norley S (2001). "High virus loads in naturally and experimentally SIVagm-infected African green monkeys". Virology 283 (2): 324–31. doi:10.1006/viro.2001.0870. PMID 11336557.
· ^ Kurth, R. and Norley, S. (1996) Why don't the natural hosts of SIV develop simian AIDS?, J. NIH Res. 8, 33-37.
· ^ Baier M, Dittmar MT, Cichutek K, Kurth R (1991). "Development of vivo of genetic variability of simian immunodeficiency virus". Proc. Natl. Acad. Sci. U.S.A. 88 (18): 8126–30. doi:10.1073/pnas.88.18.8126. PMID 1896460.
· ^ Daniel MD, King NW, Letvin NL, Hunt RD, Sehgal PK, Desrosiers RC (1984). "A new type D retrovirus isolated from macaques with an immunodeficiency syndrome". Science 223 (4636): 602–5. doi:10.1126/science.6695172. PMID 6695172.
· ^ Thomson, M. M., Perez-Alvarez, L. and Najera, R. (2002). "Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy". Lancet Infect. Dis. 2 (8): 461–471. doi:10.1016/S1473-3099(02)00343-2. PMID 12150845.
· ^ Carr, J. K.; Foley, B. T., Leitner, T., Salminen, M., Korber, B. and McCutchan, F. (1998). "Reference Sequences Representing the Principal Genetic Diversity of HIV-1 in the Pandemic". in Los Alamos National Laboratory (ed.) (PDF). HIV Sequence Compendium. Los Alamos, New Mexico: Los Alamos National Laboratory. pp. 10–19.
· ^ Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J; WHO-UNAIDS Network for HIV Isolation and Characterization. (2002). "Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000". Acquir. Immune. Defic. Syndr. 29 (2): 184–190. PMID 11832690.
· ^ Perrin L, Kaiser L, Yerly S. (2003). "Travel and the spread of HIV-1 genetic variants". Lancet Infect Dis. 3 (1): 22–27. doi:10.1016/S1473-3099(03)00484-5. PMID 12505029.
· ^ Piatak, M., Jr, Saag, M. S., Yang, L. C., Clark, S. J., Kappes, J. C., Luk, K. C., Hahn, B. H., Shaw, G. M. and Lifson, J.D. (1993). "High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR". Science 259 (5102): 1749–1754. doi:10.1126/science.8096089. PMID 8096089.
· ^ Pantaleo G, Demarest JF, Schacker T, Vaccarezza M, Cohen OJ, Daucher M, Graziosi C, Schnittman SS, Quinn TC, Shaw GM, Perrin L, Tambussi G, Lazzarin A, Sekaly RP, Soudeyns H, Corey L, Fauci AS. (1997). "The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia". Proc Natl Acad Sci U S A. 94 (1): 254–258. doi:10.1073/pnas.94.1.254. PMID 8990195.
· ^ Kahn, J. O. and Walker, B. D. (1998). "Acute Human Immunodeficiency Virus type 1 infection". N. Engl. J. Med. 331 (1): 33–39. doi:10.1056/NEJM199807023390107. PMID 9647878.
· ^ Daar ES, Little S, Pitt J, et al (2001). "Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network". Ann. Intern. Med. 134 (1): 25–9. PMID 11187417.
· ^ Burton GF, Keele BF, Estes JD, Thacker TC, Gartner S. (2002). "Follicular dendritic cell contributions to HIV pathogenesis". Semin Immunol. 14 (4): 275–284. doi:10.1016/S1044-5323(02)00060-X. PMID 12163303.
· ^ Clapham PR, McKnight A. (2001). "HIV-1 receptors and cell tropism". Br Med Bull. 58 (4): 43–59. doi:10.1093/bmb/58.1.43. PMID 11714623.
· ^ a b c d Kumaranayake, L. and Watts, C. (2001). "Resource allocation and priority setting of HIV/AIDS interventions: addressing the generalized epidemic in sub-Saharan Africa". J. Int. Dev. 13 (4): 451–466. doi:10.1002/jid.797.
· ^ Kleinman, S. (September 2004). "Patient information: Blood donation and transfusion". Uptodate. http://www.uptodate.com/patients/content/topic.do?topicKey=blod_dis/2419. Retrieved on 2008-04-03.
· ^ a b Centers for Disease Control and Prevention. (2001). "Revised guidelines for HIV counseling, testing, and referral". MMWR Recomm Rep. 50 (RR-19): 1–57. PMID 11718472.
· ^ Celum CL, Coombs RW, Lafferty W, Inui TS, Louie PH, Gates CA, McCreedy BJ, Egan R, Grove T, Alexander S, et al. (1991). "Indeterminate human immunodeficiency virus type 1 western blots: seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation". J Infect Dis. 164 (4): 656–664. PMID 1894929.
· ^ Chou R, Huffman LH, Fu R, Smits AK, Korthuis PT (July 2005). "Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force". Ann. Intern. Med. 143 (1): 55–73. PMID 15998755. http://www.annals.org/cgi/content/full/143/1/55.
· ^ Robb ML (2008). "Failure of the Merck HIV vaccine: an uncertain step forward". Lancet 372 (9653): 1857–1858. doi:10.1016/S0140-6736(08)61593-7.
· ^ Fan, H., Conner, R. F. and Villarreal, L. P. eds, ed (2005). AIDS : science and society (4th ed.). Boston, MA: Jones and Bartlett Publishers. ISBN 0-7637-0086-X.
· ^ Department of Health and Human Services (January 2005). "A Pocket Guide to Adult HIV/AIDS Treatment January 2005 edition". http://www.hab.hrsa.gov/tools/HIVpocketguide05/PktGARTtables.htm. Retrieved on 2006-01-17.
· ^ a b Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J. and Holmberg, S. D. (1998). "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection". N. Engl. J. Med. 338 (13): 853–860. doi:10.1056/NEJM199803263381301. PMID 9516219.
· ^ Department of Health and Human Services Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children (November 3, 2005). "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection" (PDF). http://www.aidsinfo.nih.gov/ContentFiles/PediatricGuidelines_PDA.pdf. Retrieved on 2006-01-17.
· ^ Department of Health and Human Services Panel on Clinical Practices for Treatment of HIV Infection (October 6, 2005). "Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents" (PDF). http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Retrieved on 2006-01-17.
· ^ Martinez-Picado, J., DePasquale, M. P., Kartsonis, N., Hanna, G. J., Wong, J., Finzi, D., Rosenberg, E., Gunthard, H.F., Sutton, L., Savara, A., Petropoulos, C. J., Hellmann, N., Walker, B. D., Richman, D. D., Siliciano, R. and D'Aquila, R. T. (2000). "Antiretroviral resistance during successful therapy of human immunodeficiency virus type 1 infection". Proc. Natl. Acad. Sci. U. S. A. 97 (20): 10948–10953. doi:10.1073/pnas.97.20.10948. PMID 11005867.
· ^ Dybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., Pau, A. K.; Panel on Clinical Practices for Treatment of HIV. (2002). "Guidelines for using antiretroviral agents among HIV-infected adults and adolescents". Ann. Intern. Med. 137 (5 Pt 2): 381–433. PMID 12617573.
· ^ Blankson, J. N., Persaud, D., Siliciano, R. F. (2002). "The challenge of viral reservoirs in HIV-1 infection". Annu. Rev. Med. 53: 557–593. doi:10.1146/annurev.med.53.082901.104024. PMID 11818490.
· ^ a b Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'Shaughnessy, M. V. and Montaner, J. S. (2003). "Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?". AIDS 17 (5): 711-720. PMID 12646794.
· ^ Chene, G., Sterne, J. A., May, M., Costagliola, D., Ledergerber, B., Phillips, A. N., Dabis, F., Lundgren, J., D'Arminio Monforte, A., de Wolf, F., Hogg, R., Reiss, P., Justice, A., Leport, C., Staszewski, S., Gill, J., Fatkenheuer, G., Egger, M. E. and the Antiretroviral Therapy Cohort Collaboration. (2003). "Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies". Lancet 362 (9385): 679-686. PMID 12957089.
· ^ A computer based study in 2006, following the 2004 United States treatment guidelines: Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR 3rd, Moore RD, Freedberg KA. (2006). "The lifetime cost of current HIV care in the United States". Med Care 44 (11): 990-997. PMID 17063130.
· ^ Becker SL, Dezii CM, Burtcel B, Kawabata H, Hodder S. (2002). "Young HIV-infected adults are at greater risk for medication nonadherence". MedGenMed. 4 (3): 21. PMID 12466764.
· ^ Nieuwkerk, P., Sprangers, M., Burger, D., Hoetelmans, R. M., Hugen, P. W., Danner, S. A., van Der Ende, M. E., Schneider, M. M., Schrey, G., Meenhorst, P. L., Sprenger, H. G., Kauffmann, R. H., Jambroes, M., Chesney, M. A., de Wolf, F., Lange, J. M. and the ATHENA Project. (2001). "Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study". Arch. Intern. Med. 161 (16): 1962-1968. PMID 11525698.
· ^ Kleeberger, C., Phair, J., Strathdee, S., Detels, R., Kingsley, L. and Jacobson, L. P. (2001). "Determinants of Heterogeneous Adherence to HIV-Antiretroviral Therapies in the Multicenter AIDS Cohort Study". J. Acquir. Immune Defic. Syndr. 26 (1): 82-92. PMID 11176272.
· ^ Heath, K. V., Singer, J., O'Shaughnessy, M. V., Montaner, J. S. and Hogg, R. S. (2002). "Intentional Nonadherence Due to Adverse Symptoms Associated With Antiretroviral Therapy". J. Acquir. Immune Defic. Syndr. 31 (2): 211-217. PMID 12394800.
· ^ Montessori, V., Press, N., Harris, M., Akagi, L., Montaner, J. S. (2004). "Adverse effects of antiretroviral therapy for HIV infection.". CMAJ 170 (2): 229-238. PMID 14734438.
· ^ Saitoh, A., Hull, A. D., Franklin, P. and Spector, S. A. (2005). "Myelomeningocele in an infant with intrauterine exposure to efavirenz". J. Perinatol. 25 (8): 555-556. PMID 16047034.
· ^ Wang C, Vlahov D, Galai N, et al. (2004). "Mortality in HIV-seropositive versus seronegative persons in the era of highly active antiretroviral therapy.". J. Infect. Dis. 190: 1046–54. PMID 15319852.
· ^ World Health Organisation (2006). "WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification" (PDF). http://www.who.int/hiv/pub/guidelines/WHO%20HIV%20Staging.pdf. Retrieved on 2006-12-27.
· ^ a b c Ferrantelli F, Cafaro A, Ensoli B. (2004). "Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines". Curr Opin Biotechnol. 15 (6): 543-556. PMID 15560981.
· ^ Mark Schoofs (2008). "A Doctor, a Mutation and a Potential Cure for AIDS". The Wall Street Journal. http://online.wsj.com/article/SB122602394113507555.html. Retrieved on 2008-11-09.
· ^ Hütter G, Nowak D, Mossner M, Ganepola S, Ganepola A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, Blau IW, Hofmann WK, Thiel E (2009). "Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation". N Engl J Med 360 (7): 692–698. doi:10.1056/NEJMoa0802905. PMID 19213682. http://content.nejm.org/cgi/content/abstract/360/7/692. Retrieved on 2009-03-31.
· ^ Levy JA (2009). "Not an HIV Cure, but Encouraging New Directions". N Engl J Med 360 (7): 724–725. doi:10.1056/NEJMe0810248. PMID 19213687. http://content.nejm.org/cgi/content/full/360/7/724. Retrieved on 2009-03-31.
· ^ Glass WG, McDermott DH, Lim JK, et al (January 2006). "CCR5 deficiency increases risk of symptomatic West Nile virus infection". J. Exp. Med. 203 (1): 35–40. doi:10.1084/jem.20051970. PMID 16418398.
· ^ UNAIDS, WHO (December 2007). "2007 AIDS epidemic update" (PDF). http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf. Retrieved on 2008-03-12.
· ^ McNeil, Jr., Donald (November 20, 2007). "U.N. Agency to Say It Overstated Extent of H.I.V. Cases by Millions". The New York Times. http://query.nytimes.com/gst/fullpage.html?res=9C01EEDF103BF933A15752C1A9619C8B63&n. Retrieved on 2008-01-16.
· ^ UNAIDS (2001). "Special Session of the General Assembly on HIV/AIDS Round table 3 Socio-economic impact of the epidemic and the strengthening of national capacities to combat HIV/AIDS" (PDF). http://data.unaids.org/Publications/External-Documents/GAS26-rt3_en.pdf. Retrieved on 2006-06-15.
· ^ World Bank (2005). "Evaluating the World Bank's Assistance for Fighting the HIV/AIDS Epidemic". http://www.worldbank.org/oed/aids/main_report.html. Retrieved on 2006-01-17.
· ^ Centers for Disease Control and Prevention (2002). "Cases of HIV Infection and AIDS in the United States, 2002". HIV/AIDS Surveillance Report. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2002report/table1.htm. Retrieved on 2009-03-31.
· ^ Duesberg, P. H. (1988). "HIV is not the cause of AIDS". Science 241 (4865): 514, 517. doi:10.1126/science.3399880. PMID 3399880.
· ^ Papadopulos-Eleopulos, E., Turner, V. F., Papadimitriou, J., Page, B., Causer, D., Alfonso, H., Mhlongo, S., Miller, T., Maniotis, A. and Fiala, C. (2004). "A critique of the Montagnier evidence for the HIV/AIDS hypothesis". Med Hypotheses 63 (4): 597–601. PMID 15325002.
· ^ For evidence that HIV is the cause of AIDS, see (for example):
, (2000). "The Durban Declaration". Nature 406 (6791): 15–6. doi:10.1038/35017662. PMID 10894520. - full text here [1].
Cohen, J. (1994). "The Controversy over HIV and AIDS" (PDF). Science 266 (5191): 1642–1649. doi:10.1126/science.7992043. PMID 7992043. http://www.sciencemag.org/feature/data/cohen/266-5191-1642a.pdf. Retrieved on 2009-03-31.
Various. "Resources and Links, HIV-AIDS Connection". National Institute of Allergy and Infectious Diseases. http://www3.niaid.nih.gov/topics/HIVAIDS/Understanding/connectionResources.htm. Retrieved on 22/02/2009.
O'Brien SJ, Goedert JJ (1996). "HIV causes AIDS: Koch's postulates fulfilled". Curr. Opin. Immunol. 8 (5): 613–8. doi:10.1016/S0952-7915(96)80075-6. PMID 8902385.
Galéa P, Chermann JC (1998). "HIV as the cause of AIDS and associated diseases". Genetica 104 (2): 133–42. doi:10.1023/A:1003432603348. PMID 10220906.
· ^ Watson J (2006). "Scientists, activists sue South Africa's AIDS 'denialists'". Nat. Med. 12 (1): 6. doi:10.1038/nm0106-6a. PMID 16397537.
· ^ Baleta A (2003). "S Africa's AIDS activists accuse government of murder". Lancet 361 (9363): 1105. doi:10.1016/S0140-6736(03)12909-1. PMID 12672319.
· ^ Cohen J (2000). "South Africa's new enemy". Science 288 (5474): 2168–70. doi:10.1126/science.288.5474.2168. PMID 10896606.
^ Sepkowitz KA (June 2001). "AIDS--the first 20 years". N. Engl. J. Med. 344 (23): 1764–72. PMID 11396444. http://openurl.ebscohost.com/linksvc/linking.aspx?genre=article&sid=PubMed&issn=0028-4793&title=N%20Engl%20J%20Med&volume=344&issue=23&spage=1764&atitle=AIDS--the%20first%2020%20years.&aulast=Sepkowitz&date=2001.
^ Weiss RA (May 1993). "How does HIV cause AIDS?". Science (journal) 260 (5112): 1273–9. PMID 8493571.
^ Cecil, Russell (1988). Textbook of Medicine. Philadelphia: Saunders. pp. 1523, 1799. ISBN 0721618480.
^ Divisions of HIV/AIDS Prevention (2003). "HIV and Its Transmission". Centers for Disease Control & Prevention. http://www.cdc.gov/HIV/pubs/facts/transmission.htm. Retrieved on 2006-05-23.
^ San Francisco AIDS Foundation (2006-04-14). "How HIV is spread". http://www.sfaf.org/aids101/transmission.html. Retrieved on 2006-05-23.
^ a b c Kallings LO (2008). "The first postmodern pandemic: 25 years of HIV/AIDS". J Intern Med 263 (3): 218–43. doi:10.1111/j.1365-2796.2007.01910.x. PMID 18205765. http://www.blackwell-synergy.com/doi/full/10.1111/j.1365-2796.2007.01910.x.
^ a b c d e f g h UNAIDS, WHO (December 2007). "2007 AIDS epidemic update" (PDF). http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf. Retrieved on 2008-03-12.
^ a b Bell C, Devarajan S, Gersbach H (2003) (PDF). The long-run economic costs of AIDS: theory and an application to South Africa. World Bank Policy Research Working Paper No. 3152. http://www1.worldbank.org/hiv_aids/docs/BeDeGe_BP_total2.pdf. Retrieved on 2008-04-28.
^ Gao F, Bailes E, Robertson DL, et al (1999). "Origin of HIV-1 in the Chimpanzee Pan troglodytes troglodytes". Nature 397 (6718): 436–441. doi:10.1038/17130. PMID 9989410.
^ Worobey M, Gemmel M, Teuwen DE, et al (October 2008). "Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960". Nature 455 (7213): 661–4. doi:10.1038/nature07390. PMID 18833279. http://www.nature.com/nature/journal/v455/n7213/full/nature07390.html. Retrieved on 2009-03-31.
^ Gallo RC (2006). "A reflection on HIV/AIDS research after 25 years". Retrovirology 3: 72. doi:10.1186/1742-4690-3-72. PMID 17054781. http://www.retrovirology.com/content/3//72.
^ a b Palella FJ Jr, Delaney KM, Moorman AC, et al (1998). "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators". N. Engl. J. Med 338 (13): 853–860. PMID 9516219.
^ Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA (2003). "Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa". Clin. Infect. Dis. 36 (5): 656–662. PMID 12594648.
^ Guss DA (1994). "The acquired immune deficiency syndrome: an overview for the emergency physician, Part 1". J. Emerg. Med. 12 (3): 375–384. PMID 8040596.
^ Guss DA (1994). "The acquired immune deficiency syndrome: an overview for the emergency physician, Part 2". J. Emerg. Med. 12 (4): 491–497. PMID 7963396.
^ Feldman C (2005). "Pneumonia associated with HIV infection". Curr. Opin. Infect. Dis. 18 (2): 165–170. PMID 15735422.
^ Decker CF, Lazarus A (2000). "Tuberculosis and HIV infection. How to safely treat both disorders concurrently". Postgrad Med. 108 (2): 57–60, 65–68. PMID 10951746.
^ Zaidi SA, Cervia JS (2002). "Diagnosis and management of infectious esophagitis associated with human immunodeficiency virus infection". J. Int. Assoc. Physicians AIDS Care (Chic Ill) 1 (2): 53–62. PMID 12942677.
^ Pollok RC (2001). "Viruses causing diarrhoea in AIDS". Novartis Found. Symp. 238: 276–83; discussion 283–8. PMID 11444032.
^ Guerrant RL, Hughes JM, Lima NL, Crane J (1990). "Diarrhea in developed and developing countries: magnitude, special settings, and etiologies". Rev. Infect. Dis. 12 (Suppl 1): S41–S50. PMID 2406855.
^ Luft BJ, Chua A (2000). "Central Nervous System Toxoplasmosis in HIV Pathogenesis, Diagnosis, and Therapy". Curr. Infect. Dis. Rep. 2 (4): 358–362. PMID 11095878.
^ Sadler M, Nelson MR (1997). "Progressive multifocal leukoencephalopathy in HIV". Int. J. STD AIDS 8 (6): 351–357. PMID 9179644.
^ Gray F, Adle-Biassette H, Chrétien F, Lorin de la Grandmaison G, Force G, Keohane C (2001). "Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments". Clin. Neuropathol. 20 (4): 146–155. PMID 11495003.
^ Grant I, Sacktor H, McArthur J (2005). "HIV neurocognitive disorders". in H. E. Gendelman, I. Grant, I. Everall, S. A. Lipton, and S. Swindells. (ed.) (PDF). The Neurology of AIDS (2nd ed.). London, UK: Oxford University Press. pp. 357–373. ISBN 0-19-852610-5.
^ Satishchandra P, Nalini A, Gourie-Devi M, et al (2000). "Profile of neurologic disorders associated with HIV/AIDS from Bangalore, South India (1989–1996)". Indian J. Med. Res. 11: 14–23. PMID 10793489.
^ Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S, Nanivadekar A (2001). "Neurological manifestations of HIV disease". J. Assoc. Physicians India 49: 343–348. PMID 11291974.
^ Boshoff C, Weiss R (2002). "AIDS-related malignancies". Nat. Rev. Cancer 2 (5): 373–382. PMID 12044013.
^ Yarchoan R, Tosatom G, Littlem RF (2005). "Therapy insight: AIDS-related malignancies — the influence of antiviral therapy on pathogenesis and management". Nat. Clin. Pract. Oncol. 2 (8): 406–415. PMID 16130937.
^ Palefsky J (2007). "Human papillomavirus infection in HIV-infected persons". Top HIV Med 15 (4): 130–3. PMID 17720998.
^ Bonnet F, Lewden C, May T, et al (2004). "Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy". Cancer 101 (2): 317–324. PMID 15241829.
^ Skoulidis F, Morgan MS, MacLeod KM (2004). "Penicillium marneffei: a pathogen on our doorstep?". J. R. Soc. Med. 97 (2): 394–396. PMID 15286196.
^ Alimonti JB, Ball TB, Fowke KR (2003). "Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS.". J. Gen. Virol. 84 (7): 1649–1661. doi:10.1099/vir.0.19110-0. PMID 12810858.
^ An Atlas of Differential Diagnosis in HIV Disease, Second Edition. CRC Press-Parthenon Publishers. 2003. pp. 22–27. ISBN 1-84214-026-4.
^ a b c d e Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JA (2002). "HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?". AIDS 16 (4): 597–632. PMID 11873003.
^ a b Clerici M, Balotta C, Meroni L, et al (1996). "Type 1 cytokine production and low prevalence of viral isolation correlate with long-term non progression in HIV infection". AIDS Res. Hum. Retroviruses. 12 (11): 1053–1061. PMID 8827221.
^ a b Morgan D, Mahe C, Mayanja B, Whitworth JA (2002). "Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study". BMJ 324 (7331): 193–196. doi:10.1136/bmj.324.7331.193. PMID 11809639.
^ Gendelman HE, Phelps W, Feigenbaum L, et al (1986). "Transactivation of the human immunodeficiency virus long terminal repeat sequences by DNA viruses". Proc. Natl. Acad. Sci. U. S. A. 83 (24): 9759–9763. PMID 2432602.
^ Bentwich Z, Kalinkovich, A, Weisman Z (1995). "Immune activation is a dominant factor in the pathogenesis of African AIDS.". Immunol. Today 16 (4): 187–191. PMID 7734046.
^ a b Tang J, Kaslow RA (2003). "The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy". AIDS 17 (Suppl 4): S51–S60. PMID 15080180.
^ Quiñones-Mateu ME, Mas A, Lain de Lera T, Soriano V, Alcami J, Lederman MM, Domingo E (1998). "LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression". Virus Research 57 (1): 11–20. PMID 9833881.
^ a b Campbell GR, Pasquier E, Watkins J, et al (2004). "The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis". J. Biol. Chem. 279 (46): 48197–48204. doi:10.1074/jbc.M406195200. PMID 15331610.
^ Kaleebu P, French N, Mahe C, et al (2002). "Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda". J. Infect. Dis. 185 (9): 1244–1250. PMID 12001041.
^ Rothenberg RB, Scarlett M, del Rio C, Reznik D, O'Daniels C (1998). "Oral transmission of HIV". AIDS 12 (16): 2095–2105. PMID 9833850.
^ Mastro TD, de Vincenzi I (1996). "Probabilities of sexual HIV-1 transmission". AIDS 10 (Suppl A): S75–S82. PMID 8883613.
^ Koenig MA, Zablotska I, Lutalo T, Nalugoda F, Wagman J, Gray R (2004). "Coerced first intercourse and reproductive health among adolescent women in Rakai, Uganda". Int Fam Plan Perspect 30 (4): 156–63. doi:10.1363/ifpp.30.156.04. PMID 15590381.
^ a b Laga M, Nzila N, Goeman J (1991). "The interrelationship of sexually transmitted diseases and HIV infection: implications for the control of both epidemics in Africa". AIDS 5 (Suppl 1): S55–S63. PMID 1669925.
^ Tovanabutra S, Robison V, Wongtrakul J, et al (2002). "Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand". J. Acquir. Immune. Defic. Syndr. 29 (3): 275–283. PMID 11873077.
^ Sagar M, Lavreys L, Baeten JM, et al (2004). "Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population". AIDS 18 (4): 615–619. PMID 15090766.
^ Lavreys L, Baeten JM, Martin HL, et al (March 2004). "Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study". AIDS 18 (4): 695–7. PMID 15090778.
^ Epstein, Helen (2007). The invisible cure: Africa, the West, and the fight against AIDS. New York: Farrar, Straus, and Giroux. ISBN 0-374-28152-1.
^ Parasitic worms may boost African HIV rates
^ Agnès-Laurence Chenine, Ela Shai-Kobiler, Lisa N. Steele, Helena Ong, Peter Augostini, Ruijiang Song, Sandra J. Lee, Patrick Autissier, Ruth M. Ruprecht, W. Evan Secor Acute Schistosoma mansoni Infection Increases Susceptibility to Systemic SHIV Clade C Infection in Rhesus Macaques after Mucosal Virus Exposure PLoS Neglected Tropical Diseases DOI: 10.1371/journal.pntd.0000265
^ Fan H (2005). Fan, H., Conner, R. F. and Villarreal, L. P. eds. ed. AIDS: science and society (4th ed.). Boston, MA: Jones and Bartlett Publishers. ISBN 0-7637-0086-X.
^ "WHO, UNAIDS Reaffirm HIV as a Sexually Transmitted Disease". WHO. 2003-03-17. http://64.233.179.104/search?q=cache:adH68_6JGG8J:tokyo.usembassy.gov//e/p/tp-20030317a3.html+site:tokyo.usembassy.gov+HIV+healthcare+injection&hl=en&gl=us&ct=clnk&cd=1. Retrieved on 2006-01-17.
^ "Financial Resources Required to Achieve, Universal Access to HIV Prevention, Treatment Care and Support" (PDF). UNAIDS. http://data.unaids.org/pub/Report/2007/20070925_advocacy_grne2_en.pdf. Retrieved on 2008-04-11.
^ "Blood safety....for too few". WHO. 2001. http://www.who.int/inf-pr-2000/en/pr2000-25.html. Retrieved on 2006-01-17.
^ a b Coovadia H (2004). "Antiretroviral agents—how best to protect infants from HIV and save their mothers from AIDS". N. Engl. J. Med. 351 (3): 289–292. PMID 15247337.
^ Coovadia HM, Bland RM (2007). "Preserving breastfeeding practice through the HIV pandemic". Trop. Med. Int. Health. 12 (9): 1116–1133. PMID 17714431.
^ Blechner MJ (1997). Hope and mortality: psychodynamic approaches to AIDS and HIV. Hillsdale, NJ: Analytic Press. ISBN 0-88163-223-6.
^ Guss DA (1994). "The acquired immune deficiency syndrome: an overview for the emergency physician, Part 1". J Emerg Med 12 (3): 375–84. PMID 8040596.
^ Hel Z, McGhee JR, Mestecky J (June 2006). "HIV infection: first battle decides the war". Trends Immunol. 27 (6): 274–81. doi:10.1016/j.it.2006.04.007. PMID 16679064.
^ Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, Markowitz M (September 2004). "Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract". J. Exp. Med. 200 (6): 761–70. doi:10.1084/jem.20041196. PMID 15365095.
^ Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, Douek DC (September 2004). "CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract". J. Exp. Med. 200 (6): 749–59. doi:10.1084/jem.20040874. PMID 15365096.
^ Appay V, Sauce D (January 2008). "Immune activation and inflammation in HIV-1 infection: causes and consequences". J. Pathol. 214 (2): 231–41. doi:10.1002/path.2276. PMID 18161758.
^ Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC (December 2006). "Microbial translocation is a cause of systemic immune activation in chronic HIV infection". Nat. Med. 12 (12): 1365–71. doi:10.1038/nm1511. PMID 17115046.
^ a b Textbook of Pathology by Harsh Mohan, ISBN 81-8061-368-2
^ World Health Organization (1990). "Interim proposal for a WHO staging system for HIV infection and disease". WHO Wkly Epidem. Rec. 65 (29): 221–228. PMID 1974812.
^ a b Centers for Disease Control (CDC) (1982). "Persistent, generalized lymphadenopathy among homosexual males.". MMWR Morb Mortal Wkly Rep. 31 (19): 249–251. PMID 6808340.
^ a b Barré-Sinoussi F, Chermann JC, Rey F, et al (1983). "Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)". Science 220 (4599): 868–871. doi:10.1126/science.6189183. PMID 6189183.
^ "1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults". CDC. 1992. http://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm. Retrieved on 2006-02-09.
^ a b Kumaranayake L, Watts C (2001). "Resource allocation and priority setting of HIV/AIDS interventions: addressing the generalized epidemic in sub-Saharan Africa". J. Int. Dev. 13 (4): 451–466. doi:10.1002/jid.798.
^ Weber B (2006). "Screening of HIV infection: role of molecular and immunological assays". Expert Rev. Mol. Diagn. 6 (3): 399–411. doi:10.1586/14737159.6.3.399. PMID 16706742.
^ Tóth FD, Bácsi A, Beck Z, Szabó J (2001). "Vertical transmission of human immunodeficiency virus". Acta Microbiol Immunol Hung 48 (3-4): 413–27. doi:10.1556/AMicr.48.2001.3-4.10. PMID 11791341.
^ Smith DK, Grohskopf LA, Black RJ, et al (2005). "Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States". MMWR 54 (RR02): 1–20. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm#tab1. Retrieved on 2009-03-31.
^ Donegan E, Stuart M, Niland JC, et al (1990). "Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations". Ann. Intern. Med. 113 (10): 733–739. PMID 2240875.
^ Kaplan EH, Heimer R (1995). "HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data". J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10 (2): 175–176. PMID 7552482.
^ Bell DM (1997). "Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview.". Am. J. Med. 102 (5B): 9–15. PMID 9845490.
^ a b c d European Study Group on Heterosexual Transmission of HIV (1992). "Comparison of female to male and male to female transmission of HIV in 563 stable couples". BMJ. 304 (6830): 809–813. PMID 1392708.
^ a b c d e f Varghese B, Maher JE, Peterman TA, Branson BM,Steketee RW (2002). "Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use". Sex. Transm. Dis. 29 (1): 38–43. PMID 11773877.
^ Leynaert B, Downs AM, de Vincenzi I (1998). "Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV". Am. J. Epidemiol. 148 (1): 88–96. PMID 9663408.
^ "Facts about AIDS & HIV". avert.org. http://www.avert.org/aids.htm. Retrieved on 2007-11-30.
^ Johnson AM, Laga M (1988). "Heterosexual transmission of HIV". AIDS 2 (suppl. 1): S49-S56. PMID 3130121.
^ N'Galy B, Ryder RW (1988). "Epidemiology of HIV infection in Africa". Journal of Acquired Immune Deficiency Syndromes 1 (6): 551-558. PMID 3225742.
^ Deschamps MM, Pape JW, Hafner A, Johnson WD Jr. (1996). "Heterosexual transmission of HIV in Haiti". Annals of Internal Medicine 125 (4): 324–330. PMID 8678397.
^ Cayley WE Jr. (2004). "Effectiveness of condoms in reducing heterosexual transmission of HIV". Am. Fam. Physician 70 (7): 1268–1269. PMID 15508535.
^ "Module 5/Guidelines for Educators" (Microsoft Word). Durex. http://www.durex.com/cm/assets/SexEdDownloads/Module_5_condoms.doc. Retrieved on 2006-04-17. [dead link]
^ PATH (2006). "The female condom: significant potential for STI and pregnancy prevention". Outlook 22 (2).
^ "Condom Facts and Figures". WHO. August 2003. http://www.wpro.who.int/media_centre/fact_sheets/fs_200308_Condoms.htm. Retrieved on 2006-01-17.
^ Patel VL, Yoskowitz NA, Kaufman DR, Shortliffe EH (2008). "Discerning patterns of human immunodeficiency virus risk in healthy young adults". Am J Med 121 (4): 758–764. PMID 18724961.
^ Dias SF, Matos MG, Goncalves, A. C. (2005). "Preventing HIV transmission in adolescents: an analysis of the Portuguese data from the Health Behaviour School-aged Children study and focus groups". Eur. J. Public Health 15 (3): 300–304. PMID 15941747.
^ Weiss HA (February 2007). "Male circumcision as a preventive measure against HIV and other sexually transmitted diseases". Curr. Opin. Infect. Dis. 20 (1): 66–72. doi:10.1097/QCO.0b013e328011ab73. PMID 17197884.
^ Eaton LA, Kalichman S (December 2007). "Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies". Curr HIV/AIDS Rep 4 (4): 165–72. doi:10.1007/s11904-007-0024-7. PMID 18366947.
^ Mattson, C.L.; R.T. Campbell, R.C. Bailey, K. Agot, J.O. Ndinya-Achola, S. Moses (June 18 2008). "Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial". PLoS One 3 (6): e2443. PMID 18560581.
^ "Recommendations for Prevention of HIV Transmission in Health-Care Settings". http://www.cdc.gov/MMWR/PREVIEW/MMWRHTML/00023587.htm. Retrieved on 2008-04-28.
^ Kerr T, Kimber J, Debeck K, Wood E (December 2007). "The role of safer injection facilities in the response to HIV/AIDS among injection drug users". Curr HIV/AIDS Rep 4 (4): 158–64. doi:10.1007/s11904-007-0023-8. PMID 18366946.
^ Wodak A, Cooney A (2006). "Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence". Subst Use Misuse 41 (6-7): 777–813. doi:10.1080/10826080600669579. PMID 16809167.
^ WHO HIV and Infant Feeding Technical Consultation (2006). "Consensus statement" (PDF). http://www.who.int/hiv/mediacentre/Infantfeedingconsensusstatement.pf.pdf. Retrieved on 2008-03-12.
^ Hamlyn E, Easterbrook P (August 2007). "Occupational exposure to HIV and the use of post-exposure prophylaxis". Occup Med (Lond) 57 (5): 329–36. doi:10.1093/occmed/kqm046. PMID 17656498.
^ a b "A Pocket Guide to Adult HIV/AIDS Treatment February 2006 edition". Department of Health and Human Services. February 2006. http://hab.hrsa.gov/tools/HIVpocketguide/PktGPEP.htm. Retrieved on 2006-09-01.
^ "A Pocket Guide to Adult HIV/AIDS Treatment February 2006 edition". Department of Health and Human Services. February 2006. http://hab.hrsa.gov/tools/HIVpocketguide/PktGARTtables.htm. Retrieved on 2006-09-01.
^ "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection" (PDF). Department of Health and Human Services Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. 2005-11-03. http://www.aidsinfo.nih.gov/ContentFiles/PediatricGuidelines_PDA.pdf. Retrieved on 2006-01-17.
^ "Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents" (PDF). Department of Health and Human Services Panel on Clinical Practices for Treatment of HIV Infection. 2005-10-06. http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Retrieved on 2006-01-17.
^ Martinez-Picado J, DePasquale MP, Kartsonis N, et al (2000). "Antiretroviral resistance during successful therapy of human immunodeficiency virus type 1 infection". Proc. Natl. Acad. Sci. U. S. A. 97 (20): 10948–10953. PMID 11005867.
^ Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV. (2002). "Guidelines for using antiretroviral agents among HIV-infected adults and adolescents". Ann. Intern. Med. 137 (5 Pt 2): 381–433. PMID 12617573.
^ Blankson JN, Persaud D, Siliciano RF (2002). "The challenge of viral reservoirs in HIV-1 infection". Annu. Rev. Med. 53: 557–593. PMID 11818490.
^ Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998). "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection". N. Engl. J. Med. 338 (13): 853–860. PMID 9516219.
^ Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS (2003). "Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?". AIDS 17 (5): 711–720. PMID 12646794.
^ Chene G, Sterne JA, May M, Costagliola D, Ledergerber B, Phillips AN, Dabis F, Lundgren J, D'Arminio Monforte A, de Wolf F, Hogg R, Reiss P, Justice A, Leport C, Staszewski S, Gill J, Fatkenheuer G, Egger ME and the Antiretroviral Therapy Cohort Collaboration (2003). "Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies". Lancet 362 (9385): 679–686. doi:10.1016/S0140-6736(03)14229-8. PMID 12957089.
^ King JT, Justice AC, Roberts MS, Chang CH, Fusco JS and the CHORUS Program Team (2003). "Long-Term HIV/AIDS Survival Estimation in the Highly Active Antiretroviral Therapy Era". Medical Decision Making 23 (1): 9–20. PMID 12583451.
^ Tassie JM, Grabar S, Lancar R, Deloumeaux J, Bentata M, Costagliola D and the Clinical Epidemiology Group from the French Hospital Database on HIV (2002). "Time to AIDS from 1992 to 1999 in HIV-1-infected subjects with known date of infection". Journal of acquired immune deficiency syndromes 30 (1): 81–7. PMID 12048367.
^ Becker SL, Dezii CM, Burtcel B, Kawabata H, Hodder S. (2002). "Young HIV-infected adults are at greater risk for medication nonadherence". MedGenMed. 4 (3): 21. PMID 12466764.
^ Nieuwkerk P, Sprangers M, Burger D, Hoetelmans RM, Hugen PW, Danner SA, van Der Ende ME, Schneider MM, Schrey G, Meenhorst PL, Sprenger HG, Kauffmann RH, Jambroes M, Chesney MA, de Wolf F, Lange JM and the ATHENA Project (2001). "Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study". Arch. Intern. Med. 161 (16): 1962–1968. PMID 11525698.
^ Kleeberger C, Phair J, Strathdee S, Detels R, Kingsley L, Jacobson LP (2001). "Determinants of Heterogeneous Adherence to HIV-Antiretroviral Therapies in the Multicenter AIDS Cohort Study". J. Acquir. Immune Defic. Syndr. 26 (1): 82–92. PMID 11176272.
^ Heath KV, Singer J, O'Shaughnessy MV, Montaner JS, Hogg RS (2002). "Intentional Nonadherence Due to Adverse Symptoms Associated With Antiretroviral Therapy". J. Acquir. Immune Defic. Syndr. 31 (2): 211–217. PMID 12394800.
^ Burgoyne RW, Tan DH (March 2008). "Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act". J. Antimicrob. Chemother. 61 (3): 469–73. doi:10.1093/jac/dkm499. PMID 18174196. http://jac.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=18174196.
^ Karlsson Hedestam GB, Fouchier RA, Phogat S, Burton DR, Sodroski J, Wyatt RT (February 2008). "The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus". Nat. Rev. Microbiol. 6 (2): 143–55. doi:10.1038/nrmicro1819. PMID 18197170.
^ Laurence J (2006). "Hepatitis A and B virus immunization in HIV-infected persons". AIDS Reader 16 (1): 15–17. PMID 16433468.
^ Planque S, Nishiyama Y, Taguchi H, Salas M, Hanson C, Paul S (June 2008). "Catalytic antibodies to HIV: Physiological role and potential clinical utility". Autoimmun Rev 7 (6): 473–9. doi:10.1016/j.autrev.2008.04.002. PMID 18558365.
^ "A Doctor, a Mutation and a Potential Cure for AIDS: A Bone Marrow Transplant to Treat a Leukemia Patient Also Gives Him Virus-Resistant Cells; Many Thanks, Sample 61". Wall Street Journal. November 2008. http://online.wsj.com/article/SB122602394113507555.html. Retrieved on 2008-11-12.
^ a b Power R, Gore-Felton C, Vosvick M, Israelski DM, Spiegel D (June 2002). "HIV: effectiveness of complementary and alternative medicine". Prim. Care 29 (2): 361–78. PMID 12391716.
^ Nicholas PK, Kemppainen JK, Canaval GE, et al (February 2007). "Symptom management and self-care for peripheral neuropathy in HIV/AIDS". AIDS Care 19 (2): 179–89. doi:10.1080/09540120600971083. PMID 17364396. http://www.informaworld.com/openurl?genre=article&doi=10.1080/09540120600971083&magic=pubmed. Retrieved on 2008-04-28.
^ Liu JP, Manheimer E, Yang M (2005). "Herbal medicines for treating HIV infection and AIDS". Cochrane Database Syst Rev (3): CD003937. doi:10.1002/14651858.CD003937.pub2. PMID 16034917.
^ a b Irlam JH, Visser ME, Rollins N, Siegfried N (2005). "Micronutrient supplementation in children and adults with HIV infection". Cochrane Database Syst Rev (4): CD003650. doi:10.1002/14651858.CD003650.pub2. PMID 16235333.
^ World Health Organization (2003-05). Nutrient requirements for people living with HIV/AIDS: Report of a technical consultation. Geneva. http://www.who.int/nutrition/publications/Content_nutrient_requirements.pdf. Retrieved on 2009-03-31.
^ Hurwitz BE, Klaus JR, Llabre MM, et al (January 2007). "Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial". Arch. Intern. Med. 167 (2): 148–54. doi:10.1001/archinte.167.2.148. PMID 17242315.
^ Zwahlen M, Egger M (2006) (PDF). Progression and mortality of untreated HIV-positive individuals living in resource-limited settings: update of literature review and evidence synthesis. UNAIDS Obligation HQ/05/422204. http://data.unaids.org/pub/Periodical/2006/zwahlen_unaids_hq_05_422204_2007_en.pdf. Retrieved on 2008-03-19.
^ Knoll B, Lassmann B, Temesgen Z (2007). "Current status of HIV infection: a review for non-HIV-treating physicians". Int J Dermatol 46 (12): 1219–28. doi:10.1111/j.1365-4632.2007.03520.x. PMID 18173512.
^ a b LawnSD (2004). "AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection". J. Infect. Dis. 48 (1): 1–12. PMID 14667787.
^ Campbell GR, Watkins JD, Esquieu D, Pasquier E, Loret EP, Spector SA (2005). "The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells". J. Biol. Chem. 280 (46): 38376–39382. PMID 16155003.
^ Senkaali D, Muwonge R, Morgan D, Yirrell D, Whitworth J, Kaleebu P (2005). "The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort". AIDS Res. Hum. Retroviruses. 20 (9): 932–937. PMID 15585080.
^ McNeil DG Jr (2007-11-20). "U.N. agency to say it overstated extent of H.I.V. cases by millions". New York Times. http://query.nytimes.com/gst/fullpage.html?res=9C01EEDF103BF933A15752C1A9619C8B63. Retrieved on 2008-03-18.
^ Gottlieb MS (2006). "Pneumocystis pneumonia--Los Angeles. 1981". Am J Public Health 96 (6): 980–1; discussion 982–3. PMID 16714472. http://www.cdc.gov/mmwr/preview/mmwrhtml/june_5.htm. Retrieved on 2009-03-31.
^ a b Centers for Disease Control (CDC) (1982). "Opportunistic infections and Kaposi's sarcoma among Haitians in the United States". MMWR Morb Mortal Wkly Rep. 31 (26): 353–354; 360–361. PMID 6811853.
^ Altman LK (1982-05-11). "New homosexual disorder worries officials". The New York Times.
^ "Making Headway Under Hellacious Circumstances" (PDF). American Association for the Advancement of Science. 2006-07-28. http://www.scienceonline.org/cgi/reprint/313/5786/470b.pdf. Retrieved on 2008-06-23.
^ Kher U (1982-07-27). "A Name for the Plague". Time. http://www.time.com/time/80days/820727.html. Retrieved on 2008-03-10.
^ Centers for Disease Control (CDC) (1982). "Update on acquired immune deficiency syndrome (AIDS)—United States.". MMWR Morb Mortal Wkly Rep. 31 (37): 507–508; 513–514. PMID 6815471.
^ Curtis T (1992). "The origin of AIDS". Rolling Stone (626): pp. 54–59, 61, 106, 108. http://www.uow.edu.au/arts/sts/bmartin/dissent/documents/AIDS/Curtis92.html. Retrieved on 2008-03-10.
^ Hooper E (1999). The River : A Journey to the Source of HIV and AIDS (1st ed.). Boston, MA: Little Brown & Co. pp. 1–1070. ISBN 0-316-37261-7.
^ Worobey M, Santiago ML, Keele BF, et al (2004). "Origin of AIDS: contaminated polio vaccine theory refuted". Nature 428 (6985): 820. doi:10.1038/428820a. PMID 15103367.
^ Berry N, Jenkins A, Martin J, et al (2005). "Mitochondrial DNA and retroviral RNA analyses of archival oral polio vaccine (OPV CHAT) materials: evidence of macaque nuclear sequences confirms substrate identity". Vaccine 23: 1639–1648. doi:10.1016/j.vaccine.2004.10.038. PMID 15705467.
^ "Oral Polio Vaccine and HIV / AIDS: Questions and Answers". Centers for Disease Control and Prevention. 2004-03-23. http://www.cdc.gov/nip/vacsafe/concerns/aids/poliovac-hiv-aids-qa.htm. Retrieved on 2006-11-20.
^ Gilbert MT, Rambaut A, Wlasiuk G, Spira TJ, Pitchenik AE, Worobey M (2007). "The emergence of HIV/AIDS in the Americas and beyond". Proc. Natl. Acad. Sci. U.S.A. 104 (47): 18566–70. doi:10.1073/pnas.0705329104. PMID 17978186.
^ "The impact of AIDS on people and societies" (PDF). 2006 Report on the global AIDS epidemic. UNAIDS. 2006.
^ Ogden J, Nyblade L (2005). "Common at its core: HIV-related stigma across contexts" (PDF). International Center for Research on Women. http://www.icrw.org/docs/2005_report_stigma_synthesis.pdf. Retrieved on 2007-02-15.
^ a b c Herek GM, Capitanio JP (1999). "AIDS Stigma and sexual prejudice" (PDF). American Behavioral Scientist 42 (7): 1130-1147. doi:10.1177/0002764299042007006. http://psychology.ucdavis.edu/rainbow/html/abs99_sp.pdf. Retrieved on 2006-03-27.
^ Snyder M, Omoto AM, Crain AL (1999). "Punished for their good deeds: stigmatization for AIDS volunteers". American Behavioral Scientist 42 (7): 1175–1192. doi:10.1177/0002764299042007009.
^ Herek GM, Capitanio JP, Widaman KF (2002). "HIV-related stigma and knowledge in the United States: prevalence and trends, 1991-1999" (PDF). Am J Public Health 92 (3): 371–7. PMID 11867313. http://psychology.ucdavis.edu/rainbow/html/ajph2002.pdf. Retrieved on 2008-03-10.
^ a b Greener R (2002). "AIDS and macroeconomic impact". in S, Forsyth (ed.). State of The Art: AIDS and Economics. IAEN. pp. 49–55.
^ Over M (1992) (PDF). The macroeconomic impact of AIDS in Sub-Saharan Africa, Population and Human Resources Department. The World Bank. http://www.worldbank.org/aidsecon/macro.pdf. Retrieved on 2008-05-03.
^ Duesberg PH (1988). "HIV is not the cause of AIDS". Science 241 (4865): 514, 517. doi:10.1126/science.3399880. PMID 3399880.
^ Papadopulos-Eleopulos E, Turner VF, Papadimitriou J, et al (2004). "A critique of the Montagnier evidence for the HIV/AIDS hypothesis". Med Hypotheses 63 (4): 597–601. doi:10.1016/j.mehy.2004.03.025. PMID 15325002.
^ For evidence of the scientific consensus that HIV is the cause of AIDS, see (for example):
"The Evidence That HIV Causes AIDS". National Institute of Allergy and Infectious Diseases. 2003. http://www.niaid.nih.gov/Factsheets/evidhiv.htm. Retrieved on 2008-12-20.
, (2000). "The Durban Declaration". Nature 406 (6791): 15–6. doi:10.1038/35017662. PMID 10894520. http://www.nature.com/nature/journal/v406/n6791/full/406015a0.html. Retrieved on 2008-05-03.
Cohen J (1994). "The Duesberg Phenomenon: A Berkeley virologist and his supporters continue to argue that HIV is not the cause of AIDS. A 3-month investigation by Science evaluates their claims." (PDF). Science 266 (5191): 1642–1649. http://www.sciencemag.org/feature/data/cohen/266-5191-1642a.pdf. Retrieved on 2009-03-31.
"HIV/AIDS Connection: Resource and links". National Institute of Allergy and Infectious Diseases. http://www3.niaid.nih.gov/topics/HIVAIDS/Understanding/connectionResources.htm. Retrieved on 2009-03-31.
O'Brien SJ, Goedert JJ (1996). "HIV causes AIDS: Koch's postulates fulfilled". Curr. Opin. Immunol. 8 (5): 613–8. PMID 8902385.
Galéa P, Chermann JC (1998). "HIV as the cause of AIDS and associated diseases". Genetica 104 (2): 133–42. PMID 10220906.
^ Smith TC, Novella SP (2007). "HIV denial in the Internet era". PLoS Med. 4 (8): e256. doi:10.1371/journal.pmed.0040256. PMID 17713982.
^ Chigwedere P, Seage GR, Gruskin S, Lee TH, Essex M (October 2008). "Estimating the Lost Benefits of Antiretroviral Drug Use in South Africa". Journal of acquired immune deficiency syndromes (1999). doi:10.1097/QAI.0b013e31818a6cd5. PMID 18931626. Lay summary.
^ Baleta A (2003). "S Africa's AIDS activists accuse government of murder". Lancet 361 (9363): 1105. doi:10.1016/S0140-6736(03)12909-1. PMID 12672319.
^ Moskowitz DA, Roloff ME (2007). "The existence of a bug chasing subculture". Cult Health Sex 9 (4): 347–57. doi:10.1080/13691050600976296. PMID 17612955.
^ Grov C, Parsons JT (December 2006). "Bug chasing and gift giving: the potential for HIV transmission among barebackers on the internet". AIDS Educ Prev 18 (6): 490–503. doi:10.1521/aeap.2006.18.6.490. PMID 17166076.
^ Graydon M (2007). "Don't bother to wrap it: online Giftgiver and Bugchaser newsgroups, the social impact of gift exchanges and the 'carnivalesque'". Cult Health Sex 9 (3): 277–92. doi:10.1080/13691050601124649. PMID 17457731.
^ Dean, T., 2008. "Breeding Culture: barebacking, Bugchasing, Giftgiving". The Massachusetts Review, Vol. 49(1), pp. 80-94.
· ^ Dowdle Wr, Nahmias AJ, Harwell RW, Pauls FP. (1967). "Association of antigenic type of Herpesvirus hominis with site of viral recovery". J Immunol 99(5): 974–80. PMID 4295116. http://www.jimmunol.org/cgi/reprint/99/5/974.
· ^ Nahmias Aj, Dowdle W.R. (1968). "Antigenic and biologic differences in herpesvirus hominis.". Prog Med Virol 10: 110–59. PMID 4304588.
· ^ Ribes Ja, Steele AD, Seabolt JP, Baker DJ (2001 Sep). "Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population". J Clin Microbiol 39(9): 3321–5. doi:10.1128/JCM.39.9.3321-3325.2001. PMID 11526170. http://jcm.asm.org/cgi/reprint/39/9/3321.
· ^ Mertz Gj, Rosenthal SL, Stanberry LR (2003 Oct). "Is Herpes Simplex Virus Type 1 (HSV-1) Now More Common than HSV-2 in First Episodes of Genital Herpes?" (PDF). Sex Trans Dis 30(10): 801–802. PMID 14520182. http://www.stdjournal.com/pt/re/std/pdfhandler.00007435-200310000-00013.pdf.
· ^ Coyle Pv, O'neill HJ, Wyatt DE, McCaughey C, Quah S, McBride MO (2003 May). "Emergence of herpes simplex type 1 as the main cause of recurrent genital ulcerative disease in women in Northern Ireland". J Clin Virol 27(1): 22–9. PMID 12727525. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VJV-46VBSGG-2&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=11a6e4b52fc4411dd5ccd276a32602b8.
· ^ a b "STD Facts - Genital Herpes". http://www.cdc.gov/std/Herpes/STDFact-Herpes.htm. Retrieved on 2008-02-22.
· ^ a b c d Gupta R, Warren T, Wald A (2007). "Genital herpes". Lancet 370 (9605): 2127–37. doi:10.1016/S0140-6736(07)61908-4. PMID 18156035.
· ^ Lafferty We, Coombs RW, Benedetti J, Critchlow C, Corey L (04 Jun 1987 Jun 4). "Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type". N Engl J Med 316(23) (23): 1444–9. PMID 3033506. http://content.nejm.org/cgi/content/abstract/316/23/1444.
· ^ a b Sakakibara R, Yamanishi T, Uchiyama T, Hattori T (August 2006). "Acute urinary retention due to benign inflammatory nervous diseases". Journal of neurology 253 (8): 1103–10. doi:10.1007/s00415-006-0189-9. PMID 16680560.
· ^ Vonk P (December 1993). "Elsberg syndrome: acute urinary retention following a viral infection" (in Dutch; Flemish). Nederlands tijdschrift voor geneeskunde 137 (50): 2603–5. PMID 8277988.
· ^ "Frequently Asked Questions: For Everyone. CDC Molluscum Contagiosum". United States Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dvrd/molluscum/faq/everyone.htm#whogets. Retrieved on 2008-06-29.
· ^ "Pamphlets: Molluscum Contagiosum". American Academy of Dermatology. 2006. http://www.aad.org/public/publications/pamphlets/viral_mollscum.html. Retrieved on 2008-11-30.
· ^ a b Weller R, O'Callaghan CJ, MacSween RM, White MI (1999). "Scarring in Molluscum contagiosum: comparison of physical expression and phenol ablation". BMJ 319 (7224): 1540. PMID 10591712. http://www.bmj.com/cgi/content/full/319/7224/1540.
· ^ a b derm/270 at eMedicine
· ^ MedlinePlus Encyclopedia 000826
· ^ a b c Tyring SK (2003). "Molluscum contagiosum: the importance of early diagnosis and treatment". Am. J. Obstet. Gynecol. 189 (3 Suppl): S12–6. doi:10.1067/S0002-9378(03)00793-2. PMID 14532898.
· ^ Prodigy knowledgebase (July 2003). "Molluscum Contagiosum". National Health Service. http://www.prodigy.nhs.uk/molluscum_contagiosum/view_whole_guidance. Retrieved on 2006-07-06. - UK NHS guidelines on Molluscum Contagiosum
· ^ van der Wouden JC, Menke J, Gajadin S, et al (2006). "Interventions for cutaneous molluscum contagiosum". Cochrane Database Syst Rev (2): CD004767. doi:10.1002/14651858.CD004767.pub2. PMID 16625612.
· ^ a b c "Frequently Asked Questions: For Everyone. CDC Molluscum Contagiosum". United States Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dvrd/molluscum/faq/everyone.htm#howlongstay. Retrieved on 2008-12-08.
· ^ "Molluscum Contagiosum - Treatment Overview". WebMD. January 12, 2007. http://www.webmd.com/skin-problems-and-treatments/tc/molluscum-contagiosum-treatment-overview. Retrieved on 2007-10-21.
· ^ Burke BE, Baillie JE, Olson RD (2004). "Essential oil of Australian lemon myrtle (Backhousia citriodora) in the treatment of molluscum contagiosum in children". Biomed. Pharmacother. 58 (4): 245–7. doi:10.1016/j.biopha.2003.11.006. PMID 15183850.
· ^ Hayes AJ, Markovic B (2002). "Toxicity of Australian essential oil Backhousia citriodora (Lemon myrtle). Part 1. Antimicrobial activity and in vitro cytotoxicity". Food Chem. Toxicol. 40 (4): 535–43. doi:10.1016/S0278-6915(01)00103-X. PMID 11893412.
· ^ Hayes AJ, Markovic B (2003). "Toxicity of Australian essential oil Backhousia citriodora (lemon myrtle). Part 2. Absorption and histopathology following application to human skin". Food Chem. Toxicol. 41 (10): 1409–16. doi:10.1016/S0278-6915(03)00159-5. PMID 12909275.
· ^ http://cks.library.nhs.uk/molluscum_contagiosum/evidence/supporting_evidence/treatments_used_in_secondary_care_for_molluscum_contagiosum
· ^ Saryazdi, S. (2004) The comparative efficacy of benzoyl peroxide 10% cream and tretinoin 0.05% cream in the treatment of molluscum contagiosum. Abstract 10th World Congress on Pediatric Dermatology. Pediatric Dermatology 21(3), 399.
· ^ http://www.emedsaver.com/index.php?pageID=0005&qryID=1&qry=Canthacur+Wart
· ^ aidsmap.com | Molluscum contagiosum
· ^ Molluscum contagiosum -Jochen Schmitt and Thomas L. Diepgen
· ^ Papa C, Berger R (1976). "Venereal herpes-like molluscum contagiosum: treatment with tretinoin". Cutis 18 (4): 537–40. PMID 1037097.
· ^ "Molluscum Contagiosum". Adolesc Med 7 (1): 57–62. 1996. PMID 10359957.
· ^ Hanna D, Hatami A, Powell J, et al (2006). "A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children". Pediatric dermatology 23 (6): 574–9. doi:10.1111/j.1525-1470.2006.00313.x. PMID 17156002.
· ^ Syed TA, Goswami J, Ahmadpour OA et al. (1998). "Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream". J Dermatol (25): 309–313.
· ^ "Cimetidine: A review of the recent developments and reports in cutaneous medicine". Dermatology Online Journal. 2003. http://dermatology.cdlib.org/92/reviews/cimetidine/scheinfeld.html. Retrieved on 2008-11-30.
· ^ "Molluscum Contagiosum". eMedicine from WebMD. 2007-5-31. http://www.emedicine.com/derm/TOPIC270.HTM. Retrieved on 2008-11-30.
· ^ Hammes S, Greve B, Raulin C (2001). "Molluscum contagiosum: Treatment with pulsed dye laser" (in German). Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 52 (1): 38–42. PMID 11220237.
· ^ Hughes P (February 1998). "Treatment of molluscum contagiosum with the 585-nm pulsed dye laser". Dermatol Surg 24 (2): 229–30. doi:10.1016/S1076-0512(97)00178-7. PMID 9491117.
· ^ Lindau MS, Munar (2004). "Use of duct tape for treatment of recurrent molluscum contagiosum" (in English). Pediatric Dermatology 21 (5): 609.
· ^ Focht DR, Spicer C, Fairchok MP (2002). "The Efficacy of Duct Tape vs Cryotherapy in the Treatment of Verruca Vulgaris (the Common Wart)" (in English). Archives of Pediatrics and Adolescent Medicine 156 (10): 971.
· a b James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
· ^ a b Walsh TJ, Dixon DM (1996). "Deep Mycoses". in Baron S et al eds. (via NCBI Bookshelf). Baron's Medical Microbiology (4th ed.). Univ of Texas Medical Branch. ISBN 0-9631172-1-1. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=mmed.section.4006.
· ^ a b c MedlinePlus Encyclopedia Vaginal yeast infection
· ^ a b c Fidel PL (2002). "Immunity to Candida". Oral Dis. 8: 69–75. doi:10.1034/j.1601-0825.2002.00015.x. PMID 12164664.
· ^ a b Pappas PG (2006). "Invasive candidiasis". Infect. Dis. Clin. North Am. 20 (3): 485–506. doi:10.1016/j.idc.2006.07.004. PMID 16984866.
· ^ Mulley, A. G.; Goroll, A. H. (2006). Primary Care Medicine: office evaluation and management of the adult patient. Philadelphia: Wolters Kluwer Health. pp. 802–3. ISBN 0-7817-7456-X. http://books.google.com/books?id=aWQhTbwoM9EC&pg=RA1-PA802&lpg=RA1-PA802. Retrieved on 2008-11-23.
· ^ Mårdh P A, Novikova N, Stukalova E (October 2003). "Colonisation of extragenital sites by Candida in women with recurrent vulvovaginal candidosis". BJOG 110 (10): 934–7. PMID 14550364. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1470-0328&date=2003&volume=110&issue=10&spage=934.
· ^ a b Schiefer HG (1997). "Mycoses of the urogenital tract". Mycoses 40 Suppl 2: 33–6. PMID 9476502.
· ^ Yamaguchi N, Sonoyama K, Kikuchi H, Nagura T, Aritsuka T, Kawabata J (January 2005). "Gastric colonization of Candida albicans differs in mice fed commercial and purified diets". J. Nutr. 135 (1): 109–15. PMID 15623841. http://jn.nutrition.org/cgi/pmidlookup?view=long&pmid=15623841.
· ^ Nwokolo N C, Boag F C (May 2000). "Chronic vaginal candidiasis. Management in the postmenopausal patient". Drugs Aging 16 (5): 335–9. PMID 10917071.
· ^ Odds FC (1987). "Candida infections: an overview". Crit. Rev. Microbiol. 15 (1): 1–5. PMID 3319417.
· ^ David LM, Walzman M, Rajamanoharan S (October 1997). "Genital colonisation and infection with candida in heterosexual and homosexual males". Genitourin Med 73 (5): 394–6. PMID 9534752.
· ^ Moosa MY, Sobel JD, Elhalis H, Du W, Akins RA (2004). "Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium". Antimicrob. Agents Chemother. 48 (1): 161–7. doi:10.1128/AAC.48.1.161-167.2004. PMID 14693534.
· ^ "Thrush". www.askdrsears.com. http://www.askdrsears.com/html/8/T083100.asp.
· ^ Craigmill A (December 1991). "Gentian Violet Policy Withdrawn". CooperativeExtensionUniversity of California -- Environmental Toxicology Newsletter 11 (5). http://extoxnet.orst.edu/newsletters/n115_91.htm.
· ^ Cowen LE, Nantel A, Whiteway MS, et al (July 2002). "Population genomics of drug resistance in Candida albicans". Proc. Natl. Acad. Sci. U.S.A. 99 (14): 9284–9. doi:10.1073/pnas.102291099. PMID 12089321.
· ^ "International Code of Botanical Nomenclature". Königstein. 2000. http://www.bgbm.org/iapt/nomenclature/code/SaintLouis/0000St.Luistitle.htm. Retrieved on 2008-11-23.
· ^ Crook, William G. (1986). The yeast connection: a medical breakthrough. New York: Vintage Books. ISBN 0394747003.
· ^ Weil A (2002-10-25). "Concerned About Candidiasis?". Weil Lifestyle. http://www.drweil.com/u/QA/QA125503/. Retrieved on 2008-02-21.
· ^ Barrett S (2005-10-08). "Dubious "Yeast Allergies"". QuackWatch. http://www.quackwatch.org/01QuackeryRelatedTopics/candida.html. Retrieved on 2008-02-21.
^ Scientists crack the genome of the parasite causing trichomoniasis. Physorg.com. Jan. 12, 2007.
^ Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE (October 2004). "Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis". Clin. Microbiol. Rev. 17 (4): 783–93, table of contents. doi:10.1128/CMR.17.4.783-793.2004. PMID 15489348. PMC: 523556. http://cmr.asm.org/cgi/pmidlookup?view=long&pmid=15489348.
^ Associated Press, Abstinence students still having sex, MSNBC, April 16, 2007. Retrieved March 12, 2008.
^ Vaginitis/Trichomoniasis :Reduce your risk, American Social Health Association. Retrieved March 12, 2008.
^ Vaginitis/Trichomoniasis :Treatment for trichomoniasis, American Social Health Association. Retrieved March 12, 2008.
· ^ “Scabies.” 15 February 2008. DermNet NZ. New Zealand Dermatological Society Incorporated. 12 Feb. 2009 < http://www.dermnetnz.org/arthropods/pdf/scabies-dermnetnz.pdf>.
· ^ “Scabies.” 15 February 2008. DermNet NZ. New Zealand Dermatological Society Incorporated. 12 Feb. 2009 < http://www.dermnetnz.org/arthropods/pdf/scabies-dermnetnz.pdf>.
· ^ “Scabies.” 15 February 2008. DermNet NZ. New Zealand Dermatological Society Incorporated. 12 Feb. 2009 < http://www.dermnetnz.org/arthropods/pdf/scabies-dermnetnz.pdf>.
· ^ "Scabies." 5 Dec. 2008. Laboratory Identification of Parasites of Public Health Concern. DPDx. CDC, Atlanta. 5 Feb. 2009 <http://www.dpd.cdc.gov/dpdx/HTML/Scabies.htm>.
· ^ "Scabies." 5 Dec. 2008. Laboratory Identification of Parasites of Public Health Concern. DPDx. CDC, Atlanta. 5 Feb. 2009 <http://www.dpd.cdc.gov/dpdx/HTML/Scabies.htm>.
· ^ http://www.cdc.gov/scabies
· ^ Markell EK, John DT, Krotoski WA. Markell and Voge's Medical Parasitology, 9th ed. Philadelphia: W.B. Saunders, 2006.
· ^ Arlian, L. Biology, Host Relations and Epidemiology of Sarcoptes Scabiei. Ann. Rev. Entomol 1989; 34:139-61. 5 Feb. 2009 <http://arjournals.annualreviews.org/doi/pdf/10.1146/annurev.en.34.010189.001035?cookieSet=1>
· ^ Scheinfeld NS (2004). "Controlling scabies in institutional settings: a review of medications, treatment models, and implementation". Amer J Clin Dermatol 5 (1): 31–7. doi:10.2165/00128071-200405010-00005. PMID 14979741.
· ^ Permethrin Factsheet (PDF)
· ^ http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202170.html
· ^ FDA Public Health Advisory: Safety of Topical Lindane Products for the Treatment of Scabies and Lice
· ^ "Lindane Post Marketing Safety Review" (PDF). U.S. Food and Drug Administration (FDA). 2003. http://www.fda.gov/cder/drug/infopage/lindane/lindaneaeredacted.pdf.
· ^ a b c http://www.fda.gov/cder/foi/label/2003/006309lotionlbl.pdf.
· ^ Commission for Environmental Cooperation. North American Regional Action Plan (NARAP) on lindane and other hexachlorocyclohexane (HCH) isomers. November 30, 2006.
· ^ U.S. EPA. Assessment of lindane and other hexachlorocyclohexane isomers. February 8, 2006
· ^ Medication Guide Lindane Lotion USP, 1%. Updated March 28, 2003.
· ^ Lin AN, Reimer RJ, Carter DM (1988). "Sulfur revisited". J Am Acad Dermatol 18: 553–58. doi:10.1016/S0190-9622(88)70079-1.
· ^ Pruksachatkunakorn C, Damrongsak M, Sinthupuan S (2002). "Sulfur for Scabies Outbreaks in Orphanages". Pediatric Dermatology 19 (5): 448–53. doi:10.1046/j.1525-1470.2002.00205.x. http://www3.interscience.wiley.com/journal/118919953/abstract. Retrieved on 2008-08-01.
· ^ Heinrich M, et al. (2005). "Plants as Medicines". in Prance G, Nesbitt M. The Cultural History of Plants. London: Routledge. pp. 228. ISBN 0415927463.
· ^ Walton SF, McKinnon M, Pizzutto S, Dougall A, Williams E, Currie BJ (May 2004). "Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol". Arch Dermatol 140 (5): 563–6. doi:10.1001/archderm.140.5.563. PMID 15148100.
· ^ Apgar B (January 15, 2000). "Efficacy and Safety of Therapy for Human Scabies Infestation". American Family Physician. http://www.aafp.org/afp/20000115/tips/15.html.
Chouela EN, Abeldaño AM, Pellerano G, et al (June 1999). "Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies". Arch Dermatol 135 (6): 651–5. doi:10.1001/archderm.135.6.651. PMID 10376691. http://archderm.ama-assn.org/cgi/pmidlookup?view=long&pmid=10376691.
Strong M, Johnstone PW (2007). "Interventions for treating scabies". Cochrane Database Syst Rev (3): CD000320. doi:10.1002/14651858.CD000320.pub2. PMID 17636630.
· ^ Borsboom GJ, Boatin BA, Nagelkerke NJ, et al (March 2003). "Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa". Filaria J 2 (1): 8. doi:10.1186/1475-2883-2-8. PMID 12769825. PMC: 156613. http://www.filariajournal.com/content/2/1/8.
· ^ "Scabies." 5 Dec. 2008. Laboratory Identification of Parasites of Public Health Concern. DPDx. CDC, Atlanta. 5 Feb. 2009 <http://www.dpd.cdc.gov/dpdx/HTML/Scabies.htm>.
· ^ Green, M. Epidemiology of Scabies. Epidemiological Reviews 1989; 11:126-150. 5 Feb. 2009 <http://epirev.oxfordjournals.org/cgi/reprint/11/1/126>.
· ^ Markell EK, John DT, Krotoski WA. Markell and Voge’s Medical Parasitology, 9th ed. Philadelphia: W.B. Saunders, 2006.
· ^ Markell EK, John DT, Krotoski WA. Markell and Voge's Medical Parasitology, 9th ed. Philadelphia: W.B. Saunders, 2006.
· ^ Roncalli, RA. The History of Scabies in Veterinary and Human Medicine from Biblical to Modern Times. Veterinary Parasitology 1987; 25: 193-198.
· ^ Roncalli, RA. The History of Scabies in Veterinary and Human Medicine from Biblical to Modern Times. Veterinary Parasitology 1987; 25: 193-198.
· ^ Roncalli, RA. The History of Scabies in Veterinary and Human Medicine from Biblical to Modern Times. Veterinary Parasitology 1987; 25: 193-198.
· ^ Markell EK, John DT, Krotoski WA. Markell and Voge's Medical Parasitology, 9th ed. Philadelphia: W.B. Saunders, 2006.
· ^ Chakrabarti A (1985). "Some epidemiological aspects of animal scabies in human population". Int J Zoonoses 12 (1): 39–52. PMID 4055268.
· ^ Ulmer A, Schanz S, Röcken M, Fierlbeck G (2007). "A papulovesicular rash in a farmer and his wife". Clin Infect Dis 45 (3): 395–96. doi:10.1086/519434. PMID 17599314.
^ Manjunatha NP, Jayamanne GR, Desai SP, Moss TR, Lalik J, Woodland A. Pediculosis pubis: presentation to ophthalmologist as pthriasis palpebrarum associated with corneal epithelial keratitis. Int. J. STD AIDS 2006; 17: 424-426
^ Klaus S, Shvil Y, Mumcuoglu KY. Generalized infestation of a 3 1/2-year-old girl with the pubic louse. Pediatr Dermatol. 1994; 11: 26-28.
^ Varela JA, Otero L, Espinosa E, Sánchez C, Junquera ML, Vázquez F. Phthirus pubis in a sexually transmitted diseases unit: a study of 14 years. Sex. Transm. Dis. 2003; 30: 292-296.
^ a b Lindane shampoo, USP, 1% prescribing information. Updated March 28, 2003.
^ (FDA). Lindane Post Marketing Safety Review (PDF). Posted 2003.
^ U.S. Centers for Disease Control and Prevention (CDC). Ectoparasitic infections. Sexually transmitted diseases treatment guidelines. 2006. MMWR Recomm Rep. 2006, August 10;55 (No. RR-11):79-80.
^ Blanc, H. W. (1890). "Anthrax: the disease of the Egyptian plagues". New Orleans Med Surg J 18: 1–25.
^ Jeanne Guillemin. Anthrax. The Investigation of a Deadly Outbreak
^ "Anthrax" by Jeanne Guillemin, University of California Press, 2001, ISBN 0-520-22917-7, pg. 3
^ Cherkasskiy, B. L. (1999). "A national register of historic and contemporary anthrax foci". Journal of Applied Microbiology 87 (2): 192–195. doi:10.1046/j.1365-2672.1999.00868.x.
^ David V. Cohn (1996-02-11). "Life and Times of Louis Pasteur". School of Dentistry, University of Louisville. http://louisville.edu/library/ekstrom/special/pasteur/cohn.html. Retrieved on 2008-08-13.
^ Mikesell, P.; Ivins, B. E.; Ristroph, J. D.; Vodkin, M. H.; Dreier, T. M.; Leppla, S. H. (1983), "Plasmids, Pasteur, and Anthrax" (PDF), ASM News 49: 320–322, http://www.asm.org/ASM/files/CCLIBRARYFILES/FILENAME/0000000221/490783p320.pdf
^ a b "Robert Koch (1843-1910)". About.com. http://german.about.com/library/blerf_koch.htm. Retrieved on 2008-08-13.
^ "Can Dogs Get Anthrax?" Canine Nation, 30 October 2001. Retrieved 17 February 2007.
^ Dragon, D. C. (1999). "A review of anthrax in Canada and implications for research on the disease in northern bison". Journal of Applied Microbiology 87: 208. doi:10.1046/j.1365-2672.1999.00872.x.
^ Suffin, S. C.; Carnes, W. H.; Kaufmann, A. F. (September 1978). "Inhalation anthrax in a home craftsman". Human Pathology 9 (5): 594–597. http://www.ncbi.nlm.nih.gov/pubmed/101438.
^ "Man who breathed in anthrax dies," BBC News, 2 November 2008. Retrieved 2 November 2008.
^ a b Bravata DM, Holty JE, Liu H, McDonald KM, Olshen RA, Owens DK (2006), Systematic review: a century of inhalational anthrax cases from 1900 to 2005, Annals of Internal Medicine; 144(4): 270–80.
^ "Anthrax, Then and Now". MedicineNet.com. http://www.medicinenet.com/script/main/art.asp?articlekey=18812&page=2. Retrieved on 2008-08-13.
^ a b "Anthrax Q & A: Signs and Symptoms". Emergency Preparedness and Response. Centers for Disease Control and Prevention. 2003. http://www.bt.cdc.gov/agent/anthrax/faq/signs.asp. Retrieved on 2007-04-19.
^ ANTHRAX, the investigation of a Deadly Outbreak, Jeanne Guillemin, University of California Press, 1999, ISBN 0=520-22917-7, chart of Russian deaths at Sverdlovsk, 1979, pg 27
^ "Anthrax and tea". Society for Applied Microbiology. 2008-03-17. http://www.sfam.org.uk/newsarticle.php?214&2. Retrieved on 2008-08-13.
^ ANTHRAX, the investigation of a Deadly Outbreak, Jeanne Guillemin, University of California Press, 1999, ISBN 0=520-22917-7, pg 34
^ "Sandia decon formulation, best known as an anthrax killer, takes on household mold". 2007-04-26. http://www.eurekalert.org/pub_releases/2007-04/dnl-sdf042607.php. Retrieved on 2008-08-13.
^ "Using Bleach to Destroy Anthrax and Other Microbes". Society for Applied Microbiology. http://ehso.com/bleach.htm. Retrieved on 2008-08-13.
^ The Bulletin Vol. 57 - No. 36 October 17, 2003PDF (332 KiB)[verification needed]
^ Madigan M; Martinko J (editors). (2005). Brock Biology of Microorganisms (11th ed.). Prentice Hall. ISBN 0-13-144329-1.
^ Decker, Janet. Deadly Diseases and Epidemics, Anthrax. Chelesa House Publishers, 2003. ISBN 0-7910-7302-5 p 27–28.
^ "Anthrax and Anthrax Vaccine - Epidemiology and Prevention of Vaccine-Preventable Diseases", National Immunization Program, Centers for Disease Control and Prevention, January 2006. (PPT format)
^ Bisher, Jamie, "During World War I, Terrorists Schemed to Use Anthrax in the Cause of Finnish Independence," Military History, August 2003, pp. 17-22. Anthrax Sabotage in Finland
^ [1]
^ "Saddam's germ war plot is traced back to one Oxford cow," The Times
^ "UK planned to wipe out Germany with anthrax". Sunday Herald (Glasgow). 2001-10-14. http://www.fpp.co.uk/bookchapters/WSC/Bwar2.html. Retrieved on 2008-08-13.
^ Southern African News Feature : the plague wars
^ ANTHRAX, the investigation of a Deadly Outbreak, Jeanne Guillemin, University of California Press, 1999, ISBN 0=520-22917-7, names of victims, pg 275-277
^ Guillmin, op. cit.
^ "Plague war: The 1979 anthrax leak". Frontline. PBS. http://www.pbs.org/wgbh/pages/frontline/shows/plague/sverdlovsk/. Retrieved on 2008-08-13.
^ Michael C. Fishbein. "Anthrax - From Russia with Love". Infectious Diseases: Causes, Types, Prevention, Treatment and Facts. MedicineNet.com. http://www.medicinenet.com/script/main/art.asp?articlekey=18982. Retrieved on 2008-08-13.
^ a b Alibek, K. Biohazard. New York, New York: Dell Publishing, 1999.
^ a b Meselson, M. et al (1994). "The Sverdlovsk Outbreak of 1979". Science 266(5188) 1202–1208
^ Sternbach, G. (2002). "The History of Anthrax". The Journal of Emergency Medicine 24(4) 463–467.
^ Bohn, Kevin (2008-08-06). "U.S. officials declare researcher is anthrax killer". CNN. http://www.cnn.com/2008/CRIME/08/06/anthrax.case/index.html. Retrieved on 2008-08-07.
^ "Cepheid, Northrop Grumman Enter Into Agreement for the Purchase of Anthrax Test Cartridges". Security Products. 2007-16-08. http://secprodonline.com/articles/2007/08/16/cepheid-northrop-grumman.aspx. Retrieved on 2009-26-03.
^ "Latest Facts Update". USPS. 2002-02-12. http://www.usps.com/news/facts/lfu_021202.htm. Retrieved on 2008-08-13.
^ "High school senior discovers ironing deactivates anthrax," Pittsburgh Tribune-Review, 20 February 2006
^ Nowakowski, John, et al. "Failure of Treatment with Cephalexin for Lyme Disease." Archives of Family Medicine, Vol. 9, June 2000.
^ Vinh DC, Embil JM (September 2007). "Severe skin and soft tissue infections and associated critical illness". Curr Infect Dis Rep 9 (5): 415–21. PMID 17880853.
^ Douso ML (2009). "Hyperbaric oxygen therapy as adjunctive treatment for postoperative cellulitis involving intrapelvic mesh". J Minim Invasive Gynecol 16 (2): 222–3. doi:10.1016/j.jmig.2008.12.007. PMID 19249714.
^ Escobar SJ, Slade JB, Hunt TK, Cianci P (2005). "Adjuvant hyperbaric oxygen therapy (HBO2) for treatment of necrotizing fasciitis reduces mortality and amputation rate". Undersea Hyperb Med 32 (6): 437–43. PMID 16509286. http://archive.rubicon-foundation.org/4061. Retrieved on 2009-03-07.
^ Adam EN, Southwood LL (August 2006). "Surgical and traumatic wound infections, cellulitis, and myositis in horses". Vet. Clin. North Am. Equine Pract. 22 (2): 335–61, viii. doi:10.1016/j.cveq.2006.04.003. PMID 16882479. http://journals.elsevierhealth.com/retrieve/pii/S0749-0739(06)00031-9. Retrieved on 2009-03-07.
^ Fjordbakk CT, Arroyo LG, Hewson J (February 2008). "Retrospective study of the clinical features of limb cellulitis in 63 horses". Vet. Rec. 162 (8): 233–6. PMID 18296664. http://veterinaryrecord.bvapublications.com/cgi/pmidlookup?view=long&pmid=18296664. Retrieved on 2009-03-07.
Cellulitis Overview (with picture).
King, Christine, BVSc, MACVSc, and Mansmann, Richard, VDM, PhD. "Equine Lameness." Equine Research, Inc. 1997. Pages 548-549.
MFMER. 'Cellulitis'. 3 July 2002. Mayo Foundation for Medical Education and Research. 30 Oct. 2003 [1].
NLM. 'Group A streptococcal infections'. 2002. National Library of Medicine. 30 Oct. 2003 [2].
Pankey, George A. "Approach to rashes and infections of the skin and subcutaneous tissues." Textbook of internal medicine. 2nd ed. 2 vols. Philadelphia: J. B. Lippincott Company, 1992.
· ^ erysipelas at Dorland's Medical Dictionary
· ^ See eMedicine link
· ^ Koster JB, Kullberg BJ, van der Meer JW (2007). "Recurrent erysipelas despite antibiotic prophylaxis: an analysis from case studies". The Netherlands journal of medicine 65 (3): 89–94. PMID 17387234.
· ^ Wollenweber, Brother Leo (2002) "Meet Solanus Casey", St. Anthony Messanger Press, Cincinnati, Ohio Page 107 ISBN 1-56955-281-9
· ^ Capaldi, Nicholas (2004). John Stuart Mill: a biography. Cambridge, UK: CambridgeUniversity Press. pp. 356. ISBN 0-521-62024-4.
eMedicine
Family Practice Notebook
DermNet bacterial/erythrasma
Photo at University of Iowa
-2106916858 at GPnotebook
Hamann K, Thorn P (1991). "Systemic or local treatment of erythrasma? A comparison between erythromycin tablets and Fucidin cream in general practice". Scand J Prim Health Care 9 (1): 35–9. doi:10.3109/02813439109026579. PMID 2041927.
^ MedlinePlus Encyclopedia Hot tub folliculitis
^ Impetigo - school sores - Better Health Channel
^ a b Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; & Mitchell, Richard N. (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier. pp. 843 ISBN 978-1-4160-2973-1
^ Stulberg DL, Penrod MA, Blatny RA (2002). "Common bacterial skin infections. In Japanese, this is known as Tobihi.". American family physician 66 (1): 119–24. PMID 12126026. http://www.aafp.org/afp/20020701/119.html.
^ http://www.bmj.com/cgi/content/full/329/7472/979
^ boil at Dorland's Medical Dictionary
^ exfoliatin at Dorland's Medical Dictionary
· ^ a b c d "HS-USA :: What is Hidradenitis Suppurativa?". http://www.hs-usa.org/hidradenitis_suppurativa.htm. Retrieved on 2007-07-08.
· ^ Gao M, Wang PG, Cui Y, et al (2006). "Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3". J. Invest. Dermatol. 126 (6): 1302–6. doi:10.1038/sj.jid.5700272. PMID 16543891. http://www.nature.com/jid/journal/v126/n6/abs/5700272a.html.
· ^ "HS-USA :: Prevalence of Hidradenitis Suppurativa". http://hs-usa.org/pub/articles/prevalence.htm. Retrieved on 2007-07-08.
· ^ Scheinfeld N (2006). "Hidradenitis should not be renamed acne inversa". Dermatol. Online J. 12 (7): 6. PMID 17459292.
· ^ Verneuil AS: Etudes sur les tumor de la peau. Arch Gen Med 1854; 94: 693.
· ^ a b DermNet acne/hidradenitis-suppurativa
· ^ ClinicalTrials.gov NCT00329823 Etanercept in Hidradenitis Suppurativa
· ^ "HSF - What is Hidradenitis Suppurativa? What is HS?". http://www.hs-foundation.org/abouths/what.htm. Retrieved on 2007-07-08.
· ^ Talmant JC, Bruant-Rodier C, Nunziata AC, Rodier JF, Wilk A (2006). "[Squamous cell carcinoma arising in Verneuil's disease: two cases and literature review]" (in French). Ann Chir Plast Esthet 51 (1): 82–6. doi:10.1016/j.anplas.2005.11.002. PMID 16488526.
· ^ Short KA, Kalu G, Mortimer PS, Higgins EM (2005). "Vulval squamous cell carcinoma arising in chronic hidradenitis suppurativa". Clin. Exp. Dermatol. 30 (5): 481–3. doi:10.1111/j.1365-2230.2005.01875.x. PMID 16045671. http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2230.2005.01875.x.
· ^ "abscesses.org - About Hidradenitis Suppurativa". http://abscesses.org/hidradenitisSuppurativa/content/view/22/33/. Retrieved on 2007-07-08.
· ^ Cusack C, Buckley C (2006). "Etanercept: effective in the management of hidradenitis suppurativa". Br. J. Dermatol. 154 (4): 726–9. doi:10.1111/j.1365-2133.2005.07067.x. PMID 16536817.
· ^ Scheinfeld N (2006). "Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab". J. Am. Acad. Dermatol. 55 (1): 163–4. doi:10.1016/j.jaad.2006.01.024. PMID 16781316.
^ a b c d Fleas, HYG-2081-97 William F. Lyon, Ohio State University entomology page. Accessed 28 December 2006
^ a b Fleas - P.G. Koehler and F. M. Oi. Printed July 1993, revised February 2003. Provided by the University of Florida
^ Order Siphonaptera - Fleas - BugGuide.Net Accessed 28 December 2006
^ [1]
^ Piper, Ross (2007), Extraordinary Animals: An Encyclopedia of Curious and Unusual Animals, Greenwood Press.
^ a b Grimaldi, D. and Engel, M.S. (2005). Evolution of the Insects. Cambridge University Press. ISBN 0-521-82149-5.
^ Natural Flea Control, 1987, Mother Earth News, Retrieved 2007-12-18
^ Warnings About Essential Oils[2]
^ Fleas
^ Fleas: Integrated pest management in and around the home. [3].
· ^ "Adult Health Advisor 2005.4: Bacteria in Urine, No Symptoms (Asymptomatic Bacteriuria)". http://www.med.umich.edu/1libr/aha/aha_asybac_crs.htm. Retrieved on 2007-08-25.
· ^ "Urinary Tract Infections". http://www.braithwaite.yourmd.com/ypol/user/userMain.asp?siteid=1713982&content=userCustomPage&bcx=My%20Doctor^TAB~Web%20Site^MNU~Dr%20S.%20Braithwaite^PST^1713982~UTI^CAT^9&pageid=336989&rndm=0.2728092846502904. Retrieved on 2007-08-25.
· ^ askdrsears.com
· ^ Urethra length is approximately 25–50 mm / 1-2 inches long in females, versus about 20 cm / 8 inches in males.
· ^ "Honeymoon Cystitis". http://healthlink.mcw.edu/article/998784819.html. Retrieved on 2007-11-02.
· ^ "BestBets: Cranberry Juice for the treatment of UTIs". http://www.bestbets.org/bets/bet.php?id=1324.
· ^ Urinary Tract Infection - Alternative medicine. Accessed October 4, 2008.
· ^ Urinary Tract Infection - eMedicine Health. Accessed December 26, 2008.
· ^ http://www.merck.com/mmhe/sec17/ch190/ch190w.html
· ^ "BestBets: Is a short course of antibiotics better than a long course in the treatment of UTI in children". http://www.bestbets.org/bets/bet.php?id=939.
· ^ Justice S, Hunstad D, Seed P, Hultgren S (2006). "Filamentation by Escherichia coli subverts innate defenses during urinary tract infection". Proc Natl Acad Sci USA 103 (52): 19884–9. doi:10.1073/pnas.0606329104. PMID 17172451.
· ^ http://www.gagazine.com/why-do-girls-get-urinary-tract-infection-more-often-than-boys/
· ^ Meyhoff H, Nordling J, Gammelgaard P, Vejlsgaard R (1981). "Does antibacterial ointment applied to urethral meatus in women prevent recurrent cystitis?". Scand J Urol Nephrol 15 (2): 81–3. PMID 7036332.
· ^ RG Jepson, JC Craig (2008). "Cranberries for preventing urinary tract infections.". Cochrane Database Syst Rev: CD001321. PMID 14973968.
· ^ Raz R, Stamm W (1993). "A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.". N Engl J Med 329 (11): 753–6. doi:10.1056/NEJM199309093291102. PMID 8350884.
· ^ Aune A, Alraek T, Huo L, Baerheim A (1998). "[Can acupuncture prevent cystitis in women?]". Tidsskr nor Laegeforen 118 (9): 1370–2. PMID 9599500. (cf acupuncture group, x2 incidents in the sham group, x3 in the control group)
· ^ Alraek T, Baerheim A (2001). "'An empty and happy feeling in the bladder.. .': health changes experienced by women after acupuncture for recurrent cystitis". Complement Ther Med 9 (4): 219–23. doi:10.1054/ctim.2001.0482. PMID 12184349.
· ^ Alraek T, Baerheim A (2003). "The effect of prophylactic acupuncture treatment in women with recurrent cystitis: kidney patients fare better". J Altern Complement Med 9 (5): 651–8. doi:10.1089/107555303322524508. PMID 14629843. (highlights need for considering different TCM diagnostic categories in acupuncture research)
· ^ Alraek T, Soedal L, Fagerheim S, Digranes A, Baerheim A (2002). "Acupuncture treatment in the prevention of uncomplicated recurrent lower urinary tract infections in adult women.". Am J Public Health 92 (10): 1609–11. doi:10.2105/AJPH.92.10.1609. PMID 12356607.
· ^ KatzAR (2003). "Urinary tract infections and acupuncture". Am J Public Health 93 (5): 702; author reply 702–3. doi:10.2105/AJPH.93.5.702. PMID 12721123.
· ^ Hanson, LÅ (2004). "Protective effects of breastfeeding against urinary tract infection". Acta Pædiatr (93): 154–156. ISSN 0803-5253. http://www.cirp.org/library/disease/UTI/hanson1/. Retrieved on 2008-08-10.